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Due to its unique capacity to regenerate continously, the olfactory neuroepithelium serves as an 
excellent model system for investigating the molecular and cellular mechanisms involved in 
neurogenesis. The OP27 cell line (generated by infecting embryonic mouse olfactory placodes with a 
retrovirus carrying the temperature-sensitive alleles of the SV 40 large T antigen) was used as an in 
vitro system to test the effects of fibroblast growth factor-2 (FGF-2) in directing olfactory 
neurogeneslS. The OP27 cells proliferate under the control of the retrovirus at the permissive 
temperature (33°C). When shifted to the non-permissive temperature (39°C) the SV40 large T antigen 
is inactivated and the cells stop dividing, thereby allowing one to study the effects of growth factors on 
these cells. Although FGF-2 also plays an important role in regulating the proliferation of neural 
progenitors, the main focus in this study was its effect on neuronal differentiation 
When shifted to 39°C in the presence ofFGF-2, OP27 cells proceed through one round of cell division 
and then give rise to a subpopulation of differentiating cells. These cells have a bipolar morphology, 
characteristic of olfactory receptor neurons (ORNs) and their number increases with time. A 
combination of RT -PCR assays, western blots and immunocytochemistry showed that these cells 
express various markers which are characteristic of their differentiation into ORN-like cells. These 
include GAP-43 and NCAM which are up-regulated, neurotrophin receptors and components of the 
olfactory chemosensory signalling system. 
Although each ORN is hypothesized to select only one of the possible 1000 olfactory receptor (OR) 
genes for expression, a series of RT -PCR and restriction enzyme digest assays revealed that 
differentiating OP27 cells are not committed to express a single OR gene. Instead, a small OR gene 











0P27 cells are induced to differentiate, new OR genes are selected for expression Furthermore, the 
OR genes identified in differentiating OP27 cells are localized on different chromosomes. 
In addition to analysing the expression of marker and OR genes, the possible role of FGF-2 in 
regulating the expression of the proneural basic helix-loop-helix transcription (bHLH) factors Mash-I, 
Ngn-I and NeuroD was investigated in 0P27 cells. These proteins are sequentially expressed during 
mouse olfactory placode development, with Mash-I appearing fIrst in apical and basal progenitor cells, 
Ngn-I transiently expressed in mitotically active basal cells and NeuroD in the last cell division and at 
the beginning of differentiation of the postmitotic neurons. The Notch signalling cascade, on the other 
hand, inhibits neuronal differentiation through the activation of Hes-l and Hes-5, both bHLH genes 
that repress expression of Mash-l and Ngn-l. At 33°C the OP27 cells express high mRNA levels of 
the Natch-I receptor and low levels of Delta-I (its ligand), Hes-I and Ngn-l. Both Mash-I and 
NeuraD mRNAs are not detected at 33°C. When shifted to 39°C and treated with FGF-2, OP27 cells 
up-regulate transcript levels of Hes-I and Delta-I. Hes-I is up-regulated before changes in 
morphology are noticed. This suggests that neuronal differentiation is delayed through the activation 
of Hes-I. On the other hand, Delta-I is up-regulated later and this is concomittant with the change in 
morphology of a subpopulation of OP27 cells. Ngn-l is expressed in differentiating OP27 cells for a 
limited period of time only, after which it disappears. NeuraD, which is expressed downstream of 
Ngn-I in the olfactory neuronal lineage in vivo, was transiently expressed in OP27 cells, downstream 
and overlapping both Ngn-I and Delta-I expression. These results indicate that FGF-2 interacts with 
the Notch signalling cascade in controlling neuronal differentiation in the olfactory neuroepithelium. 
Having examined the expression profIles of genes known to be associated with neuronal differentiation, 











in FGF-2 induced OP27 cells. Identification of these genes would allow for better understanding of the 
regulatory mechanisms involved in neuronal differentiation. This search resulted in the identification 
of 16 FGF-2 regulated gene transcripts, 15 of which were elevated and one that was transiently down-
regulated. Among those characterized are genes that have been previously identified and implicated in 
neurogenesis but shown for the frrst time in this thesis to respond to FGF-2. A second group of 
transcripts identified in this study includes previously named genes whose functions are unknown. A 
third group represents novel genes that have not been identified previously. Bioinformatic analysis of 
genes in the latter group reveales protein motifs known to be necessary for functions. For example, one 
gene contains a scaffold attachment factor box that binds to genomic scarffold attachment regions to 
organize chromatin and regulate gene expression A second novel gene with a high homology to 
GeN5-related N-acetyl transferases was predicted to contain a nuclear localization signal that may 
target the protein product of this gene to the nucleus to N-acetylate nuclear proteins. It is hoped that 
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Neurogenesis, the generation of distinct classes of neurons in the germinal neuroepithelium (the 
ventricular zone) of the vertebrate neural tube occurs through a series of well co-ordinated and 
regulated steps. Self-renewing neural stem cells give rise to lineage restricted committed neuronal 
progenitors which in turn proliferate, migrate and exit the cell cycle to differentiate into neurons. A 
number of signalling molecules, both extrinsic (e.g the fibroblast growth factors, bone morphogenetic 
proteins, etc) and intrinsic (e.g basic helix-loop-helix transcription factors) have been shown to 
possibly interact to regulate these events (Edlund and JesseL 1999). Several fmdings have implicated 
fibroblast growth factor-2 (FGF-2) as one of the key signalling molecules that regulate neurogenesis by 
controlling proliferation, lineage commitment, differentiation and survival of these progenitors. I will 
review current literature on the effects of FGF-2 on these neural developmental processes. Another 
signalling pathway that has been shown to be involved in the decision of whether the cell remains in 
the proliferative mode, or whether it progresses along the differentiation pathway to a different fate (e.g 
neurons or glia) is that activated by the cell-membrane anchored Notch. Notch influences the fate of 
the progenitor cells by regulating the expression of the basic helix-loop-helix (bHLH) transcription 
factors which are expressed transiently and sequentially by neuronal progenitor cells and their progeny 











1.1 CELLULAR STAGES OF NEUROGENESIS 
Knowledge of sequence of events involved in neurogenesis has been derived mainly from studies using 
the developing cerebral cortex as a model system, and these events seem to be well conserved in other 
parts of the central nervous system. The cerebral cortex is derived from the dorsal telencephalic 
neuroepithelium, which is also known as the pseudo stratified ventricular epithelium (PVE) or the 
ventricular zone (VZ) (Vaccarino et al., 1999). The PVENZ contains actively proliferating 
multipotent progenitor cells that give rise to the cortical neurons and glia. Cortical neurons are 
generated through a highly regulated series of events which are characterized by neuroblast 
proliferation, fate determination, migration and terminal differentiation. Before neurogenesis begins, 
the progenitor cells go through a number of symmetrical divisions to expand the progenitor pool as 
both daughter cells re-enter the cell cycle. When neurogenesis begins at E13 in the rat cortex, the VZ 
is characterized by assymetrical divisions of some of the progenitor cells. During this stage, some of 
the daughter cells re-enter the cell cycle whereas others become post-mitotic and start migrating away 
from the VZ along radial glial fibers through the intermediate zone and into the cortical plate where 
they will differentiate and form the six layers of the cortex (Fig 1.1). This period of neurogenesis 
continues through to E19 and is followed by generation of glial cells. Glial progenitor cells are also 
generated in the VZ and these migrate to the subventricular zone (SVZ) where they continue to 
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Figure 1.1 Model of the development of the embryonic cerebral cortex. The successive stages of the cell cycle are shown 
in the VZ and via asymmetric division one daughter cell (shown in red) re-enters the cell cycle while the other (in green) 
leaves the cell cycle and migrates out of the VZ along the radial glia into the cortical plate where it will differentiate. VZ, 
ventricular zone; SVZ, sub ventricular zone; IZ, intermediate zone; I-VI; six layers of the cerebral cortex. 
The fate of the multipotent cortical progenitor cells has been studied by using lineage tracing in which 
cells are marked with either retroviruses which express ~-galactosidase or dye injection and their 
developmental potentials monitored by examining the number, morphology and fate of daughter cells . 
Multipotential neural stem cells give rise to the progenitor cells which are capable of dividing a limited 












oligodendrocytes and astrocytes (glial precursor ceUs) but not both (Figure 1.2). The neuronal 
precursor cells frequently undergo one or more rounds of cell divisions before differentiating into 
neuronal cells. 
c; 
• stem cell 
C; ./ neuroblast 
/' (neuronal precursor cell) 
. " progenitor ~ 
cell C; 
o -< 
C; Dividing ceUs 
Glioblast 
(glial precursor cell) 
o astrocyte 
o oligodendrocyte 
Figure 1.2 The sequential differentiation of the different neural cell types from neural stem cells. One stem cell which is 
capable of self-renewaI gives rise to progenitor cells that have limited self-renewal. These then generate the neural 
precursors, neuroblasts and glioblasts that Ultimately give rise to the postmitotic neurons and glia (astrocytes and 
oligodendrocytes), respectively. 
1.2. FGF-2 AS AN EXTRINSIC REGULATOR OF NEURAL DEVELOPMENT 
1.2.1 FGF-2: PROTEIN STRUCTURE 
FGF-2 is a member of the large heparin-binding FGF family of signalling proteins involved in many 
biological processes during development. The family currently has 22 members (Ford-Perris et al., 
2001) that have been identified by oncogene assays, expression cloning, or low-stringency 












conserved 120 amino acid core region with 30-60% amino acid homology. They have been implicated 
in the developmental processes such as induction, patterning, mitosis and differentiation, survival and 
migration of a variety of cell types (Ornitz and Itoh, 2001, Ford-Perris et aI., 2001). 
FGF-2 is synthesized as five different forms of the protein from a single mRNA species. These forms 
differ in their amino terminus as a result of multiple translational initiation sites (Arnaud et aI., 1999). 
An ATG codon, found in a proper context to start translation, initiates the translation of a 155 amino 
acid protein (molecular weight, MW 18 kDa) while various in-frame CTG codons (coding for Leu) 
upstream of the ATG, initiate translation of proteins with 22, 22.5, 24 and 34 kDa. The higher MW 
FGF-2 proteins have a nuclear localization signal (NLS) that directs them to the nucleus, while the 
smaller 18KDa isoform lacks a NLS, and is localized in the cytosol. 
1.2.2 FGF-2 EXPRESSION PATTERNS IN THE DEVELOPING BRAIN 
FGF-2 is generally expressed throughout the developing nervous system into adulthood in both 
neuronal and non-neuronal cells. Expression studies in embryos show the mRNA is present in the rat 
telencephalon as early as E9.5 and around ElO.5 in the mouse neural tube (Kalyani et al., 1999). FGF-
2 protein levels peak during the earliest stages ofneurogenesis in the mouse VZ which gives rise to the 
cerebral cortex but gets down-regulated during mid-neurogenesis and disappears when this process is 
complete (Vaccarino et aI., 1999; Raballo et al. 2000). Levels of the FGF-2 protein are highest in the 
anterior brain regions, particularly the ventricular (VZ) and the subventricular zones (SVZ) (regions 
where neural progenitors are generated) compared to the caudal regions including the spinal cord 












1.2.3 MECHANISM OF ACTION OF FGF-2: THE FGF RECEPTORS 
Two classes of FGF receptors have been identified: the low-affinity and the high-affinity receptors. 
1.2.3.1 Heparan sulphate proteoglycans (HSPGs) 
Heparin sulphate proteoglycans (HSPGs) which are present on cell surface and in the extracellular 
matrix carry carbohydrate side chains. They form low-affinity, high capacity binding sites for FGFs. 
The essential role of HSPGs in FGF binding has been demonstrated by a number of experiments 
(Yayon et al., 1991; Bernard et al., 1991). It was found that FGFR-l could not bind FGF in cells that 
were not capable of producing heparan sulfates and could only do so once heparin was present (Yayon 
et aI., 1991), thus suggesting that an interaction with the low-affmity receptor was a pre-requisite in 
activating the high-affinity receptors. FGF-l and FGF-2 could only support proliferation of cells 
transfected with FGFR-l once heparin was present in the culture medium (Bernard et al., 1991). Both 
biochemical and X-Ray crystallography data have suggested that HSPGs interact with both FGF 
ligands and FGFRs to form active ternary signalling complexes. Different models have been proposed 
for this interaction It is possible that heparin and other heparan sulphates possibly modify the structure 
of the FGF ligand so it can be able to bind and activate the high affmity- receptor (Yayon et aI., 1991). 
HSPGs have been shown to play important roles in regulating the biological activity ofFGF ligands in 
a variety of cellular processes. They enhance the neurite outgrowth ofPC12 cells mediated by FGF-l 
and FGF-2 (Damon et aI., 1988). FGF-2 induced proliferation of neural precursor cells isolated from 













HSPGs regulate these events in a ligand and FGFR specific manner. In the immortalized EIO mouse 
neuroepithelium 2.3D cell line different HSPG forms were found to enhance the activity of FGF-2 in 
their proliferation whereas the neuronal differentiation of these cells was potentiated by activating 
FGF-l (Nurcombe et al., 1993). In these cells, HSPGs were shown to preferentially bind FGFR-l 
instead ofFGFR-3 in potentiating the mitotic effects ofFGF-2 (Brickman et al., 1995). Lastly, HSPGs 
also regulate FGF actions in a developmental stage-specific manner. It is however not clear what 
effects this have on the function on the HSPGs (Allen and Rapraeger, 2003). 
1.2.3.2 FGF tyrosine kinase receptors 
Fibroblast growth factor receptors (FGFR-) represent the high-afImity, low capacity binding sites for 
FGF ligands. They are responsible for intracellular signal transduction and for mediating biological 
response of the cells to the FGFs. There are currently 4 FGF receptor genes that have been cloned and 
a number of variants exist as a result of alternative splicing. The 4 receptors differ in structure, ligand 
binding properties, and their patterns of expression. 
1.2.3.2.1 Structure and diversity ofFGFR-s 
All FGFR·s share a common primary structure (Figure 1.3). They contain a ~20 amino acid terminal 
hydrophobic signal peptide; either 2 or 3 extracellular immunoglobulin (Ig)- like domains (I-III); a 
string of acidic amino acid residues between the first two Ig domains (known as the acid box), a 
hydrophobic transmembrane (TM) domain, the juxtamembrane (1M) domain between the TM and the 
catalytic tyrosine kinase (TK) domain which is split by 14 amino acid residues. The highest degree of 












significantly less similarity (19-40%) (Johnson and Williams, 1993). The IgIll do man is essential for 
high-affinity binding ofFGF ligands. 
Alternative mRNA splicing of the two exons that code for the C-terminal half of IgIll domain of 
FGFR-s 1 to 3 gives rise to distinct functional receptor variants, FGFR-l IDb; FGFR-I IDc; FGFR-2 
ITIb; FGFR-2 IDc, FGFR-3 IIIb; and FGFR-3 IITc resulting in differences in ligand binding affinities 
(see Table 1.1). FGFR-4 has never been shown to have alternative splicing in this region Additional 
isoforrns of FGFR-l and FGFR-2 exist as a result of alternative splicing ofIgI. FGFR-I a. and FGFR-
2a. isoforrns contain all 3 Ig loops; FGFR-I J3 and FGFR-2J3 are missing IgI and FGFR-I y lacks IgI and 
instead has a 144 bp insert in that region. FGFR-2J32 isoforms are identical to FGFR2-J31 except that 
they lack the acid box as well (Bansal et al., 1996). Since the IgI is not essential for ligand binding, the 




Figure 1.3 Schematic representation of FGFR-l-4. SP, signal peptide; IgI, IgII, IgIlJ, Ig-like domains; A, acid box; TM, 
transmembrane domain; 1M, juxtamembrane; TK 1 and TK2, tyrosine kinase domains. 
The interaction between the ligands and their receptors has been studied in vitro using a mitogenic cell 
assay in which the BaF3 cell line was engineered to express the different splicing variants (Ornitz et 
aI., 1996, Xu et al., 2000). This assay has shown that the seven receptor isoforms have distinct and 












1.2.4 Expression patterns of FGF receptors in the brain 
Differential, tissue-specific expression of the different FGFR-s has been studied using either RT-PCR, 
northern blot, RNase protection assays or in situ hybridizations. All the receptors with the exception of 
FGFR-4 have been detected in CNS neural cells. These cells were found to predominantly express the 
me isoforms of FGFR-l, FGFR-2, and FGFR-3 as early as EI0.5 (Bansal et al., 1996; Qian et aI., 
1997; Hajihosseini and Dickson, 1999). FGFR-l and FGFR-2 are expressed by both neuronal and glial 
precursor cells while the FGFR-3 is mainly expressed in glial cells (Bansal et al., 1996; Kalyani et al., 
1999). In the developing cerebral cortex, mRNA transcripts for both FGFR-I me and FGFR-2 me 
were found in both the VZ and SVZ regions whereas mainly the FGFR-2 me was still present in the 
cortex which contains differentiated neuronal cells (Dono et al., 1998). 
Table 1.1 The relative specificity ofFGFR- and FGF ligand interactions. 
FGF RECEPTORS 
FGFR-l FGFR-2 FGFR-3 FGFR-4 
lib me lib me lib me 
FGF-l +++ +++ +++ +++ +++ +++ +++ 
FGF-2 ++ +++ ++ +++ +++ 
FGF-3 + ++ 
FGF-4 + +++ + +++ ++ +++ 
FGF-5 ++ + + 
FGF-6 ++ ++ +++ 
FGF-7 +++ 
FGF-8 + ++ ++ 
FGF-9 + +++ ++ +++ +++ 
FGF-I0 +++ 
FGF-17 ++ +++ +++ 
FGF-18 + +++ 
The interaction between FGFR- and the FGF ligands has been detennined in a mitogenic assay using BaF3 cells expressing 
the various FGFR- isofonDS. FGF-l was found to maximally activate all the FGFR- isoforms. Mitogenic activities of the 
other FGF ligands were expressed relative (%) to that ofFGF-I. +t+,75-10001o; 40-75%; +,10-40%; -, <10%. +++ and 
++ represent potential interactions between the receptor and ligand. The interactions between the receptors and FGFs 11-16, 













1.2.5 FGF Receptor activation and intraceUular signalling cascades 
Activation of FGF receptors by their ligands is known to induce receptor dimerization and stimulation 
of tyrosine kinase activity. Both homodimers between receptors of the same type and/or heterodimers 
between different types, can be formed (Bellot et al., 1991). Once activated the receptor kinases 
phosphorylate each other on their cytoplasmic C-terminal tails and initiate dowstream signalling 
pathways. The key components of these intracellular signalling pathways that have been shown to be 
activated by FGF signalling include the RaslRaf7mitogen activated protein kinase (MAPK) pathway; 
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Figure lA FGF-mediated signal transduction pathways. Binding ofFGF to FGFR is followed by FGFR- dimerization and 
1he activation of their intracellular protein tyrosine kinase domains (.). This results in FGFR autophosphorylation and the 
initiation of bo1h cytoplasmic and nuclear signalling cascades. Each pa1hway will eventually result in specific effeets, e.g 
gene transcription that may cause ei1her 1he cell to proliferate, differentiate and/or survive. The caseades that are mediated 
by FGF include the Ras/MAPK, PLOy, Src, and PBK pathways. Components of these cascades transloeate to 1he nucleus 
to activate transeription factors. 
The FGFRs are linked to the signalling cascades via interactions with various scarff old and adapter 
proteins. For example, the scaffold protein FRS2 has been shown to link FGFR-l activation to the 
RasIMAPK signalling pathway (Kouhara et al., 1997). FRS2 interacts with the juxtamembrane domain 
ofFGFR-l, becomes phosphorylated and consequently binds the adapter protein Grb2 which recruits 
Sos, a guanine nucleotide exchange factor that activates the G protein Ras. Activated Ras directly 
interacts and activates Raf which in turn phosphorylates and activates MEK. The MAP kinase 
(MAPK) ERK (extracellular signal regulated kinase) is the target for phosphorylation and activation by 
MEK. ERK gets translocated to the nucleus and activates transcription factors like Elk-l and cAMP 
response element binding protein CREB (Chung eta!., 1998; Yang etal., 2004)(Fig. 1.4). 
PLC-y becomes activated by directly interacting with a phosphorylated tyrosine residue at the C-
terminus of FGFR-l. When activated, PLC-y generates inositol-l,4,5-triphosphate (IP3) and 
diacylglycerol (DAG) by hydrolysing phosphatidylinositol (PIP2). IP3 induces Ca2+ release from 
intracellular stores whereas DAG activates protein kinase C (PKC). PKC8 has been shown to mediate 
MAPK activation by phosphorylating MEK upon FGF-2 stimulation (Corbit et al., 1999) (Fig. 1.4). 
The Src pathway has not been completely characterized. It is not clear what proteins, if any, act 
upstream ofSrc following FGFRI activation (Powers et al., 2000). However, Bruton's tyrosine kinase 












phosphorylates and activates the transcription factor CREB to induce neuronal differentiation (Yang et 
a!., 2004) (Fig. 1.4). 
The PI3K pathway is, like the MAPK cascade, linked to FGFR activation via the protein FRS2. PI3K 
is recruited to FGFR via the interaction of the adapter protein Gabl with the Grb2-FRS2 complex 
(Hadari et al., 2001). Activation of this pathway has been implicated in the regulation of cell 
proliferation, neuronal differentiation and cell survival The sequential activation of BTK and CREB 
downstream of PI3K has been shown to be required to induce neuronal differentiation (Yang et al., 
2004). On the other hand, the serine-threonine kinase Akt has been shown to act downstream of PI3K 
to promote cell survival by suppressing the apoptotic function of components of intrinsic cell death 
machinery in different cell types, including cerebellar granule cells and immortalized hippocampal 
cells (Brunet et aI., 1999; Eves et al., 1998) 
FGF-2 has been shown to have multiple effects on neural cells, ranging from stimulation of cell 
proliferation to the regulation of differentiation and cell survival. 
1.2.6 EFFECfS OF FGF-2 ON NEURAL PROGENITORS 
Effects of FGF-2 on neural cells have been demonstrated both in vitro using primary cell cultures and 
cell lines and in vivo with Fgf2 knock-out mutant mice and the micro-injection of either recombinant 












1. 2. 6.1 In vitro tqffects of FGF-2 on primary cell cultures from different regions of the brain 
Using primary tissue culture assays it has been shown that FGF-2 was mitogenic for progenitor cells 
from various regions of the developing nervous system. When ElO telencephalic and mesencephalic 
neuroepithelial cells were stimulated with low concentrations of FGF-2 «O.5ng/rnl) in vitro, about 
50% of the cells incorporated [3H]-thymidine compared to 3% in control cultures. It was also shown 
that at higher FGF-2 concentrations (>O.Sng/ml), the cells differentiated to neuronal cells first and glial 
cells appearing later (Murphy et al. 1990). Similarly, FGF2 increased proliferation of multi potential 
progenitors from the embryonic mouse cerebrum, ultimately giving rise to both neurons and glia 
(Kilpatrick and Bartlett, 1995). These results suggested that FGF-2 was not only important for 
proliferation of these cells but may be important for influencing their differentiation as well. 
Three groups studying the neuronal development in the cortex and hippocampus have reported 
opposing effects of FGF-2 and neurotrophin 3 (NT-3), a neurotrophin, on neural progenitor cells 
(Ghosh and Greenberg, 1995; Vicario-Abej6n et al., 1995; Lukaszewicz et al., 2002). It was found that 
FGF-2 increased proliferation of E 16 hippocampal progenitors and maintained the expression of the 
intermediate filament nest in in these cells. In contrast, NT-3 induced neuronal differentiation of the 
progenitor cells. FGF-2 was also able to induce neuronal differentiation but when added together with 
NT-3 to cultured cells ,the effect was not additive suggesting that the same progenitor population was 
responding to both. It was therefore concluded that in these cultures there were two populations of 
cells, one responding to FGF2 by proliferating and the other by differentiating to neuronal cells 












Similarly, the study conducted by Ghosh and Greenberg (1995) showed that FGF-2 increased the 
number of cortical progenitor cells that incorporated BrdU thus expanding the precursor population It 
would seem that cell-cell contacts are required in these cultures for FGF-2 to be able to promote 
proliferation Only cells in clusters and not dissociated single cells were induced to divide by the 
administration of FGF-2. Over time the proliferating cells withdrew from the cell-cycle and 
differentiated into neurons fIrst and glia later on. NT -3 on the other hand was shown to regulate 
neuronal differentiation only. 
Lukaszewicz et al. (2002) examined in vitro the influence of both FGF-2 and NT-3 on cell-cycle 
parameters using mouse cortical precursor cells. FGF-2 increased expression levels of positive cell-
cycle regulators while NT -3 reduced their expression and instead up-regulated expression of negative 
regulators with the resultant withdrawal from the cell-cycle. A second fInding from this study was that 
FGF-2 shortened the cell-cycle by ~20-3()o1o with respect to control cultures, thus increasing the speed 
of proliferation in progenitors. This is in agreement with another in vitro study where FGF-2 was 
shown to reduce the population doubling time of a cell line derived from multipotent human 
neuroectodermal precursors (Derrington et al., 1998). 
Lastly, Qian and co-workers have shown in vitro that FGF-2 influences the differentiation of primary 
cultures of cortical progenitor cells into neuronal or glial lineages in a dose-dependent manner. Low 
concentrations were required for neuronal differentiation while oligondendrocytes were induced by 












1.2.6.2 In vivo studies oJthe effects oJFGF-2 on cerebral cortex 
The effects of FGF-2 on neuronal development in vivo have been studied by several groups and their 
findings are summarized in Table 1.2. Fgf-2 knock-out mice are viable, have normal organogenesis but 
display defects in the cerebral cortex (Ortega et al., 1998; Dono et al., 1998; Vaccarino et al., 1999; 
Raballo et aI., 2000; Korada et aI., 2002). 
These studies have shown that the absence of the gene causes defects in the developing cortex and not 
the basal ganglia which are derived from the ventral telencephalon (Ortega et al., 1998; Korada et al., 
2002). Mutant mice were characterized by significant reduction of proliferating progenitor cells in the 
dorsal VZ , which will give rise to the cerebral cortex (Vaccarino et aI., 1999; Raballo et al., 2000). 
This leads to decreased neurogenesis of the glutamatergic pyramidal neurons in the anterior regions of 
the cortex (Korada et al., 2002). The number of neurons within the developing basal ganglia or 
hippocampus were not affected by the missing Fgf-2. This suggests that the absence of Fgf-2 was 
either compensated for by other signalling molecule or it was not critical for the developing basal 
telencephalon (Raballo et al., 2000; Korada et al., 2002). However, Tao and co-workers have shown 
that injecting recombinant FGF-2 in vivo led to a 50010 increase in [3H] thymidine incorporation in 
granule cell precursors in the hippocampus and this could be negated by injecting with FGF-2 
neutralising antibodies (Tao et al., 1997). 
In agreement with the Fgf-2 knock-out studies, injection of recombinant FGF-2 into lateral ventricles 
of adult rat caused expansion of the SVZ by increasing the number of progenitors that incorporated 
BrdU. This had a stimulatory effect on the generation of olfactory bulb neurons (Kuhn et al., 1997). 












increased number of neural progenitor cells and a subsequent mcrease m neurons during cortical 
development. 
Table 1.2 A summary of the effects ofFGF-2 on neuronal development in vivo. 
Reference Type of 
experiment 
Donoetal.,1998 Fgf-2knock-out 
Korada et al., Fgf-2 knock-out 
2002 
Kuhn et al., 1997 fufusion of recombinant 
FGF -2 into lateral 
ventricless of adult rat 
Ortega et al., }?gf-2 knock-out 
1998 
Raballo et al., Fgf-2 knock-out 
2000 
Tao et al., 1997 Peripheral injection of 
recombinant FGF-2 
Wagner et aI., fujection ofFGF-2 
1999 neutralizing antibody 
Vacearino et al., Micro-injection of 
1999a recombinantFGF-2 at 
El5.5 




















Proliferation of neuronal progenitors normal 
Fraction of neuronal progenitors fail to reach target in cerebral 
cortex 
Thickness of cerebral cortex reduced by 10% 
Compressed differentiating cortical layers 
Very few differentiated large pyramidal neurons 
Reduced paravalburnin-positive neurons in adult cortical layers 
Ectopic paravalbumin-positive neurons in hippocampus 
Reduced neuron number in spinal-cord 
40% reduction in cortical glutamatergic pyramidal neurons 
Decreased number and size of neuronal population in anterior 
cortex layers 
Cortical cell migration and aggregation into specific layers not 
affected 
No significant difference in hippocampal pyramidal and 
granule cell layers 
Expansion of the SVZ and increase in the number of 
Brdlf progenitor cells 
Stimulatory effect on generation ofOB neurons 
Proliferation and differentiation of hippocampus progenitors 
not affected 
Number of glia cells not altered 
Reduction in neuronal density in most layers of motor-cortex 
No neuronal defects in striatum and hippocampus 
60% decrease in the total number ofBrdlf cells in dorsal PVE 
50% reduction in neuronal number in the cortical plate. 
Development of basal telencephalon not affected 
50% incrcase in [~ thymidine incorporation in granule cell 
precursors 
53% reduction in cerebellar granule precursor mitosis 
60% reduction in DNA synthesis 
fucrease in cortical volume and total cell volume 
70% increase in cortical plate neurons 
No significant increase in glial cell numbers 
Significant increase in glial cells when injected at E20.5 
Total number of neurons not affected 
Total cell population in adult ./. mice half that in wild-type 
Mutant mice showed reduced BrdU labeling at EIl.S 
No change in length of cell cycle 












In their study also using Fgf-2 mutant mice, Dono et al. (1998) showed that FGF-2 is essential for 
migration and differentiation of specific neocortical neurons (Table 1.2). A fraction of progenitor cells 
failed to reach their targets in the cerebral cortex and very few differentiated large pyramidal neurons 
were observed. In contrast to other knock-out studies, this group found that proliferation was not 
affected in these mutants since there was no difference in [3H]thymidine incorporation when compared 
with the wild type animals. In addition to the effects observed in cortex, there was also neuronal deficit 
in the spinal cord and both cortical neuron and glial numbers were low (Dono et al 1998), suggesting 
FGF-2 was required for the development of these structures. 
It has been suggested by in vivo studies that FGF-2 may regulate the timing of neuronal differentiation, 
after proliferating progenitor cells have exited the cell cycle. Expression of both FGF-2 and FGFR-l is 
down-regulated during mid-neurogenesis and disappears towards the end of this process, possibly to 
allow differentiation to take place (Vaccarino et al., 1999a; Raballo et al., 2000; Lukaszewicz et al., 
2002). Secondly, the effects ofFGF-2 on neuron and glial differentiation in vivo were also found to be 
critically dependent on the stage of corticogenesis. When recombinant FGF-2 was injected at Et5.5 
when the earliest neurons are generated in the cortex, the number of neurons increased by 700/0 and 
there was no significant increase in glial cell numbers. When injected at E20.5, the time when 
neurogenesis has ended and glial progenitor cells are still actively dividing in the SVZ, a large increase 












1.2.6.3 In vitro effects ofFGF-2 on cell lines 
Cell lines have been used as in vitro model systems to study the effects of FGF-2 on neuronal 
development. The rat pheochromocytoma cell line, PC12 is the best characterized model system to 
date (Vaudry et aI., 2002). When treated with FGF-2, PC12 cells extend neurites and differentiate into 
a sympathetic neuron-like phenotype (Hadari et al., 1998; Skaper et al., 2000). Another cell line, H19-
7, derived from E17 rat hippocampal cells has also been used as a model system for both neuronal 
differentiation and cell survival induced by FGF-2. H19-7 cells were immortalized with the 
temperature sensitive SV40 large T antigen (Eves et aI., 1992). When treated with FGF-2 at 39°C the 
non-permissive temperature at which the large T antigen is inactivated, H19-7 cells extend neurites, 
differentiate and express neuronal markers (Kuo et al., 1996). Both these cell lines have also been very 
useful for dissecting out the signalling transduction pathways involved in neuronal differentiation 
induced by FGF signals. Several pathways have been implicated. Sustained activation of the MAPK 
pathway was required for the neurite extension and differentiation ofPC12 cells in response to FGF-2. 
This was mediated by the recruitment of the protein tyrosine phosphatase Shp2 by FRS2 into a 
complex with Grb2, and Sos (Fig 1.4). Expression of a mutant FRS2 with a reduced association with 
Shp2 in PC12 cells allowed a transient but not sustained activation of ERK. This resulted in a 
decreased neurite outgrowth induced by FGF (Hadari et al., 1998). FGF-2 has been found to activate 
both MAPK-dependent and -independent pathways during neuronal differentiation of H19-7 cells 
(Kuo et al., 1996; Kuo et al., 1997; Chung et aI., 1998; Corbit et al., 1999). PKCO which likely acts 
downstream ofPLC-y, was shown to mediate FGF-2 induced neuronal differentiation ofH19-7 cells by 
activating the MAPK pathway at the level ofMEK (Corbit et aI., 1999) (Fig. 1.4). The Src kinase was 












H19-7 cells (Kuo et aI., 1997). The three signalling pathways (MAPK, Src and PI3K) were shown to 
stimulate CREB phosphorylation and the subsequent CRE (cAMP response element) mediated gene 
activation in H19-7 cells in response to FGF-2. CREB phosphorylation and activation in these cells 
was mediated by the protein BTK (Sung et aI., 2001; Yang et al., 2004) (Fig. 1.4). In addition to 
activating CREB, PI3K was found to activate its target Akt to inhibit apoptosis in differentiating H19-7 
cells (Eves et al., 1998). It is clear therefore that FGF-2 has multiple effects on neural progenitor cells 
and that several signalling pathways are activated to mediate these effects. 
1.2.6.4 Identity ofFGFRs that transmit FGF-2 signals during neurogenesis 
The FGFRs that mediate FGF-2 actions during neurogenesis have not been well characterized. This is 
mainly because FGFR knock-out mice die early (Deng et aI., 1994). However, FGFR-1 is likely to be 
the receptor that may mediate FGF-2 signals. Signalling through the FGFR-l was found critical for the 
proliferation of FGF-2 dependent neural stem cells in vitro (Tropepe et aI., 1999). Although the 
immortalized E10 mouse neuroepithelium 2.3D cell line expresses both FGFR-l and FGFR-3, the 
mitogenic effect ofFGF-2 was found to be transduced exclusively by FGFR-l (Brickman et al., 1995). 
Additionally, a study of chimeric mice has shown that FGFR-l is critical for neural tube development 
(Deng et al., 1997). It is not clear though which FGFR-1 isoform is required for these activities. Thus 
the generation of FGFR isoform-specific knock-outs would help in the understanding of FGF-FGFR 












1.3. INTRINSIC MOLECULES REGULATING NEUROGENESIS 
1.3.1 Basic belix-Ioop-belix transcription factors 
Neurogenesis in vertebrates involves sequential activation of transcription factors of the large family of 
evolutionary conserved basic helix-loop-helix (bHLH) family that regulate both determination and 
differentiation of neural progenitor cells. These are vertebrate homologues of the bHLH genes 
achaete-scute complex and atonal originally identified in Drosophila. The relationship between the 
various neural bHLH transcription factors is summarized in the phylogenetic tree shown in Fig. 1.5. 
The pro neurogenic members of this family include the mammalian achaete-scute homolog 1 (Mashl), 
Neurogeninl, 2 and 3 (Ngnl, Ngn2, Ngn3) which are involved in the specification of neural precursor 
populations, and the mammalian atonal homologs MathI, Math2, Math3, and NeuroD which are 
required for the terminal differentiation into neurons (Kageyama et aI., 1997). These transcription 
factors display tissue-specific expression patterns in both the CNS and the PNS. They form hetero-
dimers with the ubiquitously expressed bHLH proteins E2-2, HEB, El2 and E47 and bind to E box 
(CANNTG) containing promoter sequences via their basic domains to activate transcription of tissue-
specifc target genes to promotes neurogenesis. Involvement of the bHLH proteins in neurogenesis has 
been studied by looking at their patterns of expression during nervous system development, the 
phenotype of tissues following targeted disruption of the gene (loss-of-function) in mice and also 

















Figure 1.5 A radial phylogenetic tree of the various neural bID...n transcription factors. Full-length sequences of mouse 
(m), Xenopus (X), zebrafish (zf) and Drosophila (achaete, taplbiparous) orthologues were aligned using the Clustal W 
software (Thompson et al., 1994). The tree was constructed using the PhyloDraw drawing tool (Choi et aI., 2000). 
GenBank accession numbers: zebrafish NgnI, AF017301; atonal, L36646; mouse neuraD, U28068; Xenopus Ngnr-I, 
U67778; Ngn2, Y0762 I ; Ngn3, Y09167; Ngnl; Y09166; Math3, 085845; Math2, D44480, MathI, D43694; taplbiparous, 
AF022883;Mashl,~_008553;achaete,~_057476. 
1.3.1.1 Mash! 
In situ hybridization, northern hybridizations and immunocytochemical studies have shown thatMashl 
is transiently expressed during development of neural precursor cells in both the CNS and PNS. In the 
CNS Mashl transcripts were found in the ventral telencephalon of E13.5 rat forebrain, including the 
ventral thalamus, hypothalamus, and the ganglionic eminence but not in the dorsal telencephalon 
(Casarosa et aI., 1999; Torri et al., 1999; Schuurmans and Guillemot 2002). A northern blot analysis 
using mouse embryos revealed that Mashl transcripts are present as early as E8.S and levels increase 
until E17.5 (Guillemot and Joyner, 1993). Cells expressing Mashl in the PNS are represented by 
autonomic (but not sensory) neuronal progenitors and precursors in the olfactory epithelium (Guillemot 












Targeted gene disruption studies have been conducted to obtain insights into the functions of Mashl in 
neurogenesis. Mutant mice display a severe loss of neuronal populations in the OE and the autonomic 
nervous system, suggesting that Mashl plays a critical role in the neuronal lineages in the PNS 
(Guillemot et al., 1993). Consistent with this, forced expression of the Mashl protein in neural crest 
stem cells led to neuronal differentiation (Lo et al., 1997). In the CNS Mashl mutant mice fail to 
generate committed neuronal precursors in ventral forebrain and there was a deficit of neurons in the 
mantle zone (Casarosa et al., 1999; Torn et aI., 1999). Loss of the neuronal progenitor cell population 
suggests that Mashl has a determinative function in these cells. 
1.3.1.1 Ngnl and Ngn2 
The Ngnl and Ngn2 transcription factors represent a subfamily of bHLH factors which are closely 
related to the Drosophila tap/biparous gene and distantly to atonal (Guillemot, 1999; Hassan and 
Bellen, 2000) (Fig. 1.5). Like Mashl, Ngnl and Ngn2 are expressed specifically at early stages of 
neurogenesis. The transcripts are found in sensory neuronal precursors of the neural crest (perez et ai, 
1999). In the CNS both are expressed by neuroepithelial precursor cells in the cortical VZ during early 
neurogenesis (Sun et al., 2001). Knock-out mice show defects in neural tissues and a lack of sensory 
neurons in both dorsal root and cranial ganglia (Ma et al., 1996). Expression of downstream bHLH 
genes like neuroD and Math-3 was also negatively affected by these mutations. On the other hand, 
ectopic expression of Xenopus neurogenin related-l (Xngnr-l) in Xenopus embryos induced ectopic 
primary neurogenesis and the expression of neuroD, thus demonstrating a proneural function of this 
protein (Lee et al., 1995). In chick, forced expression ofNgnl was shown to induce a neuronal identity 













NeuroD is thought to positively regulate neuronal development at the level of post-mitotic 
differentiation. In situ hybridization in mice did not reveal any expression in cells of the VZ. Instead, 
expression was detected in subpopulations of fully differentiated neurons, including the hippocampus, 
dentate gyrus, and pyramidal neurons of the cerebral cortex (Schwab et aI., 1998; Lee et al., 2000). 
Ectopic expression in Xenopus embryonic neural ectoderm cells resulted in premature neuronal 
differentiation and inhibition of the alternative epidermal fate (Lee et al., 1995). NeuroD also inhibited 
the formation of glia in the retina (Morrow et al. 1999). A severe neurological phenotype results in 
knock-out mutant due to a failure of cerebellar and hippocampal granule cells to differentiate (Miyata 
et al., 1999). 
1.3.2 Cascades of proneural bHLH transcription factors in neuronal differentiation 
bHUI transcription factors are known to function in well co-ordinated cascades to control 
determination, commitment, proliferation and differentiation of progenitor cells. These cascades have 
been revealed by ectopic expression, loss-of-function experiments and patterns of expressions of the 
bHUI proteins. They have been observed in a few neuronal developmental contexts, including 
primary neurogenesis in Xenopus (Ma et at., 1996; Dubois et aI., 1998; Pozzoli et al., 2001), sensory 
neuron lineage in the PNS (reviewed by Anderson, 1999), the developing telencephalon (reviewed by 
Schuurmans and Guillemot, 2002) and in the OE neurogenesis [see Chapter 5, (Cau et aI., 1997; 2000; 
2002]. In primary neurogenesis and in the sensory lineage the bHLH have been shown to interact with 
members of the repeat HLH (rHLH) superfamily, particularly the Early B cell factor/olfactory 












To date, 3 mouse genes have been cloned, namely ebjl/OE-l; ebj2/0E-3; and ebj3/0E-2 and these 
share at least 75% overall identity. Orthologs of the ebj2/0E-3 and ebj3/0E-2 have been identified in 
Xenopus as Xcoe2/Xebj2 and Xebf3, respectively. 
In primary neurogenesis, X-ngnr-l has been proposed to have a determinative function It is expressed 
before the formation of the primary neurons in the neural plate. Overexpression of Xngnr-l results in 
ectopic neuronal differentiation in nonneural ectoderm and also results in ectopic expression of 
XneuroD (Ma et a!., 1996). A1though XneuroD can also induce ectopic neuron formation when 
overexpressed (Lee et ai., 1995), it cannot reciprocate the ectopic expression of Xngnr-l (Ma et aI., 
1996). This therefore suggests that both XNgnr-l and XneuroD function in a unidirectional cascade 
with XNgnr-l operating upstream of XneuroD. The expression of the rHLH factor Xcoe2lXebj2 has 
been shown to represent an intermedate step, functioning downstream of XNgnr-l and upstream of 
XneuroD to control primary neurogenesis (Dubois et ai., 1998). Overexpressed Xngnr-l results in 
ectopic Xcoe2 mRNA and Xcoe2 can in turn induce ectopic expression of Xngnr-l in a positive 
feedback loop and of the later gene XneuroD (Dubois et a!., 1998). Xcoe2lXebj2 has therefore been 
suggested to maintain the expression of the earlier gene Xngnr-l thus enforcing the commitment of 
progenitors to the neuronal fate and also promoting the neuronal differentiation. The homolog of 
Xcoe2/Xebj2. Xebj3 has recently been shown to be expressed during primary neurogenesis, but 
downstream of XneuroD (Pozzoli et al., 2001 ). Overexpression of XneuroD leads to ectopic 
expression of Xebj3, but Xebj3 cannot induce XneuroD in tum Instead, overexpression of Xebj3 
causes ectopic expression of the neuronal specific markers NCAM, N-tubulin, and neurofilament 
(Pozzoli et ai., 2001). These results would therefore deflne the following cascade during Xenopus 
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Figure 1.6 Model of transcriptional cascades implicated in different neuronal development. In primary neurogenesis 
during Xenopus development the expression of X-ngnr-l induces neuronal differentiation by activating Xebf2lXcoe2 which 
in turn induces the expression of XneuroD. Xebf2lXcoe2 can also cause expression of Xngnr-l in a positive feedback loop 
(shown by the green arrow) thus maintaining its expression. Downstream of XneuroD is the XebD protein which promotes 
neuronal differentiation by activating the expression of neuronal specific markers NCAM, N-tubulin and neurofilament. 
Overexpression ofNeuroD can also induce expression of neuronal markers. 
1.3.3 Involvement of proneural bHLH transcription factors in neuronal versus glial fate 
determination 
It has come to light through recent data that in addition to positively promoting neuronal 
differentiation, proneural bHLH factors actively inhibit gliogenesis and thus regulate the timing of glial 
differentiation. Analysis of mice deficient for proneural bHLH transcription factors Mash} and Math3 
has shown increased glial differentiation and severely reduced neurogenesis in the tectum, hindbrain 
and retina. In these mutants, cells that normally give rise to neurons become astrocytes (Tomita et al. , 












development was in observed in embryonic mice with a double mutation of the Mash] and Ngn2 genes 
(Nieto et al., 2001). Ectopic glial differentiation in these mutant mice indicate that the proneural 
factors may actively inhibit glial differentiation. 
In an important experiment Sun et al. (2001) described a mechanism by which proneural bHLH 
transcription factors actively regulate gliogenesis. Astrocytic differentiation is initiated when 
signalling molecule CNTFILIF binds and activates the receptor associated tyrosine kinase Jakl, 
followed by phosphorylation of transcription factors STATI and STAT3. The two transcription factors 
then dimerize and get translocated to the nucleus where they cooperate with Smads signalling 
molecules via the coactivator proteins p300/CBP to activate glial specific gene expression from STAT 
binding elements in glial promoters (Figure 1.7). It was found that Ngnl prevented binding to STAT 
elements by sequestering the p300/CBP-Smad complex away from glial promoters and re-directing it 
to neuron-specific promoters. Additionally, it was found that Ngnl prevented the phosphorylation of 
the STAT transcription factors by an unknown mechanism (Sun et al., 2001). These results imply that 
proneural factors may determine the timing of both neuro- and gliogenesis. However, it is currently 
unknown whether other proteins use the same mechanism These studies suggest that the proneural 
bHLH transcription factors not only determine neuronal fate via transcriptional up-regulation of 
neuron-specific target genes e.g NeuroD, but may also actively inhibit glial differentiation by reducing 



























Figure 1.7 Mechanisms by which Ngnl promotes neuronal differentiation (green arrows) while inhibiting glial 
differentiation (blue arrows). Ngnl inhibits activation ofSTATI13 transcription factors and sequesters the CBP/p300-Smad 
transcriptional co-activator complex and re-directs it towards E-box containing promoter sequences to activate transcription 
of neuronal-specific genes e.g. NeuroD to promote neuronal differentiation. 
1. 4. LATERAL INHIBITION 
Lateral inhibition is a process by which one cell out of a cluster of cells with the potential to 
differentiate into neuronal cells (the proneural cluster), is selected to be a neuronal progenitor cell, 
while the rest are inhibited from acquiring the same fate (Figure 1.8A). This process is mediated by the 
genes encoding for the single-transmembrane receptor Notch and its ligand Delta., also a single-
transmembrane protein. At ftrst, all cells in the proneural cluster are capable of becoming neuronal 












cell expresses higher levels of Delta than its neighbours, leading to an increase in Notch signalling in 
the adjacent cells thus inhibiting their differentiation along the same pathway (Fig 1.8B). 
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Cel1 becomes a neuron 
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Cell becomes non-neuronal 
Figure 1.8 The process of lateral inhibition and its molecular components. (A) Each cell in the proneura) cluster has the 
potential to become a neuron but only one cell is selected (shown in green) to become a neuroblast and inhibits its 
neighbouring cells from becoming neurons. (B) Two cells in contact are shown. At first, both cells express equivalent 
levels of Notch and Delta. Soon, the prospective neuron expresses higher levels of the ligand, Delta and activates Notch 
signalling in the other cell. The expression of proneural genes is turned off in this cell and as a result this cell is inhibited 
from acquiring a neuronal identity. On the other hand, the prospective neuron does not receive Notch signalling and the 
proneural genes (Mash! and Ngn\) are expressed at high levels, leading to expression of NeuroD and neuronal 
differentiation. 
Binding of Delta to Notch leads to activation of the Notch signalling pathway which is initiated by the 
proteolytic cleavage of the intracellular domain (lCD) of Notch, by the cytoplasmic protease Presenilin 
I (PSI). The ICD is then translocated to the nucleus where it forms a complex with the transcriptional 












expression of the proneural bHLH proteins (Mashl, NgnI, MathI) that are required for neuronal 
differentiation (Jarriault et al., 1998) (Figure 1. 9). The components of the Notch signalling pathway 
have been identified in mouse, Drosophila, and Caenorhabditis elegans and the names vary according 
to the species (Justice and Jan, 2002). These are summarized in Table 1.3. 
Responding cell 
Notch NotchICD 












Figure 1.9 The Notch-Delta signalling pathway. The ligand Delta interacts with the receptor Notch via their extracellular 
regions. The intracellular domain (lCD) of Notch is cleaved by Presenilin 1 and translocates to the nucleus where it 
complexes with the CSL transcriptional co-activator. They then bind to regulatory sequences of Hes I 1Hes5 to activate their 
transcription. HES llHESS then inhibit the transcription of the proneural bHLH proteins (Mash I, Ngn 1 etc). 
1.4.1 Role of Notch-Delta signalling 
The role of Notch signalling in the generation of the various cell types in the vertebrate nervous system 
has been addressed using both gain-of-function studies and mutant analyses of the various components 












an undifferentiated state, but recently has been found to also influence neural cell fate decisions in both 
the eNS and PNS. 
Table 1.3 The orthologues of the components of Notch signalling pathway. Shown in brackets are the 
number of orthologous genes found in each species (Justice and Jan, 2002). 
Components Drosophila Mouse C. elegans Consensus 
of the 2athwaI 
Receptor Notch (1) Notch (4) Lin-12 (2) Notch 
Ligand Delta, Serrate Delta-like-1, Lag-2 (1) DSL 
Jagged (3) 
Protease for dPs (2) Presenilin (2) Sel-12 Presenilin 
cleavege of Notch 
Nuclear Suppressor of CBF-lIRBPJK Lag-1 CSL 
transcriptional hairless Su(li) 
cofactor 
Target gene Enhancer obelit IIes (l) Lin-22 lies 
The role of Notch in maintaining the multipotent progenitor cell population has been shown by 
studying mutants that were homozygous for Hesl, Notchl, RBP-JK or PSI genes (Nakamura et ai., 
2000; Hitoshi et ai., 2002). EID.5 Hesrl - mice displayed a severe depletion in the number of 
progenitor cells compared to wild-type animals. It was found that their self-renewal capacity was 
disrupted, and the Hesrl - progenitors went tbrough only one round of cell division before giving rise to 
postmitotic neurons (Nakamura et al., 2000). Similarly, Notchr!·, RBP-JK1- and PST!- mutants showed 
depleted neural stem cells in the brains and excess neuronal and glial differentiation (Hitoshi et al., 
2002). Although neural stem cells could be generated in the absence of these genes, it was found that 
the mutant progenitors were unable to produce secondary progenitors, suggesting that they could not 
self-renew to maintain their population Introduction of a constitutively active form of Notch could 
rescue the self-renewal ability of the progenitors, suggesting Notch was critical for self-renewal of 












generation of the neural stem cells but rather critical for their maintance and inhibition of the 
differentiation pathway to both neuronal and glial cells (Hitoshi et al., 2002). Consistent with the idea 
of maintaining neural stem cells, gain-of-function experiments as shown by overexpression of 
constitutively active forms of Notch and Delta in neural precursor cells prevented them from 
undergoing neuronal differentiation, instead maintaining a neuroepithelial progenitor morphology 
(Appel et aI., 2001). 
On the other hand, Notch signalling may control the neuronaVglial fate switch of neural stem cells in 
both the CNS and PNS (Gaiano et al .• 2000; Morrison et al.. 2000; Tanigaki et al., 2001; Grandbarbe et 
aI., 2003). Recent gain-of-function experiments in vertebrates have shown that Notch directly and 
instructively induces astrocytic differentiation and inhibits both the neuronal and oliogodendrocyte 
lineage pathways. Overexpression of the constitutively active Notch ICD in E9.5 telencepahalic 
progenitors (before the onset of neurogenesis) forced the cells to adopt a radial glial identity (Gaiano et 
al., 2000). Radial glia are a specialized cell type with glial characteristics and are generated before or 
at the same time as neurons unlike other glial cells that are normally generated postnataly after 
neurogenesis (Gaiano et al. 2000). These cells act as scaffolds along which newborn neurons migrate 
to the cortex (Fig. 1.1). In a similar study using E14.5 dorsal telencephalic progenitors (during mid-
neurogenesis), activated Notch enhanced expression of glial markers at the expense of neuronal 
specific markers (Chambers et al., 2001). 
When adult hippocampus-derived progenitor cells were stably transfected with the retrovirus carrying 
the Notch lCD, the cells were transformed into an astrocytic morphology and began to express GF AP. 












suggesting Notch was actively instructing astrocytic differentiation while inhibiting the alternative fates 
(Tanigaki et aI., 2001). Similarly, when chick PNS neural crest cells were electroporated with 
recombinant retroviral vectors carrying the Notch lCD, or when exposed to a soluble form of the Notch 
ligand Delta, an increase in the generation of the glial Schwann cells was observed (Morrison et al., 
2000). 
In vitro experiments conducted by Grandbarbe et al. (2003) have provided a model by which Notch 
activation may control the generation of both neurons and glia from neural stem cells. It would seem 
that Notch acts at two stages during this process (Fig. 1.10). Firstly, it promotes the switch from 
neuronal to glial fate by inhibiting the uncommitted neural progenitor cell from differentiating into a 
neuronal precursor, instead allowing it to become a glial precursor that has the ability to form both 
astrocytes and oligodendrocytes. Secondly, Notch acts on both committed neuronal and glial 
precursors to control their terminal differentiation pathways. A consequence of Notch activation at the 
stage is that the differentiation of both neurons and oligodendrocytes is inhibited and that of astrocytes 
promoted. 
1.4.2 MECHANISM OF NOTCH ACTIVITY 
As in Drosophila, inhibition of neurogenesis by Notch signalling in vertebrates is mediated by the 
direct induction of target transcriptional repressors. Hes 1 is the best characterized antagonistic 
regulator of neuronal differentiation, downstream of Notch activation (Ohtsuka et al., 1999). The 
phenotypes of both gain- and loss-of-function in Xenopus and mice, respectively, are consistent with its 
inhibitory function in neurogenesis. Hesl homozygous mice mutants are characterized by the loss of 












r)eurofilament in the telencephalon and mesencephalon (Ohtsuka et aI., 1999; Nakamura et aI., 20(0). 
W\t:.n expressed ectopically, Hesl was found to represses neuronal differentiation of neural cells in the 
E:K tricular zone of the telencephalon (Ohtsuka et aI., 2001). Taken together these studies suggest that 
.1 is required to maintain progenitor cells in an undifferentiated state by inhibiting neurogenesis. 
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Figure 1.10 Model for the role of Notch in controlling both the neuronal/glial switch and terminal differentiation of neuro-
glial cell types of the nervous system. Notch first inhibits the specification of neuronal fate while promoting that of glia. 
During terminal differentiation Notch also inhibits the differentiation of both neurons and oligodendrocytes while 
promoting that of astrocytes. The inhibitory effects of Notch are shown in red while the stimulatory effects are shown by 
green arrows. 
Res proteins are characterized by the presence of two distinct functional domains (for dirnerization and 
for DNA binding) that are essential for their transcriptional repressor activity. The basic DNA binding 
domain contains a proline residue that decreases affinity for the E-box, instead prefering the represssor 
specific DNA site known as the N-box which is defined by the nucleotide sequence CACNAG. The 
second functional domain, represented by the 4 amino acid sequence motifWRPW (Trp-Arg-Pro-Trp) 












Drosophila or the mammalian Transducin-like Enhancer of Split (TLE) to mediate active 
transcriptional repression (Castella et aI., 1999; Nuthall et at., 2002). In this complex Hesl functions 
as a DNA binding protein while Gro/TLE provides a transcription repressor function (Fig. 1. 11 A). 
FoxglIBF-l, a winged-helix transcription mctor that has been shown to maintain cell proliferation of 
neural progenitor cells of the telencephalon and inhibit neuronal differentiation (Xuan et al., 1995) has 
recently been shown to interact with Hes 1 and GromE to repress transcription in transfected ceUs 
(Yao et at., 2001). Hesl can also achieve its repressive action in a non-DNA-binding fashion by 
titrating the proneural transcription mctors away from the E-box binding site. This mode of repression 
is achieved by Hesl interfering with the complex between the ubiquitously expressed bHLH proteins 
E12 or E47 and the proneural proteins (Fig 1.11B). 
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Figure 1.11 Two ways in which Hesl can repress transcription of prone ural bHLH transcription factors. (A) Hesl represses 
the transcription of target genes (e.g Mash I) by recruiting the GroffLE co-repressor (and possibly BF -1) and by binding to 
the N-box. Hesl may also repress its own transcription in a negative autoregulatory loop. (B) Hesl may also inhibit the 
transcription of positive bHLH proteins by titrating the ubiquitous E-proteins away from promoter sequences that contain 













Genetic studies of nervous system development have shown that the neuronal commitment bHLH 
proteins Mashl and Ngnl are targets of the Notch-Hes signalling pathway (Chitnis and Kintner, 1996; 
Blader et al., 1997; Chen et aI., 1997; de la Pompa et al., 1997; Castella et al., 1999; Cornell and Eisen, 
2002; Sriuranpong et al., 2002). Overexpression of Hes1 was shown to reduce expression of the 
human homolog of Mas-I (Hash-I) by binding directly to the N-box in its promoter (Chen et al. 1997; 
Sriuranpong et al., 2002). This is consistent with Mashl mRNA up-regulation in various brain regions 
of Note hi knock-out mutants (de la Pompa et al., 1997). 
In an in vitro approach using E17 hippocampal cell cultures expressing exogenous Mashl, Hesl was 
found inhibit the differentiation of these cells (Castella et al., 1999). It was postulated that Hesl 
prevented transcriptional activation initiated by Mash1 by titrating its heterodimer partner E2A away 
from the E-box sequences present in Mashl target genes (Castella et aI., 1999). Recently, it has been 
shown in neuroendocrine lung cancer cells that Notch may use a novel mechanism independent of 
HESl in down-regulating Hash-I. Overexpression of Notchl in these cells increased ubiquitinylation 
of the Hash-l protein and its subsequent degradation (Sriuranpong et al., 2002). 
Expression of Ngnl is also under the control of Notch signalling. Injection of a wild type Deltal into 
Xenopus embryos strongly suppressed the expression of Ngnl mRNA whereas the misexpression of a 
mutant Deltal (equivalent to blocking lateral inhibition) leads to an upregulation of Ngnl expression, 
suggesting Ngnl is a target of lateral inhibition (Blader et aI., 1997). Both Mashl and Ngnl can 
activate the Delta gene. In Mashl mutant mouse embryos, expression of both Deltal and the 
downstream effector Hes5 is lost throughout the ventral telencephalon, spinal cord, and mesencephalon 
where Mashl is normally expressed (Casarosa et al., 1999). Misexpression of Ngnl in both Xenopus 












appears that Ngnl and Mashl control the expression of Delta and are themselves down-regulated by 
lateral inhibition in a negative feedback loop which will help diversify cell types during development 
of the brain (Fig. 1.8B). In contrast, NeuroD, which is required for the terminal differentiation, is 
insensitive to direct inhibition by Notch signalling as demonstrated by the inability of the constitutively 
active Notch ICD to inhibit the ectopic neuronal differentiation when co-injected with NeuroD in 
Xenopus embryos (Chitnis and Kintner, 1996). 
1.5 INTERACTION OF THE FGF AND NOTCH SIGNALLING PATHWAYS 
One significant area that requires a closer examination is whether Notch signalling interacts with FGF-
2 in regulating neurogenesis. It is not clear whether the maintenance of stem cells and cellular 
differentiation of their progeny are regulated independently by the two distinct signals or whether the 
different signals co-operate in specifying these cellular fates. As we have seen above, there is a 
regulatory loop involving Notch and the proneural proteins in controlling the cell lineages in the 
nervous system There are not that many studies that have attempted to look at how FGF or other 
signalling molecules may interact with these. As was reviewed earlier, FGF-2 is primarily mitotic for 
neuroectodermal cells and is therefore possible that it may positively internct with the Notch signalling 
pathway to maintain these cells in a non-differentiated state. It has been shown that FGF-2 may use the 
Notch signalling pathway to inhibit the neuronal differentiation ofElO cortical precursors (Faux et aI., 
2001). FGF-2 increased the expression of Notch and down-regulated the expression of the ligand 
Delta, suggesting that Notch signalling pathway may be downstream of FGF signalling. When 
activation of Notch is inactivated by a null mutation of the Presenilin-l gene or with antisense Notch 
oligonucleotides, treatment with FGF-2 at low concentrations resulted in a profound increase in 












the mammalian mouse telencephalon neural progenitors co-operatively. Cells expressing activated 
Notch show a 4-fold increase in their ability to proliferate in response to FGF (Gordon Fishell Lab, see 
URL in reference section). Both these studies suggest that the Notch pathway may be a downstream 
cascade that transduces FGF-2 signals that ultimately result in the inhibition ofneurogenesis. 
On the other hand, FGF-2 may act to inhibit Notch signalling thus allowing neuronal differentiation to 
take place. Currently, there is no direct evidence to support this. However, NGF, via its activation of 
the protein kinase C (PKC) pathway, inhibited the DNA-binding ability of RESI by phosphorylating 
its basic DNA binding domain, thus allowing the PC12 cells to differentiate into neuronal cells (Strom 
et al., 1997). As PKC can transduce FGF-2 signals (Fig 1.4), it is therefore possible that FGF-2 may 
therefore induce neuronal differentiation in a similar manner. 
1.6 OLFAcrORY NEUROGENESIS: A MODEL SYSTEM 
The olfactory epithelium (OE) is well recognized as a simple model system to explore the molecular 
and cellular mechanisms of neurogenesis that have been mentioned above. It has several features that 
make it well suited for such studies. Its peripheral location makes it accessible. Like the neural tube in 
the nervous system, it has an epithelial structure in which neurons are generated. However, the OE has 
a much simpler structure. The tissue is made up of 3 cell types that can be distinguished from each 
other by morphology, their position in the epithelium, and cell type-specific antigenic markers. These 
are the basal cells, neurons, and sustentacular cells. Unlike the brain, the OE is populated by only one 
type of neuron, the olfactory receptor neuron (ORN). The most notable characteristic about this neuron 
is that it is replenished continuously throughout the life of an animal from a maintained population of 












lineage exist in this tissue. It is this regenerative capacity that has rendered the OE an excellent system 
in which to study the molecular and cellular events that occur during neurogenesis. 
1.6.1 Early stages of mouse OE development 
The OE develops from o1factory placodes which are formed at E9.5 from thickened patches of the 
ectoderm on the ventral sides of the head. This is followed by invagination of the placodes at EI0.5, 
forming the olfuctory pits which deepen and form recesses around E11.5. Over the next EI2.5-13.5 
period, the OE gets organized into layers (Farbman, 1994). The OE is stratified and the cell types 
found there are localised into 3 layers, the basal, middle and apical layers (Figure 1.12). The basal 
layer contains 2 types of basal cells that can be distinguished from one another. The cytokeratin 
expressing horizontal basal cells (HBCs) are smalL flat and dark cells found on the basal lamina. 
Superficial to HBCs are the globose basal cells (GBCs) which do not express cytokeratin. The middle 
layer of the OE contains both bipolar immature and mature ORNs. The latter are characterised 
physically by the apical dendritic knob and cilia which are in direct contact with the external 
environment. The ORNs send their axons and synapse directly to the o1factory bulb (OB) in the 
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Figure 1.12 The diagram of the structure of the olfactory epithelium. The sustentacular cells are located in apical layer of 
the OE while the middle layer is populated by both immature and mature olfactory receptor neurons (ORN's) whose axons 
extend into the olfactory bulb with their dendrites into the nasal cavity, in direct contact with odorants. The basal layer 












1.6.2 The neuronal lineage in the mouse OE 
A model of neuronal lineage in the OE has been proposed via the use of various tissue culture assays 
(reviewed in Calof et al., 2002). The phenotype of the cells at various stages of the differentiation 
process can be characterized by defined markers (Fig 1.13). 
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Figure 1.13 The OE neuronal lineage is characterized by 3 stages of actively dividing progenitor populations: the neuronal 
stem cell, the neuronal progenitor that expressed Mash 1, and the last proliferating cells in this lineage, the Mash 1·/NeAM'" 
immediate neuronal precursor. The lNP differentiates into a postmitotic ORN which expresses the olfactory marker protein 
(OMP) and olfactory receptors. 
There are at least 3 distinct sequential stages of mitotically active cells within the lineage. These are 
the neuronal stem cell, the neuronal progenitor cell and lastly, the immediate neuronal precursor (INP). 
To date, the identity of the neuronal stem cell is still unknown. A neuronal colony forming cell (CFU) 
has been tentatively identified as a neuronal stem cell -when grown in vitro on feeder cell layer, 
progenitor cells and ORNs are produced from this cell (Mumm et al., 1996; Calof et al., 2002). Found 
interposed between the postmitotic ORN and the neuronal stem cell are the two transit-amplifyng 
progenitors: the Mash1 expressing progenitor and the INP. The Mashl+ neuronal progenitor cell is 
thought to be the progeny of the stem cell and this cell undergoes one to two rounds of division to give 












The INP goes through several symmetrical divisions followed by differentiation of all progeny into 
ORNs. In vivo, the mitotically active cells of the neuronal lineage are found within the GBC 
population, a heterogenous cell population that has been shown to be direct precursors of ORNs. 
Mature ORNs are post-mitotic and express NCAM, proteins of the olfactory receptor transduction 
pathway and the olfactory marker protein. 
1.6.3 Regulation ofOE neurogenesis 
Regulation of OE neurogenesis by both extrinsic and intrinsic signals follows similar themes to that 
reviewed earlier in this chapter. The effects of FGF-2 on this lineage has been studied in vitro using 
explant cultures and cell lines (reviewed in Chapter 3), while studies of regulation by bHLH proteins 
and Notch signalling have been spearheaded by the laboratory of Francois Guillemot (reviewed in 
Chapter 5). 
1.7 AIMS OF THE STUDY 
The general aim of this project has been to study the role of fibroblast growth factors (FGF), 
particularly basic FGF (FGF-2) in olfactory neuronal differentiation, using a novel embryonic cell line 
(OP27) as a model system OP27, together with other similar cell lines (OP6, OP47 and OP55) were 
isolated by infection of primary cultures of olfactory epithelium from EIO.5 mouse embryos with 
retrovirus carrying temperature sensitive alleles of the SV 40 large T antigen (Illing et al. 2002). The 
retrovirus allows the cells to proliferate at the permissive temperature of 33°C, but the cells stop 












study the effects of various growth factors at the non-permissive temperature when the cells are not 
under the control of the large T antigen. These cell lines can be used as a model system to study 
neuronal differentiation in the olfactory epithelium in vitro. 
The following approach was used in this study. 
1.7.1. Determine whether FGF receptors are expressed by the cell line 
As we have seen above, one FGF ligand can only activate several FGF receptors. Therefore I sought to 
determine whether the OP6, OP27, OP47, and OP55 cell lines express a limited number or the whole 
repertoire ofFGF receptors. 
1. 7.2. Assay the response of OP27 to FGF-2 and characterise the response 
Having shown that the OP27 cell line does express receptor(s) for FGF-2, tissue culture experiments 
were designed to test whether the OP27 cell line responds to FGF-2 at the non-permissive temperature 
by proliferating or by differentiating to mature olfactory neuronal cells. Markers that characterize the 
different stages of the OE lineage were used to characterize the phenotype of the cells following 
treatment with FGF-2. These included markers that are generic to neuronal cells (NCAM, GAP-43, 
PLCy), and those that are specific to the ORNs (OMP and the proteins involved in the odorant 












1.7.3 Analysis of olfactory receptor gene expression in OP27 cells 
ORNs express olfactory receptors during their differentiation and each ORN expresses one or very few 
of these receptors. OP27 cells were investigated whether they express only one or a small repertoire 
of olfactory receptors during their induction with FGF-2. 
1.7.4. Characterization of the transcriptional expression of proneural bHLH transcription factors and 
Notch signalling pathway components in OP27 following treatment with FGF-2 
Lateral inhibition plays an important role in neuronal fate determination. I wanted to find out whether 
FGF signals lead to activation of genes downstream of the Notch signalling cascade. Semi-quantitative 
RT-PCR was used to monitor expression levels of the various components of the Notch signalling 
pathway following treatment with FGF-2. 
1. 7.4. Differential display analysis of the 0P27 cell line 
The technique of differential display was employed to identify novel genes that respond to FGF-2 
treatment and that might play a crucial role in neuronal differentiation. The identification of genes 
involved in the process of neuronal differentiation would provide an important step towards the 
understanding of the underlying molecular mechanisms. These genes would include those that have 
been activated and those that have been repressed, for neuronal differentiation to take place. In 
addition, genes that are good markers of the different stages in neuronal differentiation of olfu.ctory 
















2.1 CELL LINES 
Cell lines (IUing et aI., 2002) were routinely maintained in Dulbecco's modified Eagle medium 
(DMEM, Gibco-BRL) supplemented with 10 % fetal calf serum (FCS, Delta Bioproducts) at 33°C 
under a 10% C02 atmosphere. For passaging, cells were washed once with pre-warmed IX phosphate-
buffered saline (PBS: 0.14M NaCl, 2.7mM KCI, 8 mM Na2HP04, 1.5mM KHzP04), and detached with 
0.25% trypsinJ2.5mM EDTA solution (Gibco-BRL) for 2 min and stopped with the addition of 
DMEMlIO% FCS. After dissociation the cells were centrifuged at 1000min-1 for 5 min in a Hettich 
Rotanta bench centrifuge (Labotech) and the cell pellet was resuspended in fresh DMEMllO% FCS. 
Cells were seeded into tissue culture dishes at a density of lX104 cells/cm2. 
2.2 MULTIPLEX RT -PCR ANALYSIS OF FGFR EXPRESSION IN 0P27 CELLS: 
To determine which of the four FGFRs were present in the 0P27 cells, simultaneous amplification of 
the receptors was accomplished with a multiplex PCR technique using a single primer pair followed by 
a restriction enzyme analysis as described by McEwen and Ornitz (1996), with modifications. 
2.2.1 Isolation of RNA 
Cells grown in culture were harvested by trypsinization and total RNA isolated using the single step 
method of acid guanidium thiocyanate-phenol-chloroform extraction (Chomczynski and Sacchi, 1987). 
Briefly, the cell pellet was homogenised in 500111 solution D (4M guanidine thiocyanate, 25mM 











O.1x volume of 2M sodium acetate pH4, Ix volume of phenol pH4, and 0.2x volume of chlorofonn-
isoamylalcohol (24:1). After a 15 min incubation on ice, the samples were centrifuged at 10 OOOg for 
20 min at 4~C. The aqeous phase was mixed with an equal volume of isopropanol in a fresh eppendorf 
and incubated at -70°C for at least one hour followed by centrifugation at 10000g for 20 min at 4°C. 
,;Ifto. 
The RNA pellet was resuspended in 300~1 solution D and precipitated with an eciialyolume of 
isopropanol at ·70°C for at least one hour. Following aspiration of the supernatant, t4~ pellet was 
washed once with 70% ethanol and allowed to dry at room temperature. The RNA was" finally 
dissolved in nuclease-free water and quantitated by UV spectrophotometry. 
2.2.2 DNase! treatment 
Contaminating genomic DNA was removed from total RNA by treatment with DNaseI, followed by 
phenol-chlorofonn extraction and ethanol precipitation. Twenty ~g of total RNA was treated with 20U 
RQI DNaseI (Promega) in a 200~1 volume containing 1 x RQI DNaseI buffer (40mM Tris-HCI pHS.O, 
10mM MgS04, ImM CaCh) and 200U Recombinant RNasin® Ribonuclease inhibitor (promega) at 
37°C for 1 hour. This was followed by extraction with Ix volume of phenol pH4: chlorofonn: 
isoamylalcohol (25:24:1). The aqueous phase was mixed with O.Olx volume of ~Carrier (Molecular 
Research Centre), Ix volume 3M sodium acetate pH 5.2 and 2.5x volume ethanol, and precipitated at-
70°C for at least 1 hour. The RNA solution was centrifuged at 13000RPM for 30 min in a benchtop 
centrifuge at 4°C and the pellet was washed once with 70% ethanol and dried at room temperature. 
The pellet was resuspended in nuclease-free water and quantitated by UV spectophotometry. The 
integrity of RNA was checked by agarose gel electrophoresis. 
2.2.3 First- strand eDNA synthesis 
Five ~g of DNaseI-treated total RNA was heat-denatured at 92°C for 2 min in the presence of 500ng 
random hexamers (promega) in a 20~1 volume, followed by quenching on ice. To each sample, 6~1 of 
5x RT buffer (final concentrations: 50mM Tris-HCI pH 8.3, 75mM KCI, 3mM MgCh, IOmM DTT), 
1.5~1 of IOmM each dNTP, l~l of 40u/~1 recombinant RNasin® Ribonuclease Inhibitor and l~l of 
200U/~1 Moloney murine leukemia virus Reverse transcriptase (M-ML V RT, Promega) were added. 












2.2.4 Polymerase chain reaction (peR) 
Four microvtres of the cDNA were amplified in a 50J.lI total volume containing Ix PCR buffer (IOmM 
Tris-HCI pH 9.0, 50mM KCI, 0.1 % Triton X-IOO), 1.5mM MgCh, 0.2mM dNTPs, lOpmol of each 
.;.,... 
D0156 and DOI58 oligonucleotides (Table 2.1), and 1 U Taq polymerase (promega). T~ sarpples were 
then subjected to 30 cycles of 94°C for I min, 55°C for 2 min, and 72°C for 2 min, f6110~e.d by a final 
extension at noc for 5min in the Omnigene thermocycler (Hybaid). The amplification of the expected 
" 
product size (341bp) was confirmed by analysing 5J.lI of the reaction on a 2% agarose gel. Following 
the gel analysis, the PCR reactions were purified using the Wizard PCR Preps DNA Purification 
System® (Promega). 
Table 2.1 RT -PCR primers used to characterize the OP27 cell line. 
Gene Name Primers Sequence 5'-3' Sizes Expected (hpj Reference" 
cDNA size Genomic 
FGFR D0156 TCNGAGATGGAGRTGATGAAb 341 bp >530 McEwen 
D0158 CCAAAGTCHGCDATCTTCATb andOmitz, 
1996 
FGFRI F1189 CTGGTCACAGCCACTCTCTGCAC 823; lO90bp -34700 This study 
Rll90 CCAGGTACAGAGGTGAGGTCATC 
F1l91 ACTTTGCGCTGGTTGAAAAACGGC 
FGFR2 FGFR2-f CCTCCAAGCTGGACTGCC 777bp -21500 This study 
FGFR2-r TGCCACGGTGACCGCCTC 
FGFR3 FR3f CCGGCCAACCAGACAGCC 997bp 3731 This study 
FR3r TTGCAGGTGAGCTGTTCCTC 
FGFR4 FR4f GCTATCTCCTGGATGTGC 936bp 5987 This study 
FR4rp ACACCCAGCAGGTTGATG 
Olfactory ORF3 AGATCTAGATGGCITAYGAYMGITAYGTIGCb 530 530 Ngai et al., 
Receptor ORC GCTCTAGAT ARATRAAIGGRTTIARCAT
b 
1993 
OMP OMPfp AAGGTCACCATCACGGGCAC 242 242 Barberet 
OMPrp TTTAGGTTGGCATTCTCCAC al.,2000 
~he source of the nucleotide sequences of the primers used in this thesis 












2.2.5 Restriction Enzyme digestion of the PCR products 
Eight micn:]litres of the purified PCR products were digested separately with EcoRl, Pstl and Pvull 
(Amersham) by adding 11-11 of the appropriate lOx buffer and 11-11 of the enzyme and incubating at 37°C ,... 
for at least 1 hour. The digested samples were mixed with 2.S1-11 of Sx loading buffer.{50rpM EDTA 
pH8.0, SOmM Tris-HCI pH 8.0,50% glycerol) for non-denaturing PAGE and subsequentlr .~lysed on 
a 12% non-denaturing IX TBE (90mM Tris-borate pH 8.3, ImM EDTA) polyacrylamide gel. After 
1< 
the electrophoresis, the gel was fixed and silver-stained as described previously (Bassam et a!., 1991). 
Briefly, the gel was fixed in 10% acetic acid for 20 min and rinsed in dH20 for 2 min thrice. This was 
followed by impregnating the gel with a freshly made mixture of 0.1% AgN03 and 0.055% 
fonnaldehyde for 30 min. The colour reaction was developed with a solution of 3% Na2C03, 0.055% 
fonnaldehyde and 0.0002% Na2S203.5H20 (sodium thiosulphate) for 2-5 min and stopped with 10% 
acetic acid for 5 min. 
2.3 DETERMINATION OF 0P27 FGFR SPLICE ISOFORMS 
2.3.1 First- strand cDNA synthesis 
cDNA synthesis was perfonned in a 201-11 reaction containing 51-1g heat-denatured (65°C,S min) total 
RNA, 2S0ng random hexamers, ImM dNTPs, Ix RT buffer, 0.11-1g/!!1 BSA, 20U recombinantRNasin® 
Ribonuclease Inhibitor, 500ng oligo-edT) and 200U M-MLV RTase, incubated at 42°C for 1 hour and 
heat-inactivated at 95°C for 5 min. 
2.3.2 FGF receptor 1 RT-PCR 
Twenty 1-11 of the RT reaction were used in a 100!!l reaction volume with Ix PCR buffer (2.SmM TAPS 
pH9.3, 50mM KCI, 2mM MgCh, ImM !3-mercaptoethanol), 1.5mM MgCh, 10pmol of each F-1l89 
and R-1190 oligonucleotides (Table 2.1), 5% DMSO and 2.5U SuperThenn DNA polymerase 
(Southern Cross Biotech.). The reactions were run for 30 cycles at 94°C for I min, 60°C for 1 min and 
72°C for 3 min followed by a 5 min incubation at 72°C. The PeR-amplified products were analysed 












Southern blot analysis to analyse the specificity of the RT-PCR products. The 3' ECL labelling and 
detection system (Amersham) was used for labelling the internal oligonucleotide, F-1191 (Table 2.1), 
hybridizatiqn and detection as recommended by the manufacturers. The RT -PCR products were cloned 
into the pGEM-T cloning system (promega) and the nucleotide sequence of the inserts was verified by 
automated sequencing. 




PCR amplification of the FGF receptor 2 was performed using an aliquot of 4 J.lI of the above RT 
reaction, Ix PCR buffer, 20 pmol of each forward and reverse primers (Table 2.1), O.2mM dNTP, 3mM 
MgCh and I U SuperTherm Taq in a 50 J.lI reaction volume. The cycling conditions were the same as 
those used for FGF receptor 1 above. The RT -PCR product was cloned into the pGEM-T cloning 
system and verified by partial sequencing of the cloned fragment using the Sequenase 2 sequencing kit 
(USB). 
2.3.4 Restriction fragment analysis of RT-PCR products for detection of FGF receptor splicing 
isoforms 
The RT -PCR products were purified using the Wizard PCR Preps DNA Purification System (promega) 
as instructed by the manufacturers. To discriminate between the lJIb and IIIc isoforms of FGFR 1, 
10111 of the RT -PCR product was subjected to a restriction digestion analysis with the endonucleases 
AccI and VspJ (Amersham) in a 20111 reaction containing IX final concentration of the appropriate 
buffer and incubated at 37°C overnight. F or the FGF receptor 2, EcoRV was used to discriminate 
between the lJIb and lIle isoforms in a similar digestion reaction set up. The digest products were 












2.4.1 0P27 CELL CULTURE IN FGF-2 
For the FGF-2 experiments, cells were plated in petri-dishes at the density of 5x104 cells/cm2 and 
allowed to grow in DMEMflOOIo FCS until 70% confluence at the permissive temperature (33°C). At 
,,," 
time 0, the cells were shifted to the non- permissive temperature (39°C) in serum-free DME,M: Ham's 
F-12 (1:1, vol/vol) medium containing N2 supplement (5,...g/ml insulin, 50llg/ml transf~rrin, 20nM 
progesterone, 100,...M putrescein, 30nM sodium selenite, all Sigma), 5 Ulml heparin (Sigma) aqd FGF-
2 at 5 ng/ml (a kind gift from John Heath, University of Birmingham, UK). The cells were grown at 
this temperature for different time points. After the specified times at 39°C, images of cells were 
captured using a lOx objective on an Olympus microscope. At least 3 images were captured per dish. 
The analySIS® software (Soft Imaging System GmbH) was used to analyse the digital images. 
2.4.2 QUANTITATIVE ANALYSIS OF FGF-2-INDUCED DIFFERENTIATION OF 0P27 
CELLS 
2.4.2.1 Number a/bipolar cells 
With the help of the analySIS@ package, the percentage of cells with bipolar morphology was 
determined by counting the number of bipolar cells in a field per total number of cells in that field. Ten 
randomly photographed fields from 3-4 plates were counted for each time point and averaged. Bipolar 
cells were defined as cells with neurite-like extensions emanating from either side of the cell body, 
with one neurite longer than the size of two cell bodies. 
2.4.2.2 Survival assay 
104/ml cells were seeded in 6-well tissue culture dishes in DMEMfl0% FCS and allowed to adhere at 
33°C. At day 0, the medium in 3 wells from a dish was replaced with 2ml of serum-free DMEM: 
Ham's F-12 containing N2 supplement, heparin and FGF-2 per well while that in the other 3 wells was 
replaced with the same medium but with no FGF-2 (control cultures). The dishes were shifted to 39°C 












each well were trypsinized, incubated in Trypan blue and unstained cells (live cells) were counted 
using a haemocytometer . 
• 
2.4.2.3 Cell proliferation assay 
OP27 cells were differentiated as mentioned in 2.4.2.1. DNA synthesis was measured by labeling 
.. l 
cultures with CH]thymidine (SCi/mmol, Amersham) at 2!!Ci/ml per well for 24hrs. At the end of the 
" 
24hr-Iabelling period, the medium was removed and each well was washed twice with ice-cold PBS 
followed by 2 washes in ice-cold 5% (vol/vol) trichloroacetic acid and aspirated. The cells were then 
solubilized in 0.5ml of 0.25M NaOH. Incorporated 3H-thymidine was quantified by liquid scintillation 
counting of 400!!1 of solubilised cells. Counts from the triplicate wells were averaged and plotted using 
the Microsoft® Excell 2000 software. 
2.5 WESTERN BLOT ANALYSIS 
OP27 cells were treated with FGF-2 as detailed in 2.4.1. Control and differentiated OP27 cells were 
washed twice with ice-cold PBS, and harvested using cell scrapers. The cell suspension was 
centrifuged at 1400rpm for 5min at 4°C and the cell pellets were resuspended in ice-cold lysis buffer 
(SOmM Tris-Cl pH 7.5, 150mM NaCl, 1 % NP-40, 5mM EDT A, lO!!g/ml aprotinin, 10!!g/mlleupeptin, 
40!!g/ml PMSF). Suspensions were homogenized, incubated on ice for 10 min and .cleared by 
centrifugation at 14 000 rpm for 2min to remove cell debris. Protein assays were performed with the 
Bio-Rad Protein Assay kit (BioRad) based on the Bradford dye-binding procedure. For immunoblot 
analysis, 20!!g of proteins from the control and differentiated OP27 cells were separated by SDS-
polyacrylamide gel electrophoresis in 7.5% resolving gel using the Mini-Protean system apparatus 
(BioRad). Proteins were then electrotransferred to a Hybond P transfer membrane (Amersham) using 
the Mini Trans-blot Electrophoretic Transfer Cell (BioRad). The membranes were then blocked at 
room temperature for lh using TBS (IOmM Tris-HCI pH 7.4, O.SM NaCl) containing S% (w/v) fat-free 
dry milk. The blots were incubated overnight at 4°C with primary antibodies at various dilutions 
(Table 2.2) in TBS containing 2% (w/v) fat-free milk. Membranes were washed 3 times in TBS/O.l % 
Tween-20 for Smin at room temperature and incubated with horseradish perixodase-conjugated 












immunoreactivity for NST, TrkB, PLCy2, Gaolf, and f3-actin was detected by chemiluminescence 
using a commercial kit (pierce), while that for NCAM, TrkC and ACIII was detected as follows: (a) 
13.3 III P-(#)umaric acid (Sigma) (stock solution: 14mg P-coumaric acid Iml DMSO) and 1.66111 of 
30% HzOz were added to 3mI of 100mM Tris-HCI pH 8.5 (b) 30111 of 3-aminophalhydmzin (Sigma) .... 
(stock solution: 44mg/ml DMSO) was added to 3ml of 100 mM Tris-HCI pH 8.0 (c).'botl;t solutions 
were then mixed together and poured over the membrane and incubated for 5 min. The s,ignals for all 
antibodies were visualised by exposing the plastic-wrapped membmnes to X-my film after removal of 
" 
excess substmte. 
Table 2.2: List of antibodies and the dilutions used for immunoblotting (western) and 
immunocytochemistry (ICC) 
Species Source Dilution Dilution 
Primary antibody (Western) (ICC) 
J3-actin8 Mouse monoclonal Sigma 1:5000 
Adenyl cyclase type III (AC-III) Rabbit polyclonal Santa Cruz 1:500 
Neural cell adhesion molecule (NCAM) Rabbit polyclonal Chemicon 1 :5000 
Neuron specific tubulin (NST, J3-IIIt Mouse monoclonal Babco 1:250 
Olfactory G protein (Gas/Olf)8 Rabbit polyclonal Santa Cruz 1:1000 1:1000 
Phospholipase C gannna (PLCy)8 Rabbit polyclonal Santa Cruz 1:500 1:1000 
TrkB8 Rabbit polyclonal SantaCruz 1:500 1:1000 
TrkC Rabbit polyclonal SantaCruz 1:500 1:750a 
HRP conjugated secondary antibodies 
Mouse IgG-HRP Goat Dako 1:2000 
Rabbit IgG-HRP Goat Bio-Rad 1:10000 
Goat IgG (H+L)-HRP Rabbit Molecular Probes 1:1000 
Fluoresceine conjugated secondary antibodies 
Mouse- Alexa 488 Goat Molecular Probes 1:100 
Rabbit- Alexa 488 Goat Molecular Probes 1:100 













2.6.1 Coatiljg slides 
4-chamber slides and 12mm round glass covers lips were coated with the E-C-L cell attachment matrix 
, .... 
(entactin-collagen N-Iaminin) (Upstate biotechnology) at 7.51lg/cm2 and 5 Jlg/cm2, re1pec~ively, and 
incubated at 33°C for 1 hour. The slides were then rinsed twice with Ix PBS. 
" 
2.6.2 Plating on slides 
OP27 cells were plated onto E-C-L coated 4-chamber slides at 1.5x104/ml and expanded at 33°C. Cells 
were then differentiated at 39°C in the serum-free medium with FGF-2 for the indicated time periods; 
washed with PBS; fixed with 4% PFA for 10 minutes at room temperature; washed 3x5 min in PBS 
and stored at 4°C in 0.1 % sodium azide in PBS until ready for use. Cells were permeabilised with 
0.1% Triton X-I 00 in PBS for 30 min and blocked in 4% normal serum in PBS for 15 min at room 
temperature. Subsequently, cells were incubated overnight at 4°C with primary antibodies (Table 2.2) 
in 2% normal serum in PBS. Negative controls were incubated with 2% normal serum in PBS only. 
After washing with PBS twice for 5 min, the cells were incubated for 1 hr at room temperature in the 
dark with the appropriate fluorescently conjugated secondary antibodies (Table 2.2) diluted 1: 1 00 in 
2% normal serum. The slides were washed 2x 5min with PBS and DAPI (Sigma) was used to visualise 
nuclei at a 1: 15000 dilution of the 5mg/ml stock. The slides were then covers lipped using Vectashield 
mounting medium and images captured. lllustrations were assembled and processed digitally using the 
Adobe® Photoshop® 5.0 software (Adobe Systems). 
2.7 Olfactory Receptor RT -PCR conditions and identification of receptors 
The PCR was performed in a 20111 reaction volume on a GeneAmp ® PCR System 9700 thermocycler 
(PE Biosystems) using 2.51l1 of first-strand cDNA template (-625ng total RNA), O.4U Super-Therm 
polymerase, Ix reaction buffer, 2mM MgClz, O.2mM each dNTP, and 21lM each ORF3 and OR-C 
primers (Table 2.1). The cycling conditions for olfactory receptor (OR) PCR were as follows: 2 cycles 
of denaturation at 94°C for 4 min, annealing at 50°C for 2 min and extension at 72°C for 3 min and 28 












The PeR was concluded with a 10 min extension at 72°C. The RT-PCR product was gel-purified 
using the GeneClean IT kit (BioRad) and sub-cloned into the pGE~ -T Easy vector system. 
Recombinant plasmids were identified by EcoRI digestion of miniprep DNA and sequence identity of 
clones was determined by automated sequence analysis. Characterization of recepto,[ clones was 
achieved by PCR with SP6 and T7 primers followed by restriction enzyme digest analysis. <. 
2.8 SEMI-QUANTITATIVE RT -PCR 
" 
Total RNA from FGF-2 induced OP27 cells was isolated using TRI REAGENTfM (Molecular Centre) 
and treated with DNase I to remove contaminating genomic DNA Five J.!g of DNase I-treated RNA 
was heat-denatured at 65°C for 5 min and then reverse transcribed in a 20 J.!l reaction volume 
consisting of IX M-MLV reaction buffer, ImM of each dNTP, O.lmg/ml BSA, 0.251lg 0Iigo(dT)15 
primer, 0.251lg random hexamers, 20U recombinant RNasin ribonuclease inhibitor, and 200U M-MLV 
reverse transcriptase, RNase H Minus (promega Corp.). The reaction was carried out at room 
temperature for 10 min, at 37°C for 90 min, and finally at 75°C for 10 min. A negative control reverse 
transcription reaction for each sample was also performed in the absence of reverse transcriptase. 
Semi-quantitative RT -PCR was carried out using 1 J.11 of each RT reaction or negative control 
(equivalent ofO.25J.1g total RNA) with primers for target cDNA and l3-actin in the same reaction tube. 
The PCR reaction contained Ix ~ buffer [16mM ~)2S04, 67mM Tris-HCI (pH 8.8), 0.1% 
Tween-20], 0.2mM each of dNTP, 2!J.M each forward and reverse primer of the target cDNA, 0.05 J.!M 
each l3-actin primer (Table 2.3), 2mM MgClz (1.5mM MgCh for Notch-l amplification), either 5% 
DMSO (for Hes-l, Ngn-l, Gap-43, NeuroD) or 5% formamide (for BF-I) and 0.5U BIOTAQTM DNA 
polymerase (BIOLINE) in a 25 J.!l reaction volume. The annealing temperature for each transcript is 
shown in Table 2.3. The number of cycles for PCR was within the linear range of amplification (26 
cycles). Following PCR, halve of the reaction mixture was analysed on 2% agarose gels and visualized 
by ethidium bromide staining. Images of stained gels were captured using the GeneSnap software 
(Sygene) and saved as TIFF files. Band intensities were analysed with the QuantityOne® software 
(BioRad) by placing rectangular objects over each band and quantitated. Expression levels were 












Table 2.3 Primers used for RT-PCR and semi-quantitative RT-PCR 
Gene Name Primers Sequence (5'-3') Sizes Expected (bp) Ta(oqd Referenee" 
eDNA size Genomic 
1906 • 19G6F AAAGGAACCGGCCTATGAGCAAG 202 202 60 This study 
1906R ATCGCTCGACACAGCACCTTTTC ,,... 
20A4 20A4F CGCCTCAGGTGTTTGAAC 1139 >5000 5f This study 
20A4R CATGACTTGGATCCTCAATG ,,' 
20A6 20A6F TCAAACCGATCTCTCGTCGAT 207 5% 60 This study 
20A6R GGAAGCCTCTTTGCAGATGC 
II 
20m 20G2s CTGGTGGGGTTGCTAAGGGAGAGAAGTG 219 219 60 This study 
GGACACAGCCCCTTCACATGTGCAAAG 
20G3 EST3pl CAGGTGTCCACACGACGATGTCTC 580 ? 60 This study 
EST3p2 CCTAACTGCCGCCCTTGGTTTCTC 
~-actine MAC302 CATTGTTACCAACTGGGACGACA 360 360 55 or 60 DIing et 
MAC480 AGCCATGTACGTAGCCATCCAG 186 186 55 or 60 al.,2002 
MAC666 GCTCGGTCAGGATCTTCATGAGG 
BF-l F510 ACGAGGATCCGGGCAAGGGC 350 350 59 DIing et 
R1474 TACGAATTCGGTGGAGAAGGAGTGG a/.,2002 
Delta-l De1tal-5' TGTGACGAGCACTACTACGGAGAAG 315 2739 55 Fauxet 
Deltal-3' AGTAGTTCAGGTCTTGGTTGCAGAA al.,2001 
GAP43 F747 GACGCTGTAGACGAAGCC 473 473 55 Tloli and 
R1219 GACTCCTCAGAACGGAAC DIinge 
Hesl Hesl-A TGGAGCTGGTGCTGATAACAG 365 498 60 This study 
Hesl-B ATTCTTGCCCTTCGCCTCTTC 
Hes5 Hes5A CCGCTCCGCTCCGCTCGCTAA 449 592 60 b 
Hes5B GCTGGGGGCCGCTGGAAGTGG 
Mash-I Mash 1 A CTCTTAGCCCAGAGGAAC 454 825 60 b 
MashlB GGTGAAGGACACTTGCAC 
NeuroD NeuroDA TTAAGGCGCATGAAGGCCAAC 499 499 60 This study 
NeuroDB TGAGGGGTCCGTCAAAGGAAG 
Neurogenin 1 NgnlA TCCAGCAGCAACAGCAGCA 175 175 60 b 
NgnlB TTCCTGCTCTTCGTCCTGGG 
Neurogenin2 Ngn2A GGACATTCCCGGACACACAC 545 813 60 b 
Ngn2A AGATGTAATTGTGGGCGAAG 
Notch-l 5' primer TTACAGCCACCATCACAGCCACACC 360 360 60 Fauxet 
3' primer ATGCCCTCGGACCAATCAGA al.,2001 
0lf-l OLF-S2 TGTCCACAATAACTCCAAGCACGG 306 306 60 minget 
OLF-AS3 CAGAACTGCTTGGACTTGTACGAC al.,2002 
OTX2 Otx2f CTCTAGTACCTCAGTCCC 242 242 Calofet 
Otx2r GTCCAGGAAGCTGGTGAT al.,19% 
PP2B56y B56GF CCGTGGCCCTTCTCCACATTCG 288 >30000 60 This study 











~he source of the nucleotide sequences of the primers used in this thesis 





cthe MAC302 and MAC666 primers amplify a 360 bp fragment, whereas MAC480.'an~ MAC666 
amplify a 180 bp PCR product 
2.9 mRNA DIFFERENTIAL DISPLAY 
2.9.1 DNase treatment 
Total RNA was extracted from the cells after 0, 6, 24 and 48 hours in FGF-2 at 39°C using the 
TriReagent method. The RNA samples were then DNaseI treated using the MessageClean™ kit 
according to the manufacturer's recommendations (GenHunter Corp.). Briefly, 10-50 Ilg of RNA was 
treated with 10 U of RNase-free DNaseI at 37°C for 30 min, followed by extraction with phenol-
chloroform (3: 1). The RNA was precipitated with 0.3 M sodium acetate and 2.5 volumes of ethanol at 
minus 70°C for at least 1 h, followed by centrifugation for 10 min at 4°C. The pellet was resuspened in 
DEPC-treated H20, quantified by absorbance at 260nm and analysed in a 1 % formaldehyde agarose gel 
to check integrity of samples. 
2.9.2 First-strand eDNA synthesis and peR 
Differential-display PCR was performed with the RNAimage Kit 3 following the manufacturer's 
instructions (GenHunter Corp). Briefly, Illg of DNase I treated RNA from each time point was reverse 
transcribed with the one base anchored 3' oligodT primers H-TnA, H-TuC and H-TnG (H=AAGCTT, 
HindIII restriction endunuclease site Table 2.4). The resulting cDNAs were amplified in duplicate with 
these anchored primers and arbitrary primer set H-AP17 to H-AP24 (Table 2.4) in the presence of 
ABTaqPlus DNA polymerase (Southern Cross Biotech) and [a_33P]dATP. Samples were then 













Table 2.4: RNAimage 3 kit Differential Display Primers 
Priqler Sequence 5'-3' 
One-base anchored oligo(dT) primers 
" .... 













2.9.3 peR reamplification 
PCR amplification products exhibiting differences in treated, compared to non-treated 0P27 cells, were 
excised and eluted by boiling in 100f.l1 H20 for lOmin. Following ethanol precipitation, the cDNAs 
were reamplified by PCR using the appropriate primer combinations and PCR conditions similar to the 
differential display procedure, except that the final dNfP concentration was at 20f.lM, and no isotopic 
label was used. PCR products were analysed on a 1-2% agarose gel. 
2.9.4 Reverse northern slot-blot 
Reverse northern slot-blot was performed combining the protocols described by Zhang et al. (1996) 
and Jung et al. (2000) with modifications. The candidate differentially expressed cDNAs were re-
amplified in a 50f.l1 volume using the same conditions described in 2.9.3, PCR products analysed, gel-
extracted using the GENECLEAN IT gel extraction kit. PCR products of house-keeping genes, p-actin, 












screen) were also generated. For blotting, 30IJ.1 of each PCR re-amplified cDNA was mixed with 1OIJ.I 
of 2M, denatured by incubating at 100°C for 10min and neutralized with IOIJ.1 of 3M sodium acetate, 
pH S.O. Finally, the samples were made up to 11OIJ.I with dH20 and kept on ice. Fifty fll of each 
sample was blotted onto duplicate Hybond W membranes using a 48 well slot-b.!ot manifold 
(HoeferCo). The membranes were UV cross-linked and rinsed in 6xSSC before hyb~diZ4tion. The 
cDNA probes were prepared from Sflg of each of the two RNA samples (control vs c{(lls that were 
treated with FGF-2 for 6hrs) by reverse transcription in a 50fll reaction that consisted of Ix ¥-MLV 
RT buffer, 30J!M dNTP (without dCTP), and O.SlJ.g oligodT. After Smin incubation at 6SoC, the 
samples were shifted to room temperature for 10 min, SOflCi of [a}2P]dCTP (3000Ci/mM) and 500U 
M-ML V reverse transcriptase (Promega) were added followed by incubation at 37°C for 1 hr. After 
reverse transcription, spin columns were used to remove the unincorporated labeL Ten million cpm of 
each of the cDNA probes from the control and treated cells were heat denatured and used to probe the 
duplicate blots in 10ml of hybridization buffer containing 0.1% SDS; 50% formamide; Sx SSC; SO mM 
NaP04; pH 6.8; 0.1 % Sodium Pyrophosphate; 5x Denhardt's Solution and 50 flg/ml sheared Herring 
Sperm DNA at 42°C overnight. Filters were washed twice in 2x SSC, 0.1 % SDS at room temperature 
for 30 min.; twice in 1 x SSC, 0.1 % SDS for 30 min. at room temperature; once in O.2x SSC, 0.1 % SDS 
for 30 min. at 55°C, and finally in 0.1 x SSC, 0.1 % SDS for 30 min. at S5°C until the background was 
low when detected using the Geiger counter. The filters were exposed to the phosphoscreen for up to 2 
days. The phosphoscreen was scanned on a Molecular Imager FX system and hybridisation signals 
were quantitated using QuantityOne® software (BioRad, Hercules, CAl. Band intensities were 
analysed by placing rectangular objects over each band and quantitated. The background intensity 
around each spot in each blot was subtracted from the signal intensity of each spot. No intensity was 
determined in cases where there was no visible signal in the blot. The intensities of the DD cDNAs in 
each blot were normalized to those of the house-keeping genes using 2 approaches. The first approach 
was adapted from Dilks et al. (2003). In this method, the intensities of the house-keeping genes were 
determined in both blots and the intensity of each house-keeping gene in blot 1 was then divided by its 
counterpart in blot 2. The ratios for GAPDH and 21 C2 were then averaged and applied as a scaling 
factor to the intensities of the clones in blot 2. Finally, the intensities of the clones in blot 2 were 
divided by those in blot 1 and expressed as a fold-change difference in expression compared with the 












divided by the signals for GAPDH and 21C2 in each blot. Because both approaches produced similar 
results, only the results generate by the first method are presented in the thesis. 
t 
2.9.5 Northem- blot analysis 
Twenty J.lg total RNA along with 5J.lg RNA molecular weight markers were size fractionated overnight . , 
on a denaturing gel containing 1% agarose, 20mM MOPS, 5mM sodium acetate, 6% formaldehyde and ,. 
ImM EDTA, transferred to a Hybond N+ membrane by capillary blotting and immobilised by UV 
crosslinking. cDNA fragments for the candidate differentially expressed were labelled with the 
MegaPrime DNA labelling kit using [a-32P]dCTP (Amersham Pharmacia Biotech). Unincorporated 
dNTPs were removed with spin column chromatography. The probes were hybridized at 42°C 
overnight in a buffer containing 0.1% SDS; 50% formamide; 5x SSC; 50 mM NaP04; pH 6.8; 0.1 % 
Sodium Pyrophosphate; 5x Denhardt's Solution and 50 J.lg/ml sheared Herring Sperm DNA. Blots 
were washed twice in 2x SSC; O.I%SDS for 30 min at room temperature, once in Ix SSC; 0.1% SDS 
for 30 min at room temperature and once in 0.2x SSC; 0.1 % SDS for 45 min at 55°C. The results were 
visualised by autoradiography on Hyperfilm MP X-ray films (Amersham Pharmacia Biotech). 
2.9.6 Verification of differential expression by semi-quantitative RT-PCR 
cDNA fragments were cloned using the pGEM-T Easy cloning system following the manufacturer's 
instructions. The plasmids containing the cloned inserts were sequenced in both 5' and 3' directions 
using a Molecular Dynamics Mega BACE 500 fluorescent sequencing facility available at the 
Department of Molecular and Cell Biology, University of Cape Town, South Africa. Gene-specific 
primers were then designed (Table 2.3) and semi-quantitative RT -PCR used to confirm diffferential 
gene expression as mentioned in section 2.8. 
2.10 Rapid Amplification of eDNA Ends (RACE) 
To determine the 5'- and 3' - ends of the cDNAs identified in the differential display screen, 5' and 3' 
RACE was performed by using the SMART RACE cDNA amplification kit (ClonTech). Briefly, the 












heat-denatured (70°C for 2min) total RNA from OP27 cells treated with FGF-2 for 4Shrs, 1 J..I.M 5'-
RACE cDNA synthesis primer (5'-CDS), IJ..1.M SMART IT oligonucleotide, Ix first-strand buffer 
[50mM Tris-HCI (PHS.3), 75Mm KCI, 6mM MgCb], 2mM DTT, 1 mM dNTP and 200U SuperScript IT 
M-MLV RNaself reverse transcriptase (Gibco-BRL). The mixture was incubated at 42°C for 90 min, 
".. , 
followed by dilution of the first-strand reaction with 100J..l.I of Tricine-EDTA buffer [lOmM Tricine-
KOH (pHS.5), ImM EDTA] and incubating at 72°C for 7 min. The 3'- RACE -Ready.cDNA was 
synthesised using the same procedure except that the 5' -CDS and SMART IT oligonucleotid~s were 
replaced with IJ..1M 3'- CDS primer. The PCR included 2.5J..1.1 of 5'- or 3'- RACE -Ready cDNA, Ix 
universal primer mix (UPM), 0.2J..1M gene specific primer, Ix Advantage 2 PCR buffer [(40mM 
Tricine-KOH, pH S.7; 15mM KOAc; 3.5mM Mg(OAch; 3.75J..1.g1ml BSA; 0.005% Tween-20; 0.005% 
Nonidet-P40)], O.2mM dNTPs and 1 x Advantage 2 Polymerase mix in a total volume of 50J..l.L The 
sequences of the kit primers and all gene-specific primers are shown in Table 2.4. The PCRs were 
performed in a GeneAmp PCR System 9700 (perkin- Elmer) using cycling parameters recommended 
by the kit manufacturers. Ten to 20J..l.I ofPCR reaction were analysed on 1.2% agarose and transferred 
overnight onto Hybond W membrane for Southern blot analysis using an internal oligonucleotide as a 
probe to confirm identity of RACE product. The positive RACE products were purified by using the 
GENECLEAN IT gel extraction kit (BIO 101 Inc.) and ligated into the pGem-T Easy system (promega 
Corporation). The sequences of both strands were determined by cycle sequencing. 
2.11 I.M.A.G.E. eDNA clones 
The 1M.AG.E. cDNA clones matching the cDNAs isolated in the differential display screen were 
purchased from Research Genetics as bacterial stocks grown in LB with 8% glycerol and 50J..l.g1ml 
ampicillin. Individual clones were isolated by streaking out the stocks on LB agar plates containing 











































Searches for homologies or identities of cDNAs were perfonned using the BLAST algorithm (Altschul 
et al., 1990) against the nucleotide and protein databases and also to expressed sequence tags databases 
(dbEST) at the NCBI (htt;p:llwww.ncbi.nlm.nih.gov). Various web-based bioinfonnatics tools were 












Table 2.6 Bioinformatic Tools used in the analysis of the genes identified in the DD screen 
Anal~is • Tool URL Reference 





Sorting signals and PSORTII http://psort.nibb.ac.jp/form.html Nakai and Horton, 
subcellular 1999 
localization 
Identification of PROSITE http://wv.w.expasy.chlprositel Hofinann et al.,'"1999 
functional motifS 
Identification of SMART http://smart.embl-heidelberg.del Ponting et aI., 1999. 
domains 
Identification of SignaJP v 1.1 http://www.cbs.dtu.dklservices! SignaJP Nielsen et ai., 1997 
signal peptide and 
cleavage site 
Prediction of TargetP vl.OI http:// wv.w.cbs.dtu.dklservicesl TargetP Emanuelsson et af., 
subcellular 2000. 
localization 
Analysis of Predotar v 0.5 http://www-inra.fr/predotar 
mitochondrial 
target sequence 
Phylogenetic ClustalW http://www.ebi.ac.uklcJustalw/ Higgins et al., 1994. 
analysis 















Effects of FGF -2 on the immortalized olfactory placodal 
cell line OP27 
3.1 Introduction 
The OE provides a useful model to identify molecular factors that regulate neurogenesis. There is 
increasing evidence indicating that cell numbers at each stage of the ORN lineage are regulated by 
extrinsic factors. A number of these signalling molecules have been reported to regulate olfactory 
neurogenesis, including FGFs, retinoic acid, epidermal growth factor (EGF), transforming growth 
factor (TGF-~) and leukemia inhibitory factor (LIF) (Calof et al., 1991; Mahanthappa and Schwarting, 
1993; DeHamer et aI., 1994; Satoh and Yoshida, 1997; Mackay-Sim and Chuah 2000; Illing et al., 
2002). 
As shown in Chapter 1, FGF-2 has many roles in neuronal development, including effects on 
proliferation of progenitor cells, differentiation, migration and survival. There is increasing evidence 
that FGF-2 may play similar roles in OE neurogenesis. This has come from work done in vitro using 











3.1.1 Expression ofFGF-2 and its receptors in the OE 
Although there is little consensus as to the type of cells that express FGF-2 or its subcellular 
localization, its expression in the OE has been shown by various laboratories. In one study using adult 
mice, the FGF-2 protein was detected in nuclei of the sustentacular cells and some apically located 
neurons (Goldstein et aI., 1997). In another study, high immunoreactivity was detected in the 
cytoplasm of sustentacular cells with lower levels in neurons and basal cells while the mRJ~A levels 
were high in the basal and neuronal layers with low levels detected in the sustentacular cells (Hsu et al., 
2001). In neonate mice there was extensive immuno-labelling throughout all layers of the OE (Chuah 
and Teague, 1999). There have been no studies of FGF-2 expression in the OE during embryonic 
development 
Knowing which FGF receptors are expressed in the OE can provide clues about the role of FGF in 
olfactory neurogenesis. From published reports, FGFR-l and FGFR-2 seem to be the only FGF 
receptors that are present in the OE (reviewed by Mackay-Sim and Chuah 2000). Using RT-PCR, 
~A transcripts of both receptors were identified in olfactory mucosal extracts of both embryonic 
and adult mice (DeHamer et aI., 1994; Hsu et al., 2001). High FGFR-l immunoreactivity was 
observed in both basal and neuronal layers and very little in the sustentacular cells (Nibu et aI., 2000; 
Hsu et al., 2001). The expression of the FGFR-2 protein has not been reported in this tissue. 
Analysis of which receptor splice variants are expressed in the OE or in any other tissue can define the 
FGF ligands the cells can respond to (Omitz et al., 1996, see Table 1.1). Using RT-PCR with primers 
specific for each FGFR- splice variant, a limited set of the variants, namely FGFR-I IITb, FGFR-I lITe 












This would suggest that these splice variants may mediate signals initiated by the fo llowing FGF 
ligands: FGF-l; FGF-2; FGF-4; and FGF-9. FGF-2 has a high affinity for FGFR-l nlc and to a lesser 
extent FGFR-2 IDc (Table 1.1). FGF-l, FGF-2, FGF-4, FGF-7 and FGF-8 have been shown to 
stimulate proliferation of olfactory cultures but only FGF-2 (see below) and FGF-8 have been shown to 
be expressed in the OE (DeHamer et al., 1994; Calof et aI., 20002;). 
Currently, there is no information available regarding differential spatial or temporal expression of the 
3 identified splice variants in the OE during development (ie. whether a particular receptor isoform is 
expressed at a certain stage of the ORN lineage). This can be achieved through direct in situ 
hybridization studies using the splice variants as riboprobes and should help define the role of FGF in 
each stage of the ORN lineage. 
3.1.2 Role ofFGF-2 in the development of the OE neuronal lineage 
There is no universal agreement on the role ofFGF-2 in olfactory neurogenesis, although the general 
consensus is that it is a mitogen for the OE neuronal precursors. It seems that the role ofFGF-2 in OE 
neurogenesis is to regulate the number of cell divisions that precursor cells go through and not to 
determine the fates of these progenitors. In explant cultures derived from EI4.S-ElS.S mouse OE, 
FGF-2 was found to significantly increase the proliferation of transit amplifYing celIs and as a result 
delayed their differentiation. In these cultures, FGF-2 was also found to support the proliferation of a 
rare stem-like cell (DeHamer et al., 1994). In the absence of any growth factor, the INPs divide only 
once and differentiate terminally to give rise to ORNs. In the presence of FGF-2 the number ofINPs 
that went through 2 rounds of cell division instead of one, increased before they differentiated 












Similar results were observed in studies conducted by MacKay-Sim and co-workers. The number of 
ORNs induced by TGF~2 (a differentiation factor in these cultures) increased in progenitor cell cultures 
that had been pre-treated with FGF-2, compared to control cultures that did not receive FGF-2. In 
these cultures, FGF-2 stimulated proliferation of the progenitor basal cells but had no effect on both the 
differentiation and survival of these cells (Newman et ai., 2000). Additionally, treatment of the adult 
rat olfactory epithelium-derived NIC cell line with FGF-2, was found to suppress neuronal 
differentiation as evidenced by the reduction in the expression of neuronal markers. Instead, the NIC 
cells were maintanied in a proliferative state (Goldstein et aI., 1997). 
However, neuronal differentiation is not precluded by the mitogenic actions of FGF-2 in olfactory 
cultures. Cells of a line derived from human fetal OE increased eH]-thymidine incorporation in 
response to FGF-2 treatment and these cells later differentiated into neuronal cells, suggesting that 
FGF-2 may influence initial stages of differentiation (Ensoli et aI., 1998). FGF-2 induced neuronal 
differentiation in OE explant cultures of both embryonic mouse and adult human OE with the 
phenotype of the bipolar cells confrrmed by expression of neuronal specific markers (MacDonald et aI., 
1996; Murrel et aI., 1996). Lastly, FGF-2 was found to enhance ORN regeneration and the subsequent 
reinnervation of the olfactory bulb following chemical lesion of the adult rat neuroepithelium (Herzog 
and Otto, 1999). 
To establish the absolute functions of FGF-2 in the ORN lineage, analysis of mice carrying null 
mutations in the FGF-2 gene would be necessary. Fgf-2 knockout mice have been generated to study 
its effects in the development of the cerebral cortex (Dono et aI., 1998; Ortega et aI., 1998). However, 












This chapter describes the differentiation of a novel cell line, OP27, derived from ElO.5 mouse OE 
(Illing et ai., 2002) and the molecular characterization ofthe cell line following treatment with FGF-2. 
3.2 RESULTS 
3.2.1 0P27 CeUs Express FGF Receptors 
FGF-2-mediated activities, including proliferation, differentiation, and/or survival require binding of 
the growth factor to its high-affmity tyrosine kinase receptors. To determine whether the OP27 cell 
line expressed any of the 4 FGF receptors, I used an approach that was described by McEwen and 
Ornitz (1997). A pair of degenerate primers based on conserved sequences in the tyrosine kinase 
domain ofFGFR-I-4 (Fig. 3.1) was used to simultaneously amplify all FGFR-s by RT-PCR, followed 
by specific restriction enzyme analysis with enzymes that recognize each FGFR to yield unique 
digestion fragments (Table 3.1). 
Table 3.1 Predicted restriction endonuclease digest patterns for mouse FGFR RT-PCR product amplified with the 
degenerate primers, DOl 56 and DOl58 (McEwen and Ornitz, 1996). The sizes of the digested fragments are in base-pairs 
(bp). 
Enzyme FGFR-l FGFR-2 FGFR-3 FGFR-4 














RT-PCR with the degenerate primers, D0156 and D0158 (Table 1.1; Fig. 3.1A) gave the expected 
341bp product in the OP6, OP27, OP47 and OP55 olfactory placode cell lines (Fig 3.1B). To 
distinguish between the FGFRs expressed in 0P27 cells, the RT-PCR product was digested with PvuII, 
PstI, and EcoRI. Each of the RE digest analysis gives unique fragments. PvuII recognizes both FGFR-
1 and FGFR-2 but with distinct digest patterns, while Pst! and EcoRI recognize FGFR-3 and FGFR-4, 
respectively (Table 3.1). Only PvuII was able to completely digest the PCR product to yield the 
expected fragments for FGFR-I and FGFR-2, while Pst! and EcoRI did not yield any digest fragments 
(Fig 3.1C). This analysis therefore suggested that only FGFR-l and FGFR-2 were expressed in the 
OP27 cell line. The absence ofFGFR-3 and FGFR-4 expression in these cells was further confirmed 
by RT-PCR using gene specific primers for both primers (Fig.3.2). 
3.2.2 Alternative splice forms ofFGFR-l and FGFR-2 mRNAs in the OP27 ceD line 
All the FGFRs with the exception of FGFR-4 are expressed in multiple variant forms arising from 
alternative splicing of mRNA transcripts (Johnson and Williams, 1993). The isoforms of the FGFRs 
generated by splicing result in distinct binding specifities and affmities for their ligands. I determined 
by gene-specific RT-PCR which splicing variants ofFGFR-1 and FGFR-2 are expressed in the OP27 
cells. All FGF receptors contain the signal peptide, 3 extracellular immunoglobulin (Ig)- like domains 
(I-ill), a string of acidic amino acid residues (known as the acidic box) between the frrst two Ig 
domains, a hydrophobic transmembrane (1M) domain, the juxtamembrane (JM) domain between the 
TM and the split tyrosine kinase (TK) domain FGFR-l was amplified using a sense primer, Fl189 
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Figure 3.1 Identification ofFGFR-s expressed in the OP cell lines. (A) Sequence alignment of tyrosine kinase domains of 
mouse FGFR-I-4, showing the conserved nucleotides ( oo. ) and restriction enzyme sites in bold and underlined. Primers 
00156 and 00158 are indicated. Adapted from McEwen and Ornitz, 19%. (B) The 341bp RT-peR product amplified in 
the OP cell lines. -, non reverse transcribed RNA sample; +, reverse transcribed RNA samples used as templates for RT-
peR. Ml, l00bp marker (from the top 1500; 1000; 900; 800; 700; 600; 500; 400; 300; 200; 100 bp, Promega). (e) The 
RT-peR product from the OP27 cell line was digested with the restriction enzymes and analysed on a non-denaturing 
polyacrylamide gel. The FGFR-l specific digest patterns are indicated with black arrows, and the FGFR-2 specific digest 
patterns are indicated with red arrows. The undigested R T -peR product is indicated with the black arrow-head. M2, 
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Figure 3.2 Expression ofFGFR-3 and FGFR-4 in the brain, OP27 cell line, and olfactory epithelium. RT-PCR products of 
FGFR-3 (997 bp) and FGFR-4 (936 bp) were detected in brain and olfactory epithelium (OE). FGFR-3 and FGFR-4 were 
not detected in the OP27 cell line. -, non reverse transcribed RNA sample; +, reverse transcribed RNA samples used as 
templates for RT -PCR M, A. DNA digested with PstI as a molecular weight marker, sizes (in bp) shown on the left. 
The primers encompass at least 2 alternatively spliced regions of FGFR-I : the first Ig domain (Ig I) and 
the second half of IgllI which gives rise to either the IIIb or IIIc isoforrns. Splicing in the Ig I domain 
generates isoforms known as FGFR·l a, which contains Ig I together with the other 2 Ig domains, 
FGFR-IP which lacks the 267 bp exon for the Ig I, or FGFR-ly which, like the p-isoform lacks IgI but 
has an 144 bp insertion instead of the 267 bp exon (Fig 3.3A, Yamaguchi et aI., 1994). RT-PCR with 
the FGFR-l oligonucleotides in the OP6, OP27, OP47 and OP55 cell lines yielded fragments of 1090 
bp, 967 bp, 823 bp encoding the a, y, and P isoforrns, respectively. These RT-PCR products were 
subsequently confIrmed as FGFR-I transcripts by Southern blot analysis with a fluorescently labeled 
internal oligonucleotide, 1-1191 (Fig. 3.3B). The FGFR-l P isoform is the predominant PCR product in 
all four cell lines, with the FGFRI-a and FGFRI-y isoforms expressed in much less abundance. To 
distinguish between the IIIb and me isoforrns in OP27, the FGFR-I RT -PCR product was digested 
with Vspl and Acel restriction endonucleases which recognize the IIIb and me isoforrns, respectively 
(Fig. 3.3 C, Kalyani et aI., 1999). The product of the predominant 823 bp FGFR-l P RT-PCR product 
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Figure 3.3 Identification of the isofonns of FGFR-l expressed in 0P27 cells. (A) General structure of FGFR-l showing the 
alternatively spliced variants (presence or absence of IgI domain and alternative use of exons, IIIb or IIIc for the C-terminal 
end ofIgIlD; and the positions ofRT-PCR primers as indicated by arrows. FI189 and RII90 primers are specific for the 3 
variants of FGFR- I viz. a. (containing all 3 Ig domains); /3 (missing Igl); y (contains a 144bp insert instead ofIgl); 1-1191 
an internal oligonucleotide used for Southern blot analysis ofFGFR-1 PCR products. SP, signal peptide; L II, III, Ig-like 
domains; A, acid box; IIIb/c, either the IIIb or IlIc splice isoform; TM, transmembrane; TKI and TK2, split tyrosine kinase 
domain; CT, C-terminal cytoplamic tail. (8) Southern blot analysis of FGFR-I RT-PCR products using the internal 
oligonucleotide 1-1191 in (A) as a probe. Three hybridising bands representing the 3 variants a., /3, and y are shown. (C) 
Restriction digestion of the IIIb and IlIc isoforms ofFGFRI/3. Vspl recognizes the IIIb isoform and digests this isoforrn to 
generate two fragments of sizes 638 bp and 185 bp. AceI recognizes the IlIc isoform and gives rise to the 7 12 bp and I I I 
bp fragments. The sites for the restriction enzymes are shown in brackets. (D) The 823 bp FGFR-I/3 RT-PCR product 












Digestion with AccI of the 823 bp PCR product gives rise to 712 bp and 111 bp digest fragments, thus 
confIrming the presence of the FGFR-1 IIle isoform (only the 712 bp fragment is visible on the gel in 
Fig. 3.3D). Digestion of the PCR product with Vspl does not result in any fragments. The FGFR-l 
RT -PCR product was subsequently cloned into the pGEM-T vector. Nucleotide sequence analysis 
confIrmed that the IIIc variant ofFGFR-1 was expressed in the OP27 cells. 
For analysis of expression of FGFR-2 splice variants in OP27 cells, the PCR primers were also 
designed to amplify both the IIlb and IIIc isoforms. The sense primer (FR2f) was located in the region 
between IgII and the N-terminal end ofIgIlI while the antisense primer sequence (FR2r) was proximal 
to the tyrosine kinase domain (Fig. 3AA). These primers were able to amplify the expected -770 bp 
product (Fig 3AC, lane 2). Digestion of the PCR product with EcoRV which recognizes the IIIc 
isoform of FGFR-2 isoform and not rub (Orr-Urtreger et aI., 1993) (Fig. 3AB) resulted in complete 
cleavage of the FGFR-2 to give digest products of 279 bp and 498 bp (Figure 3AC lane 3). This 
suggests that FGFR-2 nIb is not present and only the FGFR-2-IIIc isoform is expressed in the OP27 
cell line. 
In summary, OP27 cells express a subset of the FGF receptors. FGFR-l IIle is expressed in OP27 cells 
as the 3 alternatively spliced variants, FGFR-la, FGFR-1j3 and FGFR-ly with the FGFR .. lj3 being the 
predominant isoform FGFR-2 was also detected in OP27 cells and identified as the IIIc isoform. 
FGFR-2 is also known to occur as a receptor with either three or two Ig domains (Bansal et ai., 1996). 
However, I was only interested in determining whether both FGFRs were expressed as either the IIIb or 
IIIc splice form since these determine ligand binding specificity, I did not determine whether FGFR-2 
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Figure 3.4 Identification of the isofonns ofFGFR-2 expressed in OP27 cells. (A) General structure of FGFR-2 showing the 
positions of RT -PCR primers as indicated by arrows. SP, signal peptide; 1, II, III, Ig-like domains; A, acid box; illblc, 
either the lITh or IlIc splice isoform~ TM, transmembrane; TKI and TK2, split tyrosine kinase domain; CT, C-terminal 
cytoplamic tail . (B) Diagrammatic representation of the restriction digest analysis of the lITh and IIIc isofonns of FGFR2 
RT-PCR product amplified with the FR2f and FR2r primers. EcoRV recognizes the TIrc isoform only resulting in digest 
fragments of 279 bp and 4% bp fragments . The site for each restriction enzyme in each of the FGFR-2 isofonn is shown in 
brackets. (C) The FGFR-2 primers, FR2f and FR2r amplified the expected 77Sbp PCR product (lane 2) that was completely 
digested with EcoRV (lane 3) which is specific for the IIIc isoform of FGFR-2. The digest products of the FGFR-2 IDe 













Since I had established that the OP27 cells expressed FGFRs, I sought to study the effects ofFGF-2 on 
these cells. FGF-2 has high affinity for the FGFR-l me isoform and to a lesser extent, the FGFR-2IDc 
isoform (Omitz et al., 1996). Since theIgi is not essential for ligand binding, the FGFR-1a and FGFR-
1P do not show any significant difference in ligand binding (Xu et aI., 1999). 
3.2.3 FGF-2 promoted the outgrowth of bipolar ceUs 
To study the effects ofFGF-2 on the OP27 cells, the cells were cultured at 33°C in DMEM and 10% 
FCS until they reached 70010 confluence. At time 0, the media was replaced with either N2 (control 
cultures) or with N2 plus Snglml FGF-2 and cells were shifted to the non-permissive temperature 
(39°C). After 24 hours at 39°C, the control cultures had the same morphology as the cells at the 
permissive temperature (33°C) and no phase-bright cell bodies were visible (Fig. 3.5A and Fig 3.SC). 
In contrast, phase-bright cell bodies were clearly visible in OP27 cells treated with FGF-2 for 24 hours. 
Secondly, several cells had changed morphology at this time to take on a bipolar morphology, with 
neurite-like extensions emanating from either side of the cell bodies (Fig 3.SB). At this stage several 
cells still had the same morphology as the cells at 33°C. After 2 days the number of cells with the 
bipolar morphology had increased compared to the 24 hour time point and continued to be prominent 
until after 10 days (Fig. 3.5D-E, G-H). Meanwhile, the cell density of control cultures that were not 
treated with FGF-2 decreased as the cells were observed to detach from the culture dishes, round-up 
and float on the culture medium with very few cells still attached. This was especially evident after 4 
days in culture (Fig. 3.5 F). The cell density of FGF-2 treated cultures also decreased with time but 












Figure 3.5 Phase-contrast micrographs of OP27 cells cultured at 33°C and at 39"C under serum-free conditions with or 
without FGF-2 for 10 days. At the pennissive temperature of 33°C (A), they grow as clusters of flat and irregularly shaped 
epithelial cells. When shifted to the non-permissive temperature of 39"C with FGF-2, the cells assume a bipolar shape, 
developing neurite-like processes (arrows), conoommitant with the reduction in the size of the cytoplasm $, D, F, G and 
H). Phase-bright cell bodies are evident in cells treated with FGF -2 (indicated by *). There were no morphological changes 
observed in cultures without FGF-2 (C and E). Instead, the cells looked unhealthy at first (C) with the nuclei not readily 
apparent. After 4 days without FGF-2 (E), a large proportion of the cells were rounded up, detached and found floating on 












A: 0P27 cells at day 0 B: After 1 day at 3<J>C with FGF-2 
C: After 1 day at 3<J>C without FGF-2 D: After 2 days at 3<J>C with FGF-2 
E: After 4 days at 3<J>C without FGF-2 F: After 4 days at 3<J>C with FGF-2 












3.2.4 Quantitation of bipolar cells in culture 
The bipolar cells that appeared following treatment of OP27 cells with FGF-2 were quantified. The 
proportion of bipolar cells was determined over the time course of the FGF-2 assay. The first 2-4 days 
in culture was characterized by a lag phase in the appearance of bipolar cells, with the proportion of 
bipolar cells around 20-30% during this period. At 6 days in vitro (DN) the proportion of bipolar cells 
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Figure 3.6 Time course of the percentage of bipolar cells in OP2? cultures treated with FGF-2 . Each point represents the 
mean ± SEM of cell counts on each often randomly photographed fields (at magnification lOX) taken from 3-4 plates per 












3..2.5 Effect ofFGF-2 on the survival ofOP27 ceUs 
The total number of viable OP27 cells in both N2 and N2 + FGF-2 was counted every 2 days beginning 
at 2DN at 3goC, to quantify the effect of FGF-2 on their survival. When cultured in N2 only, the 
OP27 cultures showed a significant decline in number of viable cells (Fig. 3.7). After 10 days in 
culture, only 0.3% of the cells originally present at day 0 remained. To determine whether the decline 
in cell numbers in N2 began at 2 DIV, the number of cells was counted at day 0 and at day 1 following 
the shift to N2. At IDIV the cell numbers had already declined, and by 2DN approximately half the 
numbers at 33°C (day 0) remained (Fig. 3.7 insert). This suggests that the shift to the serum-free media 
and to the non-permissive temperature of 3goC compromised the survival of OP27 cells. 
In contrast, the cultures had a better survival in the presence of FGF-2. Within 24 hrs following the 
shift to N2 + FGF-2 and to 3<JOC, the total number of cells was double the number present at day O. 
This is in direct contrast to the cell numbers at the same period in control cultures without FGF-2 where 
the numbers were halved compared to day 0 (Fig. 3.7 insert). It is likely that the OP27 cells went 
through one round of cell division at 3goC in the presence of FGF-2, with cell numbers doubling. 
However, cell numbers declined steadily after 24 hrs even though they were maintained above those of 
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Figure 3.7 Effect ofFGF-2 on 0P27 cell survival at 39°C. 3x104 cells were plated on six-well culture dishes and cultured 
with or without FGF-2 at the non-permissive temperature (39°C). After every 2 day interval the cells from a dish were 
harvested by by trypsinization and the number of viable cells was determined by the exclusion of the Trypan blue dye. The 
insert (from a separate experiment) shows the 0P27 cell numbers determined at day 0 and at 1 and 2 days in vitro. The 
numbers increased for the first 24hrs at 39°C in the presence ofFGF-2 and decreases thereafter. Values are the means and 
standard deviations of three wells for both the experiment and the control. The graph shown above is a representative of 
two independent experiments. 
3.2.6 Effect of FGF-2 on the proliferation of 0P27 cells 
FGF-2 has a mitogenic role for the neuronal precursors in the OE and elsewhere in the nervous system 
(see section 3.1 and Chapter 1). It was therefore possible that the increased survival of OP27 cells at 
39°C in the presence of FGF-2 (particularly within the first 24 hours when cell numbers were twice 
those at day 0) compared to control cultures without the growth factor was a result of increased 
proliferation mediated by FGF-2. To test this hypothesis, the effect of FGF-2 on the proliferation of 
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Figure 3.8 [)f]-thymidine incorporation of OP27 cells in response to FGF-2. Cells were plated on six-well culture dishes 
and cultured with or without FGF-2 at the non-permissive temperature (39°C). Both the treated and control cells were 
incubated with eHl-thymidine for 24hrs prior to measuring [~-thyrnidine incorporation by scintillation counting. The 
incorporation was determined for every second day at 39°C. The insert shows the [~-thymidine incorporation determined 
for the 0P27 cells at day 0 and the first 48hrs at 39°C (I and 2 days in vitro). Values are the means and standard deviations 
of three wells for both the experiment and the control 
As shown in Fig 3.8, there was a significant reduction in the (,H]-Thymidine incorporation when the 
OP27 cells were cultured in the absence of FGF-2 under serum-free conditions. In 24 hours [~]-
thymidine incorporation had dropped to -20010 of the cells at day 0 and by 2DIV this dropped further to 
0.3%. Cell cultures treated with FGF-2 showed a higher ('H]-thymidine incorporation compared to 
control cultures. The eH]-thymidine incorporation at IDlY was -70% of that at day 0, compared to 
the 20010 by the control cultures at the same time (Fig 3.8 insert). The relatively high eH]-thymidine 
incorporation in FGF-2 treated cultures is consistent with the doubling of the ceU numbers at the same 












2 to 4 days. From 6DN onwards [~-thymidine incorporation was low and similar to that of control 
cultures. This would suggest that the FGF-2 treated cells were gradually withdrawing from the cell 
cycle. However, since the apparent decline in eH]-thymidine incorporation beyond 4 days parallels the 
massive death of cells (Fig 3.7) it may not be possible to conclude rigorously that 0P27 cells cultured 
beyond 4 days are not mitotically active. The data in Fig. 3.8 was thus normalized for the cell numbers 
shown in Fig. 3.7. This normalization appears in Fig. 3.9. Similarly to the data shown in Fig. 3.8, the 
flfst 2 days are characterized by a decline in [~-thymidine incorporation in total cell numbers. 
However, between 2 and 4 days, there was a significant increase in [3H]-thymidine incorporation which 
may suggest that a sub-population of OP27 cells was still mitotically active at this stage. Beyond 4 
days there was a decline again thus indicating that OP27 cells at this stage were indeed not 
proliferating. Neuronal differentiation is preceded by exit from the cell cycle. The increase in the 
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Figure 3.9 [3H] thymidine incorporation nonnalized for total OP27 cells. The data shown in 3.8 was nonnalized with that 












3.2.7 Phenotypic characterization ofFGF-2-induced neuronal differentiation ofOP27 ceDs 
Defmed molecular markers can characterize the phenotype of the cells at the various stages of the ORN 
differentiation pathway. Various molecular biology techniques including RT-PCR, western blot 
analyses and immunocytochemistry have been used to defme the phenotype of differentiated cells 
(Cunningham et aI., 1999; Murrell and Hunter, 1999; Barber et aI., 2000; Illing et al., 2002). A 
selection of these markers had already been used to characterize the OP27 cell line following retinoic 
acid-induced differentiation (Illing et aI., 2002). I have used the same markers to characterise the 
behaviour of the OP27 cells under the influence ofFGF-2, using the above-mentioned techniques. 
3.2.7.1 RT -PCR characterization 
RT-PCR assays were performed on total RNA isolated from the OP27 cells at different time points of 
differentiation using oligonucleotide primer pairs specific for growth associated protein-43 (GAP-43) 
and olfactory marker protein (OMP) (Tables 2.1 and 2.3). GAP-43 is a membrane associated 
phosphoprotein whose wide expression in the nervous system is correlated with process-outgrowth, 
axonal regeneration and synaptogenesis. In the olfactory epithelium GAP-43 is expressed in immature 
ORNs that are not terminally differentiated (Pellier et al., 1994). Using a semi-quantitative RT-PCR 
assay, the message for GAP-43 was found to be transiently up-regulated as the OP27 cells 
differentiated. At the non-differentiated state and after 6 hours following FGF-2 treatment, very faint 
bands were detected. The mRNA levels for GAP-43 increased after 24 hours and peaked at 48 hours 
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Figure 3.10 Transient up-regulation of GAP-43 mRNA expression by FGF -2 in OP27 cells. (A) A representative 
semiquantitative RT -PCR analysis of GAP-43 rnRNA in OP27 cells treated with FGF -2 for the indicated times. Cells that 
had not been treated (33°C) were included as controls. GAP-43 and ~-actin were amplified together in the same reaction 
tube. hr, hours; d, days. (+) amplification from RNA that had been reverse transcribed, (-) RNA that were not reverse 
transcribed as negative controls. Molecular weight sizes (in base pairs, bp) are indicated on the left. (B) GAP-43 and ~­
actin mRNA levels were determined by densitometric scan of the bands at each time-point. Data are expressed as fold 
increase in the ratio of Gap-43/~-actin with the value of the cells at 33°C (time 0 days) taken as I and represent mean ± 
SEM values of3 independent experiments. Significance, *P<O.05, compared to 0-1 day and 6-10 days. 
OMP is the classical marker for mature olfactory neurons in vivo (Rogers et aI., 1987). I determined 
whether the OP27 cells express any OMP transcripts as the cells differentiated. A faint transcript of 
242 bp was amplified after 10 days following FGF-2 treatment but this was never reproducible from 
experiment to experiment (results not shown). This suggests that that even though these cells resemble 
differentiating cells morphologically, they do not differentiate into mature olfactory neurons in 10 days 












3.2.7.2 Western blot analyses 
OP27 cells were induced to differentiate for Sand 10 days in vitro (SDIV and lODIV, respectively) and 
examined for the expression patterns of markers characteristic of differentiating olfactory neurons, 
using western blot analyses. Neuron specific type TIl J3-tubulin (NST) is among the earliest 
characterized markers of neuronal differentiation Its expression occurs just before or during the last 
division of neuronal precursors of both PNS and CNS (Roskams et aI., 1998). OP27 cells express high 
levels of NST at the non-differentiated state but expression levels decreased when the cells were 
induced to differentiate in the presence ofretinoic acid (Illing et aI., 2002). When the cells are induced 
with FGF-2 at 39°C the NST levels were also found to decrease after SDIV and 10DIV compared to 
the non-differentiated state (Fig. 3.11 A). 
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Figure 3.11 Expression patterns of P-Ill neuron-specific tubulin (NST) and neural cell adhesion molecule (NCAM) on 
0P27 cells treated with FGF-2. Immunoblot of OP27 cel.ls was prepared using total protein lysates from cells at 33°C and 
cells that had been treated with FGF-2 at 39°C for 5 days in vitro (SDJV) and 10 days in vitro (IODIV). The olfactory 
epithelium (OE) was used as a positive control. Each blot was used for each of the olfactory neuronal developmental marker 












The neural cell adhesion molecule (NCAM) is widely expressed throughout the nervous system and has 
been implicated in the control of neural progenitor cell proliferation and differentiation (Amoureux et 
aI., 2000). During vertebrate development multiple splice variants of NCAM are expressed. The 3 
major isoforms are the NCAM120, NCAM140, and NCAM180, based on their molecular weights. In 
addition, NCAM is posttranslational1y modified by addition of long chains of polysialic acid residues. 
This polysialylation results in the abberant electrophoretic migration of smeared bands of NCAM in 
immunoblots (Fujimoto et al., 2001; Illing et al., 2002). As the neurons mature NCAM becomes less 
sialylated and appears as distinct bands on immunoblots (Illing et aI., 2002). At the non-differentiated 
state (33°C) the 0P27 cells presented a very faint smeared band of whereas the band that was detected 
in the cells that were induced to differentiate for 5DIV was broad and smeared. The band at 10DW 
was broader than that at 5DIV, with the molecular weight band increased. This may indicate an up-
regulation in the expression of the shorter NCAM isoforms (NCAM120 and NCAM140). 
Alternatively, the increased smearing at 10DIV may indicate an increased polysialylation (Fig. 3.IIB). 
The pattern of expression of the tyrosine receptor kinases, TrkB and TrkC, was also analyzed in 
differentiating OP27 cells. These are the cognate receptors for the neurotrophins, brain-derived 
neurotrophic factor (BDNF) and neurotrophin-3 (NT -3), respectively, that have been suggested to have 
roles in a number of cellular processes, including development, differentiation, survival and neuronal 
regeneration Both TrkB and TrkC receptors are alternatively spliced to yield isoforms containing a 
catalytic tyrosine kinase (TK+) and truncated isoforms (TK-) which lack the TK domain (reviewed by 
Carter and Roskams, 2002). It has already been shown that OP27 cells express both the TK+ and TK-
isoforms of both TrkB and TrkC. As the OP27 cells differentiate in response to retinoic acid the 
predominant isoform of TrkB expressed becomes the ~90KDa kinase inactive truncated form (Illing et 












detected in OP27 cells at 33°C with the anti-TrkB antibody. A 140KDa band representing the full-
length receptor was not detected in the OP27 cells. Secondly, the ~90KDa band was lost in OP27 cells 




















Figure 3. 12 Expression patterns of the components of the neurotrophin signal transduction cascade in OP27 cells treated 
with FGF-2 . Immunoblot ofOP27 cells was prepared using total protein lysates from cells at 33°C and cells that had been 
treated with FGF-2 at 39°C for 5 days in vitro (5DIV) and 10 days in vitro (100IV). (A) OP27 cells express mainly the 
truncated isoform of TrkB (indicated with an arrow) at 33°C which is downregulated as the cells differentiate. (B) 
Predifferentiated and differentiating OP27 cells express both the full-length (arrowhead) and truncated (arrow) isoforns of 
TrkC. PLC-y2 is also expressed as both its full-length (l40KDa) and processed (IOOKDa) forms. Each blot was used for 












TrkC, on the other hand was detected as two protein bands that migrated at -140KDa (for the TK+ 
isoform) and 90KDa (the TK- isoform). At the non-differentiated state, only the 90KDa TK- isoform 
form is present. At 39°C, expression of the 90KDa TK- isoform increases and the 140KDa TK+ 
isoform is detected (Fig. 3. 12B). This pattern of expression of TrkC observed in OP27 cells treated 
with FGF-2 is similar to that observed when these cells were induced to differentiate with retinoic acid 
(IUing et a!., 2002). 
The effector enzyme, phospholipase C gamma 2 (PLC-y2) is tyrosine phosphorylated in response to 
neurotrophins acting on TrkB or TrkC receptors and is also implicated in FGF-2 signalling (Yamada et 
al., 2002). OP27 cells express two forms ofPLC-y2: the phosphorylatable 140KDa full-length form 
and the 100KDa cleavage product that cannot be phosphorylated. As the cells were induced to 
differentiate with retinoic acid they continued to express both forms with the full-length form 
predominating (Illing et aI., 2002). In this study the full-length form of PLC-y2 predominated at all 
time points. Both were also up-regulated after 5 and 10 days of FGF-2 treatment compared to the 
control cells at 33°C (Fig. 3. 12B). 
Finally, antibodies recognizing the olfactory signal transduction components, Golf and the olfactory 
specific effector adenylate cyclase (ACIll) were demonstrated by western blot analysis to react with 
appropriately sized proteins in OP27 cell at different time points of differentiation (Fig 3.13). Both Golf 
and ACIII are expressed in OP27 at 33°C when the cells are not differentiated and Golf continues to be 
expressed at 39°C when cells are differentiating under the influence of FGF-2. ACIII on the other 
hand, gets down-regulated with FGF-2-induced differentiation of these cells, with expression levels 






















Figure 3.13 Expression patterns of Gaolf and type III adenylate cyclase (ACIlI) on OP27 cells treated with FGF -2. 
Immunoblot of OP27 cells was prepared using total protein lysates from cells at 33°C and cells that had been treated with 
FGF-2 at 39°C for 5 days in vitro (SDlV)and 10 days in vitro (IODlV). The olfactory epithelium (OE) was used as a 
positive control. The same blot was used for each of the olfactory signal transduction components (and those shown in Fig. 
3.10) and later reprobed with f3-actin to verify loading. 
3.3.7.3 Immunocytochemical characterization ofFGF-2-difTerentiated 0P27 cells 
The FGF-2-induced differentiation in OP27 cells was also characterized by immunocytochemistry 
using some of the antibodies used for western blot anlyses to establish their cellular localization in the 
differentiating cells. The ant i-TrkB polyclonal antibody was detected closer to cell bodies of cells with 
shorter neurites while staining in cells with longer neurites was evident in the processes (Fig 3.14A). 
Similarly, the high affinity NT3 receptor TrkC was also immunolocalized closer to cell bodies of cells 
with shorter neurites whereas cells with longer processes had staining both in the cell bodies and at the 












localized throughout the processes in all the cells that were stained (Fig 3.14C). The olfactory G-
protein (Golf) was mainly found localized to cell bodies in a majority of cells and in out-growing neurite 
processes in few of cells (Fig 3.14 D). Negative controls with no primary antibody failed to reveal any 
















Figure 3.14 Immunocytochemical characterization of OP27 cells with olfactory signalling proteins. Shown are images of 
OP27 cells treated with FGF-2 for 10 days at 39"C and immunostained (green) with anti-TrkB (A), anti-TrkC (B), anti-PLC-
y2 (C) and Gaolf (D). Staining in the cell bodies is indicated with long arrows while staining in processes is indicated with 













The OP27 cell line was isolated by infection of primary cultures ofE10.5 mouse olfactory placode with 
the retrovirus containing the tempereature sensitive SV40 large T antigen. The cells proliferate under 
the control of SV 40 large T antigen at the permissive temperature (33°C). Shifting the cells to 39°C 
allows the study of the effects of growth factors of neuronal differentiation when the eells are not under 
the control of the SV 40 large T antigen The OP27 cells have been shown to respond to retinoic acid 
and differentiate into olfactory receptor neurons (ORN) that express endogenous olfactory receptors 
and neuronal markers (Illing et aI., 2002). I have extended these studies and examined the response of 
OP27 cells to FGF-2, a growth factor which has been shown to be important for neuronal 
differentiation 
To test whether FGF-2 had any effects in the proliferation, differentiation, and! or survival of OP27 
cells, I first checked whether these cells express the receptors for this growth factor. RT -PCR was used 
to examine the expression ofFGFR-l to FGFR-4 and the isoforms of these receptors. I discovered that 
the 0P27 cells express a limited set of FGFR-s, these being FGFR-1 and FGFR-2. This pattern of 
expression is consistent with that found in E14.5-E15.5 explant cultures of mouse OE (DeHamer etal., 
1994). This FGFR- expression pattern is also similar to that observed in adult mouse OE in vivo (Hsu 
et ai., 2001) but differes in the subtype of the receptor that is expressed in both systems. OP27 cells 
express only the me isoforms of both FGFR-l and FGFR-2 wherease the adult mouse OE contained 
the IIIb isoforms of both FGFR-I and FGFR-2 and the me isoform of only FGFR-1 (Hsu et ai., 2001). 
The expression of the me isoform ofFGFR-2 in the embryonic OP27 cells versus the IIIb in the adult 












In addition, the FGFR-l I1Ic expressed in OP27 cells appears as the 3 variants, a, ~, and r which differ 
in the sequence concerning Ig-I domain in the extracellular region. Another olfactory cell line, JFEN, 
which was derived from a human olfactory neuroblastoma tumour was shown to also express the a, ~, 
and r isoforms of FGFR-l, although it was not shown whether the FGFR-I was either the IDb or IDc 
(Nibu et aI., 2000). 
In addition to the alternative splicing of the IgIII domain in the extracellular region ofFGFR, a second 
splicing event occurs in the juxtamembrane region, resulting either in the inclusion or deletion of the 
dipeptide Val-Thr (VT) (Gillespie et aI., 1995; Twigg et al., 1998). VT is required for the interaction 
of FGFR with the signalling adapter protein FRS2 (Burgar et aI., 2002) and to initiate downstream 
signalling through the RASIMAPK pathway (Twigg et al., 1998). The analysis of FGFR splice 
variants expressed in OP27 cells is therefore not comprehensive. However, the main focus here was to 
demonstrate that OP27 cells express both FGFR-l IDc and FGFR-2 IDc and can therefore respond to 
FGF-2. 
By extrapolation of BaF3 mitogenic assays which assayed FGFR-FGF ligand interactions (Table 1.1), 
it is likely that OP27 cells could interact with the following FGF ligands, FGF-l, FGF-2, FGF-4, and 
FGF-9, and to a lesser extent, with FGF-5, FGF-6 and FGF-17 (Table 3.2). The actions of some of 
these ligands have already been demonstrated in OE explant cultures. FGF-l, FGF-2, and FGF-4 were 
found to stimulate proliferation ofINPs in EI4.5-EI5.5 OE explant cultures (DeHamer et aI., 1994). 
The function ofFGF-9 in OE development has not been demonstrated yet. There is evidence that FGF-
9 is required for survival and not for the differentiation of bulbospinal neurons (Pataky et al., 2000). 












FGF-7 was also found to support the proliferation of the INPs but at lower effect compared to FGF-l, 
2, and -4 (DeHamer et al., 1994). FGF-8 was found to stimulate the proliferation of the putative OE 
neuronal stem cell (Calof et aI., 2002). The binding study by Ornitz et al. (1996) in BaF3 cells showed 
that FGF-7 and FGF-8 exert their effects through activation ofFGFR-2-illb, FGFR-3-Ilic and FGFR-4 
receptors. FGFR-2-illb has been detected in purified adult OE by RT-PCR but FGFR-3-illc and 
FGFR-4 were not detected in the OE (Hsu et al., 2001). It is therefore unclear how the effects ofFGF-
8 in OE lineage can be mediated. 
Table 3.2 FGF ligands that the 0P27 cells could respond to, as a result of expression of the IIIe isoforms of both FGFR-l 
and FGFR-2 in these cells. These FGF-FGFR interactions are extrapolated from the mitogenic assays nsing BaF3 cells 
(I able 1.1). +++, ++ represent level of interaction ofligand and receptor. 
Interaction FGFR-l IIIc FGFR-2 IDc 
+++ FGF-l, FGF-2, FGF-4 FGF-I, FGF-4, FGF-9 
++ FGF-5, FGF-6 FGF-2, FGF-6, FGF-17 . 
In this study the effect of FGF-2 on OP27 cells was analysed under serum-free conditions at the non-
permissive temperature (39°C). I found that FGF-2 had effects on both the rate of cell division and 
differentiation of OP27 cells under these conditions. The rate of cell division of FGF-2 treated OP27 
cells was higher in than in control cells. As a result, the total number of viable cells at each time point 
were always greater in the presence ofFGF-2 compared to controls. However, there was a progressive 
decline in eH]thymidine incorporation in FGF-2 treated cells with time, and by 6 days cells had ceased 
dividing. This is similar to the observation that a fraction of OP27 cells continue dividing for up to 4 












Neuronal differentiation is preceeded by exit from the cell cycle. The decrease in thymidine 
incorporation with time in culture thus suggested cessation of DNA replication and cell division and 
beginning of differentiation Indeed, the cells began to undergo a morphological change indicative of 
differentiating ORNs. The decline in thymidine incorporation was accompanied by a gradual increase 
in the number of bipolar cells. The increase was particularly noticeable between 6 and 10 days when 
cell division had stopped. 
Both treated and untreated cells displayed cellular death as judged by the decrease in numbers. 
However, OP27 cells treated with FGF-2 were always maintained in higher numbers than control 
cultures without FGF-2. It appeared that FGF-2 may be protecting the cells from death. Apoptosis is 
induced by the activation of the cellular death protease Caspase (Bae et al., 2000). FGF-2 was found to 
protect rat hippocampal cells from death by delaying the onset and peak activation of caspases (Eves et 
al.,2001). FGF-2 may thus protect OP27 cells in a similar manner. It is clear though that FGF-2 is not 
sufficient on its own to prevent apoptosis. Thus additional molecules may be required. The 
neurotrophin BDNF has been shown to promote cell survival in mouse OE both in vivo and in vitro 
(Holcomb et al., 1995) and its cognate receptor TrkB is expressed in OP27 cells. 
The expression patterns of various markers which characterize different stages of olfactory neuron 
development were analyzed in OP27 cells that had been treated with FGF-2. GAP-43 is the among the 
ftrst neuron-specific markers to be expressed in differentiating olfactory receptor neurons (ORNs) 
during embryogenesis. It is a marker for immature ORNs and is expressed transiently during the early 
stages of differentiation. Its expression coincides with process outgrowth and synaptogenesis in the 
mouse OE (Biffo et aI., 1990). A semi-quantitative RT-PCR assay showed a transient up-regulation of 












hours with maximum levels reached after 48 hours. After 2 days the GAP-43 mRNA levels decreased 
but were still higher than at the predifferentiated state. This is an indication that the OP27 cells were 
indeed differentiating into neuronal cells. The GAP-43 protein was also shown to up-regulated in 
OP27 cells following retinoic acid induced differentiation (Illing et aI., 2002). The high levels of GAP-
43 mRNA at 24 and at 48 hours coincided with the appearance ofthe first OP27 cells with neurite-like 
extensions. 
The expression ofNST, NCAM, TrkB, TrkC, PLC-y2, Golf and ACIII was also analyzed using western 
blots. These proteins were expressed both at 33°C and at the non-permissive temperature but there 
were characteristic changes in their expression patterns as the cells were induced to differentiate. The 
NST protein is present at 33°C but its expression is down-regulated as OP27 cells differentiate and 
mature into ORNs. Although this mirrors what has already been reported in ORNs both in vivo and in 
vitro (Roskams et al., 1998; Illing et aI., 2002), it is not clear what the significance ofNST down-
regulation following FGF-2 induction is. 
Another proof that the OP27 cells differentiate into neuronal cells in the presence of FGF-2 is the 
expression of NCAM In the OE, NCAM is used as a marker to distinguish between the immediate 
neuronal precursors which are negative for NCAM and the post-mitotic neurons (both immature and 
mature) which do express NCAM (Calof et al., 1991). I have shown, using western blots, that FGF-2 












Do the OP27 cells become tenninally differentiated under the conditions used here? The best example 
of specific marker for ORNs is the OMP, a developmentally regulated, abundant 19KDa cytoplasmic 
protein whose expression is largely the hallmark of ORN maturity (Carr et al., 1998). I could not 
reproducibly show that OP27 cells express OMP mRNA transcripts following their induction to 
differentiate. OMP mRNA transcripts were present in FGF-2 treated cells only after 10 days (one out 
of 4 experiments) but this was never reproducible from experiment to experiment. It has been shown 
that cells that express GAP-43 are not tenninally differenitated neurons since they are devoid of OMP 
expression (Pellier et aI., 1994). OP27 cells still express GAP-43 transcripts even after 10 days in 
culture, albeit at lower levels compared to at 48 hours. It was therefore concluded that under the 
conditions used in this thesis OP27 cells did not achieve tenninal differentiation. It is, however, 
possible that with longer time points in culture I would have been able to detect OMP expression in 
OP27 cells. It is also possible that FGF-2 is not enough on its own to promote the OP27 cells to 
progress from the immature neuronal state to a terminally differentiated and mature OMP expressing 
cell state. Other signals may be required for the maturation of these cells. In a study using the 3NA12 
cell line, the neutrophins BDNF and NT-3 were demonstrated to promote the progression of these cells 
into mature and OMP expressing cells (Barber et aI., 2000). TrkB and TrkC, the cognate receptors for 
BDNF and NT -3, respectively, and their signalling component PLC-y2 were shown to be present in 
OP27 cells. The expression ofTrkB was, however lost as the OP27 cells differentiated while TrkC and 
PLC-y2 prevailed. NT-3, the ligand for the TrkC receptor, could therefore be the neutrophin that may 
be required for the maturation of OP27 cells. 
In summary, I have shown that the OP27 cell line expresses the receptors that are known to transduce 












characteristic of differentiating immature olfactory receptor neurons in vivo, as analyzed by the 
expression of various neuronal markers. However, the culture conditions used here did not support the 
maturation of the OP27 cells as they do not express OMP, the defmitive marker for mature olfactory 
neurons. In Chapter 4 I demonstrate that the differentiating OP27 cells express olfactory receptors as 












Analysis of olfactory receptor gene expression in 0P27 
cells 
4.1 Introduction 
The neurons in the olfactory epithelium (OE) specifY their functional identity by selecting one olfactory 
receptor (OR) to express (Malnic et al., 1999; Reed, 2000). ORs are G-protein coupled seven 
transmembrane proteins responsible for mediating the interaction of odours from the external 
environment with the brain resulting in smell detection. 
4.1.1 Discovery of OR genes 
OR genes were ftrst cloned from the rat using degenerate RT -PCR with primers that annealed to 
conserved regions of the G-protein coupled receptor (GPCR) superfamily (Buck and AxeL 1991). This 
landmark discovery was based on the assumption that since G-proteins had been found in earlier 
experiments to mediate olfactory signal transduction, it was therefore highly likely that ORs belong to 
the GPCR superfamily of proteins that are characterized by seven hydrophobic transmembrane (TM) 
domains. The initial discovery in rats was soon followed by cloning of more genes from species such 
as chickens, Zebraftsh, Drosophila, mouse, dog and human (Selbie et al., 1992; Ngai et aI., 1993; Issel-











The OR gene products are encoded by an -lkb intronless open reading frame (ORF). There are several 
amino acid sequence motifs that are conserved in all ORs and that distinguish them from other GPCRs 
(Fig. 4.1, Mombaerts, 1999). These include the LHTPMY motif in intracellular loop 1; 
MA YDRYV AlC at the end of TM3 and beginning of intracellular loop 2; SY at the end of TM5; 
FSTCSSH in the beginning ofTM6 and PMLNPF in TM 7. The high degree of variability among the 
ORs is evident in TMs 3, 4 and 5. It has been suggested that these variable regions may form odorant-
binding sites. 
Figure 4.1 The structure of OR as exemplified by the receptor OR IIS which was cloned by Buck and Axel (1991). The 
cylinders represent the hydrophobic transmembrane (TM) domams with 1 the most N-tenninal TM domain and 7 the last 
TM (the TM domains are numbered 1-7). Conserved residues of a OR subfamily are shown as white ba1ls while the gray 
balls represent the variable amino acids. The regions that contain the conserved motifs that distinguish ORs from other 












4.1.2 OR Repertoire and genomic organization 
ORs represent the largest family in the mammalian genome, encompassing different subfamilies. 
Current estimates of the complexity of the OR gene repertoire stand at about 1200-1300 genes in mice, 
1000 in humans and 100 in zebrafish (Zhang and Firestein, 2002; Godfrey et aI., 2004). These genes 
are randomly clustered in a number of chromosomal locations in all species studied. In some locations 
the cluster(s) can be characterised by intergenic distances of anything between 5-50kh. There is no 
ordered arrangement of the genes in a cluster and transcription may occur in either direction 
(Mombaerts, 1999; Kratz et ai., 2002). 
It is thought that the OR gene repertoire has expanded through numerous duplications of entire 
chromosomal portions, followed by mutations within the duplicated regions to increase diversity 
(Dryer and Berghard, 1999). Some of these mutations may have resulted in pseudogenes: 60-700/0 of 
human OR genes do not code for any functional OR proteins as these have ORFs that are either 
interrupted with stop codons, or that lack conserved motifs (Glusman et aI., 2000). 
4.1.3 Patterns of olfactory receptor expression 
The patterns of expressions of OR genes in the OE have been largely studied using a series of in situ 
hybridization experiments with riboprobes derived from cloned OR cDNAs. Expression is first 
detected in immature neurons and has never been observed in the mitotically active ORN precursors 
(Qasba and Reed, 1998; Fan and Nga~ 2001; Iwema and Scwob, 2003). Additionally, experiments 
using bulbectomized animals have shown that the expression of ORs is activated independently of the 












A number of studies have reported that in mice each ORN expresses only one or very few of the 1000 
OR genes. This hypothesis was based on the fmding that a given riboprobe hybridized to a very small 
subset (about 0.1%-1%) of mature ORNs (Malnic et ai., 1999). A limited number of single-cell RT-
PCR data support this hypothesis: using degenerate primers recognising conserved regions in OR 
sequences, it was found that a single neuron expressed only one OR gene (Malnic et al., 1999; Touhara 
et al., 1999). There is, however, one study where it was shown that one cell expressed at least two 
different OR genes (Rawson et aI., 2000). Moreover, each ORN expresses either the maternal or the 
paternal allele of the transcript and never both, a phenomenon known as monoallelic expression (Chess 
et ai., 1994). 
Various laboratories have independently shown that a given OR probe is restricted to one of four 
parallel topographic zones in the OE of mammals (Ressler et aI., 1993; Strotman et aI., 1994; Vassar et 
aI., 1993). ORNs expressing a given OR are randomly distributed in a punctate pattern within a zone, 
intermingled with ORNs expressing different receptors. However, the axons of the ORNs that express 
the same OR gene, while randomly distributed in that zone, converge to the same glomerulus in the 
olfactory bulb (Ressler et aI., 1994; Vassar et al., 1994). 
Examination of the pattern of expression in zebrafish, chick and fruit-fly has revealed a temporal 
pattern of expression during development. In zebrafish a staggered onset of expression of a subset of 
OR genes was observed in four consecutive time-periods after fertilization Most genes with same 
onset of period were found clustered in the genome (Argo et al., 2003). A similarly staggered onset of 
expression was observed with 3 different Drosophila OR (DOR) genes. Expression of 2 DORs was 
shown to begin much later than that of the other one. However, unlike in Zebrafish, the two 












At least two onset groups of OR have also been reported in chicks, with 6 ORs easily detected at E5 
whereas a second group could be detected later (Nef et al., 1996). In contrast to the asynchrony in the 
expression of the different ORs observed in chick, fly and fish, a group of different ORs were 
expressed simultaneously during embryogenesis in rodents (Strotmann et a/., 1995; Sullivan et a/., 
1995). 
4.1.4 Regulation of OR gene expression 
The regulatory mechanisms that are responsible for the choice of just one OR to be expressed by an 
ORN are largely unknown. There are hypotheses that have been suggested or that are currently being 
explored to unravel these control mechanisms. One theory that has been suggested involves DNA 
rearrangement events in either the ORNs or the basal cells whereby a single OR gene gets translocated 
from a cluster by DNA recombination into close proximity to an active promoter for expression or else 
the active promoter itself gets translocated upstream of a single OR gene (Mombaerts, 1999; Kratz et 
al.,2002). This hypothesis has been tested by two independent laboratories using cloning experiments 
by nuclear transfer of a postmitotic, OMP+ cell into enucleated oocytes. It was hypothesized that, if an 
irreversible DNA rearrangement event occurred in the locus of the OR gene of the cell used for the 
transfer, then all the ORNs of the cloned mouse should express the same receptor. This was not the 
case. The ORNs of the cloned mice expressed a repertiore of OR genes and their patterns of expression 
were not different from that of the ORNs of the wild-type mice (Eggan et a/., 2004; Li et a/., 2004). 
Yeast artificial chromosome (Y AC) transgenic mice carrying OR clusters have been used to define cis-
regulatory elements or locus control regions (LCRs) that may be involved in the choice of OR to 












the transcription initiation site of a given OR gene, with some at hundreds of kilobases away while 
some were found at close proximities to the OR gene (Qasba and Reed, 1998; Kratz et al., 2002; 
Serizawa et al., 2003). One such LCR, known as the H region, has recently been shown to control the 
expression of clustered OR genes by stochastically selecting just one gene at a time and activating its 
expression from that cluster. When the H region was deleted from a Y AC containing tagged OR genes 
in a cluster, the expression of these transgenic DRs was completely abolished (Serizawa et al., 2003). 
A negative feedback regulation mediated by the OR themselves has recently been proposed to ensure 
that one ORN selects and expresses only one OR gene. Two groups using transgenic mice carrying OR 
genes with either full-length or deleted ORFs have independently shown that when one OR gene is 
stochastically selected from a cluster and activated, the expressed OR protein then generates a feedback 
signal that will inhibit the activation and expression of the other OR genes either in that cluster or in 
other clusters in that cell. When an OR gene with a deleted coding region is selected there is no 
feedback signal and as a result the cell can choose a second functional OR (Serizawa et aI., 2003; 
Lewcock and Reed, 2004). 
There is also the hypothesis that the selection of one OR gene to activate may be a consequence of 
specific combinations of transcription factors interacting with binding sites in the proximal promoter of 
that OR (Kratz et aI., 2002). Potential binding sites of various transcription factors have been 
identified in promoters of mouse and human OR genes. These were identified using either in silico 
methods or yeast one-hybrid screens. The identified transcription factors included the olfactory neuron 
specific factor 1/eady B cell factor-like 1 (DIE-I); 01E-2, pituitary homeobox I-factor (Ptx-I); binding 
factor for early enhancer (BEN); aristaless-like homeobox 3 (Alx-3); lim-homeobox-2 factor 












313 (HNF313); and aryl hydrocarbon nuclear translocator (Arnt) (Glusman et aI., 2000; Hoppe et aI., 
2000; Hoppe et al., 2003; Sosinsky et al., 2000). The interaction of these OR promoter motifs with the 
transcription factors has been demonstrated using electrophoretic mobility gel shift assays (Hoppe et 
al.,2003). Whether these proteins regulate the expression of the ORs is yet to be demonstrated. A few 
transcription factors have been shown to regulate the expression of an OR or a subset of these genes in 
non-vertebrates. In C. elegans the olfactory-specific transcription factor odr-7 (a member of the 
nuclear receptor superfamily) has been shown to regulate the expression of the OR gene odr-lO 
(Sengupta et aI., 1996). The expression of odr-lO was barely detectable in odr-7 mutant worms when 
compared to the wild-type. Expression of a subset of Drosophila ORs (DORs) was shown to be 
differentially regulated by the transcription factor Acj6. A group of DOR genes that expressed in the 
maxillary palp (one of two olfactory organs found in the fly) were affected by a null mutation in the 
acj6 gene whereas the absence of the gene had no effect in the expression of a subset of DOR genes 
expressed in the antenna (the second olfactory organ) (Clyne et al., 1999). 
It has been postulated that the choice of OR may be either a cell-autonomous event, may be affected by 
local environmental factors and/or the choice may be a result of a stochastic selection of a single OR 
from a cluster in the genome (Fan and Nga~ 2001; Iwema and Schwob, 2003). 
In a previous study, the OP27 cell line was shown to express a single OR, 0R27-3, following induction 
with retinoic acid (Illing et al., 2002). I therefore sougbt to establish whether the OP27 cells expressed 
any endogenous OR genes in response to FGF-2 treatment, and to determine whether these cells 













4.2.1 0P27 cells express OR transcripts when differentiated 
0P27 cells that had been treated with FGF-2 at 39°C were analyzed for the expression of OR genes by 
performing RT-PCR with RNA isolated from 5 pooled tissue culture petri-dishes. A pair of degenerate 
primers, OR-F3 and OR-RC (Table 2.1), which are based on the conserved motifs MA YDRYV A at the 
end of TM3 and MLNPFIY in TM7 (Fig. 4.1), respectively, amplified the expected -530bp PCR 
product on OP27 cells treated with FGF2 for 48hrs onwards (Fig. 4.2). In order to analyze the identity 
and diversity of the OR gene transcripts expressed in 0P27 cells in vitro, the amplification product 
from the 2-day time point was cloned into the pGEM-TEasy® and pC~ vector systems and the 
nucleotide sequence was initially determined for 3 recombinant plasmids, 270R-69, 270R-70 (both in 
pCRIJ) and 270R-71 (cloned in pGEM-TEasy®). The clones were sequenced in both directions to 
reveal 534 bp nucleotide sequences. 
2d 4d 6d lOd OE 
+ + + + + + + M 
Figure 4.2 RT -PCR analysis of the expression of olfactory receptors in differentiating OP27 ceUs. Expression was 
determined in OP27 cells at 33°C and in cells that had been treated with FGF -2 for I, 2, 4, 6, and 10 days at 39°C. +, 
reverse transcribed RNA templates, -, non-reverse transcribed RNA samples used as negative controls, M, 100 bp ladder as 
a molecular weight marker with sizes shown on the left in base pairs (bp). cDNA from the olfactory epithelium (OE) was 












The nucleotide sequences of the 3 clones were compared to each other and revealed at least 99% 
sequence identity between them, with 4 base substitutions. 270R-70 and 270R-71 were 99.8% 
identical with one base difference. whereas 270R-69 bad 3 base differences with 270R-70 and 4 with 
270R-71 (Fig. 4.3 A). Figure 4.3B shows representative chromatograms for the base substitutions in 
the 3 OR clones. The 4 base differences between the clones resulted in a few amino acid substitutions 
in the deduced protein sequence of 270R-71. However, BLASTp searches against GenBank database 
with all 3 clones showed the greatest homology to the OR6-13 (Illing et a!.. 2002. accession number 
AF042359) and Olfr57 (also known as MOR139-3, accession number XP _137190) odorant receptors 
(Fig. 4.4). I concluded that the determined nucleotide sequences of the 3 clones represented one OR 
gene (referred to as Type 1 in this study). It is possible that the base substitutions in the three clones 












ORF3 ----.. [I] SphI 
A OR69 CATCTGTCACCCCCTGCATTACATGATCATCATGAGCACAAGACGCTGTGGATTGATGATTCTGGCAT 68 
OR70 CATCTGTCACCCCCTGCATTACATGATCATCATGAGCACAAGACGCTGTGGATTGATGATTCTGGCAT 68 
OR71 CATCTGTCACCCCCTGCATTACATGAACATCATGAGCACAAGACGCTGTGGATTGATGATTCTGGCAT 68 
OR 69 69 GCTGGATTATAGGTGTTATAAATTCCCTGTTACACACCTTTTTGGTGTTACGGCTGTCATTCTGCACA 136 
OR70 69 GCTGGATTATAGGTGTTATAAATTCCCTGTTACACACCTTTTTGGTGTTACGGCTGTCATTCTGCACA 1 36 
OR71 69 GCTGGATTATAGGTGTTATAAATTCCCTGTTACACACCTTTTTGGTGTTACGGCTGTCATTCTGCACA 13 6 
[2] 
OR69 13 7 AACTTGGAAATCCCCCACTTTTTCTGTGAACTTAATCAAGTTGTACACCAGGCCTGTTCTGACACCTT 20 4 
OR70 13 7 AACTTGGAAATCCCCCATTTTTTCTGTGAACTTAATCAAGTTGTACACCAGGCCTGTTCTGACACCTT 204 
OR71 137 AACTTGGAAATCCCCCATTTTTTCTGTGAACTTAATCAAGTTGTACACCAGGCCTGTTCTGACACCTT 204 
OR69 205 TCTTAATGATATGGTAATTTACATTACAGCTATGCTACTGGCTGTTGGCCCCTTCTCTGGTATCCTTT 272 
OR70 20 5 TCTTAATGATATGGTAATTTACATTACAGCTATGCTACTGGCTGTTGGCCCCTTCTCTGGTATCCTTT 272 
OR 71 205 TCTTAATGATATGGTAATTTACATTACAGCTATGCTACTGGCTGTTGGCCCCTTCTCTGGTATCCTTT 272 
[3] 
OR69 273 ACTCTTACTCTAGGATAGTATCCCCCATTTGTGCAATCTCCTCAGTGCAGGGGAAGTACAAAGCATTT 340 
OR70 273 ACTCTTACTCTAGGATAGTATCCTCCATTTGTGCAATCTCCTCAGTGCAGGGGAAGTACAAAGCATTT 340 
OR71 27 3 ACTCTTACTCTAGGATAGTATCCTCCATTTGTGCAATCTCCTCAGTGCAGGGGAAGTACAAAGCATTT 340 
[4] 
OR69 341 TCCACCTGTGCATCTCACCTCTCAGTTGTCTCCTTATTTTATTGCACCCCCCTGGGAGTGTACCTCAG 408 
OR70 34 1 TCCACCTGTGCATCTCACCTCTCAGTTGTCTCCTTATTTTATTGCACCCTCCTGGGAGTGTACCTCAG 40 8 
OR71 34 1 TCCACCTGTGCATCTCACCTCTCAGTTGTCTCCTTATTTTATTGCACCCTCCTGGGAGTGTACCTCAG 408 
OR6 9 409 CTCTGCTGTGACCCAAAACTCACATGCTACTGCAACAGCTTCATTGATGTACACTGTGGTCACCCCC 475 
OR70 409 CTCTGCTGTGACCCAAAACTCACATGCTACTGCAACAGCTTCATTGATGTACACTGTGGTCACCCCC 475 
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Figure 4.3: Nucleotide sequence alignment ofOR-69; OR-70; and OR-71 clones from the 0P27 cell line treated with 
FGF2. A. Identical nucleotide sequences are shaded. The nucleotide sequences of the primers ORF3 and ORC are 
not included in the alignment. The SphJ recognition site in all 3 OR genes is indicated. B. Representative 
chromatograms showing the base substuitions (underlined). Top row, OR69; middle row, OR70; bottom row, OR71 . 
The positions where there are base substitutions in the three OR clones are indicated with bracketed numbers in the 

























ICHPLHYMI IMSTRRCGLMlLACWIIGVINSLLHTFLVLRLSFCTNLEIPHFFCELNQVVHQAC 64 
ICHPLHYMNIMSTRRCGLMlLACWIIGVINSLLHTFLVLRLSFCTNLEIPHFFCELNQVVHQAC 64 
ICHPLHYMI IMSTRRCGLMlLACWIIGVINSLLHTFLVLRLSFCTNLEIPHFFCELNQVVHQAC 64 
ICHPLHYM I I MSTRRCGLMI LACWI IGVI NSLLHTFLVLRLSFCTNLEIPHFFCELNQVVHQA C 64 
SDTFLNDMVIYITAMLLAVGPFSGILYSYSRIVSSICAISSVQGKYKAFSTCASHLSVVSLFYC 128 
SDTFLNDMVIYITAMLLAVGPFSGILYSYSRIVSSI CAISSVQGKYKAFSTCASHLSVVSLFYC 128 
SDTFLNDMVIYITAMLLAVGPFSGILYSYSRIVSSICAISSVQGKYKAFSTCASHLSVVSLFYC 128 
SDTFLNDMVIYITAMLLAVGPFSGILYSYSRIVSPICAISSVQGKYKAFSTCASHLSVVSLFYC 128 
MOR139- 3 129 TLLGVYLSSAVTQNSHATATASLMYTVVTP 158 
OR71 129 TLLGVYLSSAVTQNSHATATASLMYTVVTP 158 
OR6-13 129 TLLGVYLSSAVTQNSHATATASLMYTVVTP 158 
OR69 129 TPLGVYLSSAVTQNSHATATASLMYTVVTP 158 
Chapter 4 
Figure 4.4 Amino acid alignment of OR69 and OR71 with the published odorant receptors that revealed high homology, 
MOR139-3 and OR6-13 , between the primer regions MA YDRYV A at the end ofTM3 and MLNPFIY in TM7. 
4.2.2 Differentiated OP27 ceDs express a smaU repertoire of the OR gene family 
I wanted to established whether the cell line expressed only one of the reported -1300 mammalian OR 
genes when induced to differentiate. The cells expressed the 0R27-3 receptor when induced to 
differentiate in the presence of RA (Illing et aI., 2002) which is a different OR reported for the 2 day 
time point of FGF-2 induction I analyzed an additional 21 randomly selected recombinant plasmids 
containing the PCR products from the 2 day time point, to see whether other ORs were expressed. The 
inserts were PCR-amplified using the SP6 and T7 primers which flank the muhiple cloning site of 
pGEM-TEasy® cloning vector, generating a 714bp product. The amplicons were subsequently digested 
with the restriction enzyme SpbI and analyzed on a 2% ethidium bromide stained agarose gel to 
determine the digest pattern of each clone. Sphl restricts the 270R-69, -70 and -71 clones (Fig. 3.4) to 
generate fragments of sizes 470bp and 200bp (orientation 1, Fig. 4.5A) or 534bp and 140bp 





























Figure 4.5 Restriction analysis of 270R clones from the 2-day time point A. The OR peR products were subcloned into 
the pGE~-T Easy vector and inserts amplified with the T7 and SP6 primers to give a 714bp product The orientation of 
the insert in the vector is one of two possibilities such that digestion of Type 1 OR peR products with SphI would result 
into one of the two digestion patterns shown. B. SphI digestion of the peR products from recombinant plasmids cloned 
from the 2 day time point 71, control plasmid OR71 showing the diagnostic 470bp and 200bp SphI digestion pattern. Ml 
and M2 are the pBluescript II SK+ -HpaII and pBR322-HpaII molecular weight markers, respectively. Sizes of molecular 
weight markers are shown in base pairs, bp. Ten of the 21 peR products, indicated by asteriks, were not digested with 
Sphl. 
Digestion of the peR products with SphI is shown in Fig. 4.5B. Analysis of the digestion pattern 
shows that 11/21 of the peR products were Type 1 OR, giving a characteristic SphI digestion pattern. 
Five of the 21 clones (270R-72; 77; 80; 82 and 92) gave digest patterns corresponding to orientation 
1; while the other six (270R-73; 74; 81; 83; 89 and 91) gave patterns corresponding to orientation 2. 
peR products from ten OR clones (270R-78; 79; 84; 85; 86; 87; 88; 90; 93 and 94) were not digested 












these peR products. The nucleotide sequences of all the clones that did not digest and 3 clones that did 
digest (OR74; 89; and 92) were determined. Sequence analysis of these clones showed that OR74; 89; 
and 92 were Type 1 ORs with 98.3% identity to OR69 and 98.5% identity to OR71, thus cOnIrrming 
the restriction digest patterns. On the other hand, OR78; 79; 84; 85; 86; 87; 88; 90; 93; and 94 were 
sequences of 3 completely different OR genes ( OR types 2, 3, and 4). In short, I could identify 4 
different OR genes that were expressed by OP27 cells at the 2 day time point following induction with 
FGF2. These are summarized in Table 4. L 
Table 4.1 The different types of OR genes identified in OP27 cells pooled from 5 petri-dishes, following FGF-2 induced 
differentiation for 2 days. The published mouse OR genes that have high homologies with the 270R genes are also shown. 
OR Clones representing the particular OR Type BLAST MATCH Accession Amino acid 
TYPE Number homology 
Type 1 270R-69; -70; 71; 72; 73; 74; 75; 76; 77; 80; 81; OR6-13 AF042359 99% 
82;83;89;91;92 MOR139-3 XM 137190 
Type 2 270R-84; 87; 88; 90; 93; 94 01fr18 XM 146869 100010 
Type 3 270R-78; 79; 85 MOR141-3 XM 146415 98% 
Type 4 270R-86 MOR135-7 NM 147008 98% 
4.2.3 Sequence homology of the OP27 OR clones 
Nucleotide and the deduced amino acid sequences of a representative of each OR type was compared 
with those of the other three. Differences in both the nucleotide and amino acid sequences between the 
OR genes were quite significant. An amino acid sequence alignment of the 4 OR genes is shown in Fig 
4.6. The presence of the amino acid motifs that are conserved in all OR's demonstrates that these 
clones belong to the OR superfamily. Highest sequence similarity was in TM6 whilst TM4 and TM5, 











Type 2 : OR8 4 1 
Type 3 : OR8S 1 
Type 1 : OR71 1 
Type 4 : OR86 1 
Type 2 : OR84 69 
Type 3 : OR8S 69 
Type 1 : OR71 69 
T ype 4 : OR86 
Type 2 : OR84 
Type 3 : OR8S 
T ype 1: OR7l 
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Figure 4.6: Alignment of the amino acid sequences of 270R clones. The deduced amino acid sequences of the 4 types of 
OR transcripts from the end transmembrane domain TM3 to TM7 are aligned. The blue shading indicates identical amino 
acid residues while COllSelVed residues are shaded in gray. The positions of the transmembrane domains TM4-TM6 are 
indicated. The consensus amino acid motifs for olfactory receptors are indicated with red asteriks. The position of the 
termination signal in 270R86 is indicated by a *. 
The sequences of the 4 OR gene transcripts identified in OP27 were compared to the GenBank 
nucleotide and ammo acid databases. The sequences were homologus to other known olfactory 
receptors. The results are described below and summarized in Table 4.1. Even though the ORF of the 
type 4 OR (represented by 270R-86) was interrupted by a single stop codon (Fig. 4.6), there was an 
overall 99010 identity with the olfactory receptor MOR135-7 (accession number NM_147008). Both the 
forward and the reverse sequences of the 270R-86 showed this stop codon. However, the stop codon 
in 270R-86 was not conserved in the nucleotide sequence alignment with MORI35-7. It is possible 













4.2.4 Amplification of OR gene transcripts from genomic DNA results in a more heterogenous 
mixture of sequences 
The ORFs of OR genes have no introns, thus making it impossible to design degenerate primers 
spanning an intron. Consequently, peR products resulting from amplification of either eDNA or 
genomic DNA cannot be differentiated. The cloning of the 4 different types of OR genes instead of 
just one specific OR in the OP27 cells might therefore be a consequence of genomic DNA 
contamination. However, the RNA that was used for the first strand cDNA synthesis was always 
pretreated with DNaseI to remove any contaminating DNA. Subsequent to the treatment, the RNA was 
used as a template in a peR with the degenerate primers or any other primers to check if any peR 
product would result. Indeed these reactions failed to amplify any peR product. Lastly, as shown in 
Figure 4.2 the RNA samples that were not reverse transcribed did not result in any amplification as 
expected of a sample with no genomic contamination. A second control experiment to exclude any 
possibility of contamination was therefore to perform a peR on genomic DNA, clone the peR products 
and determine the distribution of OR expression in these clones. Amplification from genomic DNA 
should result in a large variety of OR genes. To confirm this hypothesis, a peR on genomic DNA was 
therefore performed; the peR products were subcloned and nucleotide sequences of inserts from 9 
randomly chosen recombinant plasmids were determined. Indeed, the peR products cloned from the 
peR on genomic DNA were a more heterogenous mixture of OR sequences than the RT -peR product. 










































































































































TTTTGTT! GCC CTCTGGTTTT CT C 253 
CTTTGC ATA GCTGGGTGGTGGT 256 
TGTTATT GTC CTTGGTGTTTTT 254 
TATTCTGATATGT CCTTGGCTTCATC 258 
TATCCTI GGG CATCATTATTATT 254 
TGTCAT AGGGC GTTATTGTCATT 254 
TGCCCTT CATC CATCCTTATATTC 254 
CATCAGT GGGCC ATGCCGCTCAGT 253 
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Figure 4.7: Nucleotide sequence alignments of the genomic olfactory receptor clones. 
Chapter 4 
4.2.5 Repertoire of OR expression in differentiating OP27 cells changes at a later time point 
In order to see whether OP27 expressed the same reportoire of ORs following FGF-2 induced 
differentiation, I analysed expression of ORs at a later time point. RNA was extracted from 5 pooled 
plates after 4 days ofFGF-2 treatment. OR PCR products were cloned, the inserts were PCR-amplified 
as described above, and the peR products digested with restriction enzymes that recognized each 
specific OR type described earlier (Table 4.4). SphI (specific for type 1) and PvuII (recognizes type 2) 
digested only one of the 18 day 4 OR clones to give the expected digestion pattern (Fig. 4.8A and B). 
Pvull additionally digested two other clones (270R-I and 270R-24) but these did not result in the 
same digestion pattern as type 2, nor each other, thus suggesting that these were different OR genes. 
NheI and VspI which recognize type 3 and type 4, respectively, did not result in any digests at this 
stage of differentiation (Fig. 4.8C and D). These digest patterns would suggest that type 1, and type 2 
are expressed again in an independent experiment. However, the majority of the OR clones were 
different. Nucleotide sequences of 9 randomly selected clones from this time point viz. 270R-7, -10, -
12, -14, -15,-1S!, -19, -20, and -23 were therefore determined and analyzed. All 9 clones encoded 4 
additional putative OR types that were different from the clones described earlier. The 4 day tirne-
point OR clones and the matching olfactory receptor proteins whose sequences are available in 
GenBank are summarized in Table 4.3 . A sequence alignment of the deduced amino acid sequences of 












Table 4.2: Restriction enzyme digest patterns used to identify OR peR products cloned from OP27 cells following 4 days 
of treatment with FGF-2. Digestion of peR products of Type 1, 2, 3, and 4 ORs with Spbl, PvuII, NheI, and VspI, 
respectively gives a unique restriction enzyme digest profile, shown in bp. 
Type I: OR-71 
Type 2: OR-84 
Type 3: OR-85 
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A: Type 1 
B: Type 2 
C: Type 3 
D: Type 4 
Figure 4.8: Restriction digestion analysis of OR transcripts cloned from OP27 cells that had been treated with FGF2 for 4 
days. Sphl (A), Pvu1l (B), NheI (e) and VspI (0) RE digests which recognised Type 1, Type 2, Type 3, and Type 4 OR, 
respectively, were used to characterise 18 OR peR products cloned from OP27 cell cultures following 4 days treatment 
with FGF-2. SphI (A) digested ORJ peR product while digestion of OR6 peR product with PvuII (B) gave RE digest 
pattern consistent with Type 2 OR. Pvull also digested peR products from ORI and 0R24 giving a different digest pattern. 
NheI (C) and VspI (0) did not digest any of the clones. OR71, 84, 85 and 86 were included as controls for Type 1, 2, 3, and 












Table 4.3: Summary of 4 additional OR types that were expressed in OP27 cells after 4 days in FGF-2. The BLAST 
matches of the OR types are also included. 
OR Type Clones representing OR type BLAST MATCH Accession Amino acid homology 
Number 
TypeS 270R-7, -10, -14, -18, -19 MOR256-23 XM 195302 %% 
Type 6 270R-15 MOR257-1 NM 146987 100% 
Type 7 270R-20 MORI65-6 NM 146787 100% 
Type 8 270R-12, -23 MOR257-4 AY073654 100% 
Type 4 : OR86 I CrpLHYTS IMS PKLCTCLMLLLWILTTSHAMMHTLLAARLSFC~NNVILsrrCDLFAVLKLSCD-TY 67 
Type 7 . OR20 I CNPLLYN I VMS PKMCSYLMLGSYLMG FSGAMI HTGCVLRLS rCDGNI IN HyrCDLLPLL QLSCTSTY 68 
Type 2 : OR84 I CHPLHYQ tIMNPRLCGLLVtLSVLISLrvSQLfiNSWLQLTyrKSVDISHrrCDPSQLLNLACSOTr 68 
Type 3 : ORBS I CH PL HYTVLMNPKLCSQLLLLAWLrSILGALP~SLTAL~SFCAVVEIPHYrCELPEVLKLACSOTF 68 
Type 1 : OR69 I CH PLHYM IIMSTRRCGLMILACWIIGVINSLLHTrLVliRLSrCTNL~IPHrrCELNQVVHQACSDTr 68 
Type 6 : OR15 VCN PLRYTVVMNPRLCMGLAGVSWFVGWNSAV~TAVTMSLPTCGHNVLNHVACETLALVRLACVDIT 68 
Type 8 : OR23 VCNPLRYTVVMNPRLCMGLAGVSwrvGWNSAV~TAVTMRLPTCGHNVLNHVACETLALVRLACVDIT 68 
Type 5 : OR10 VCHPLHYTSIMHPLLCHALAISSWVGGLVNSLTQTSLIMTIPLCGH-HLNHrrCEMLVLLKLACEDTV 67 
Type 4 : OR86 68 INDLMILIFGGLlrII PFLLIVISYAR I ISS~LKVPSTQG I YKVrSTCGSHLSWSLrYGTIIGLYLC 135 
Type 7 : OR20 69 VN~IEVLIVAGKDIIVPTVIIFISYGF I LSS FQMKSTKGMSKArSTCSSH fIAVSLFFGSGAFMYLK 136 
Type 2 : OR84 69 TNNIVMYFVGAISGrL PISGIrrSYYKIVSSILRMPSPGGKYKAFSTCGSHLSWCLrYGTGLGVYLS 136 
Type 3 : OR85 69 INNVVL~IVTGI MGrrpLAGILFSYSQ IVTSVLRISTVRGKYKAFSTCGSHLSVVSLrYGTCLGVYLS 136 
Type 1 : OR69 69 LNDMVI~ITAMLLAVGPrSGILYSYSRIVSPICAI SSVQGKYKAFSTCASHLSVVSLrYCTPLGVYLS 136 
Type 6 : OR15 69 LNQWILASSWVLLVPCSLVSLSYAH IVAAIMKIRST QGRRKAFETCASHLTVVSMSYGMALFTYMQ 136 
Type 8 : OR23 69 LNQVVILASSWVLLVPCCLVSLSYAY IVTAILKIRSTQGRRKAFGTCASHLTVVSMSYGMALFTHME 136 
Type 5 : ORI0 68 GTEJl.NLFVAGAIILVCPVALILGTYAH I AHAVLKIKSRSGRRKALGTCGSHLTVVr LFYGSAMYMYLQ 135 
Type 4 : OR86 136 PSGNNSTVKEIAMAMMYTVVT P 157 
Type 7 : OR20 137 PNSTGTMNNGKIPSII YT ILI P 158 
Type 2 : OR84 137 SAVSLSPRKGAvASIVYT VVT P 158 
Type 3 : OR85 137 SIWIQASWAGVFASVLYTVVT P 158 
Type 1 : OR69 137 SAVTQNSHATATASLMYTVVT P 158 
Type 6 : ORIS 137 PRSTASAEQDKLVVLFYAVVT P 158 
Type 8 : OR23 137 PTSTASAEQDKVVVVFYAVVT P 158 
Type 5 : OR10 136 PVHVYSGS EGKrAALFYTIITP 157 
Figure 4.9 Alignment of the deduced amino acid sequences of the 270R clones, between the primer regions MA YDRYV A 
at the end of TM3 and MLNPFIY in TM7. The clones were from both the 2 day time-point (Type 1-4) and 4 day time-












4.2.6 Genomic organization of270R clones 
A different set of ORs were expressed in OP27 cells in the retinoic acid experiment (Illing et al., 2002), 
at the 2 day time-point and at the 4 day time point in FGF-2. In order to see whether these ORs were 
clustered together, or randomly distributed in the genome, I used the Entrez MapViewer tool available 
at the NCBI to determine the chromosomal localization of the ORs identified in differentiating OP27 
cel1s. This analysis revealed that the OR types are widely distributed in the genome and most are found 
within OR clusters with OR genes from either the same family or different families. Some were found 
on the same chromosome but were mapped to distinct loci (Fig. 4.10). Type 2 and type 7, for an 
example, were located on chromosome 9 with an intergenic distance of ~18.5M (Fig. 4.10B,G). 
Similarly, type 4 and type 5 ORs occupy distinct positions on chromosome 11 (Fig. 4.IOD, E). OR 
types 6 and 8 which had a very high amino acid sequence homology (Table 4.4; Fig. 4.9) were mapped 
adjacent to one another on chromosome 6 and have the same transcriptional orientation (Fig. 4.10F). 
Both genes belong to the same OR gene family (family 257, Zhang and Firestein, 2002). The type 1 
OR and type 3 ORs were mapped to chromosomes 10 and 8, respectively (Fig. 4.10 A, C). Type 3 OR 
is one of only two OR genes housed in chromosome 8 (Zhang and Firestein, 2002). There was, 
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Figure 4.10 A Map View output of the genomic organization of the olfactory receptors identified in OP27 cells_ The 
OR genes highly homologous to those expresssed in OP27 cells are shown in bold. The transcriptional orientation of 
the genes is indicated by the arrows. Arrows facing down represent the positive strand whilst arrows facing up 













One fundamental characteristic of OR gene expression is that each ORN selects only one of the 
reported 1300-1500 genes in mice to express. Following induction with retinoic acid, the OP27 cell 
line was shown to express just one OR gene, the 0R27-3 receptor (Illing et al., 2002). I have 
investigated whether these cells were committed to express this particular receptor, or whether they 
could express different OR(s) following FGF-2 treatment. This investigation was carried-out using 
RT -peR with degenerate primers that recognize conserved regions in OR sequences. A peR product 
obtained from cells pooled from several culture dishes after 2 days of treatment with FGF-2 was cloned 
and restriction enzyme digest analysis of 24 clones indicated that they encoded 4 different types of OR 
transcripts with little homology between them and 0R27-3. Moreover, a different OR repertoire was 
expressed by OP27 cells after 4 days of differentiation. RE digest analysis of 18 clones from a peR 
product obtained at the 4-day time-point indicated that there were at least 4 types of OR transcripts 
expressed. These results are different from the results obtained in the retinoic acid experiment in which 
only the 0R27-3 receptor was identified (Illing et al., 2002). I have excluded any possibilIty that the 
results obtained in this study may have been a consequence of genomic DNA contamination. 
Secondly, the expression of only 0R27-3 in the retinoic acid experiment was reported from one time 
point only and from a single culture dish whereas in this study the expression of the small repertoire of 
OR transcripts was based on RNA extracted from OP27 cells pooled from several plates and from 
different time points. These observations would therefore suggest that the OP27 cell line is not 
committed to express a single receptor as previously suggested in Illing et al (2002). Instead, these 
cells are capable of expressing a small repertoire of OR genes each time they differentiate. It is likely 
that within the pool of OP27 cells a small percentage of the neurons express ORs, with each cell 












ORs from single cells. Whether individual cells indeed expressed only one OR could be resolved using 
single-cell RT-PCR 
An important question in this field is how an individual ORN selects an OR gene to express and how to 
ensure that only one and no other ORs are expressed. Several theories have been proposed. One of 
these was the genomic DNA rearrangement hypothesis that has since been disproved (Eggan et ai., 
2004; Li et ai., 2004). There is also the possibility that specific combinations of transcription factors 
acting on gene-specific promoter regions activate the expression of only one gene. However, when two 
copies of the same OR transgene having the same regulatory sequence were tagged with different 
markers, it was found that only one of the two copies was expressed by individual ORNs (Serizawa et 
al., 2000). This therefore makes theory that transcription factors may be involved in selecting one OR 
gene to activate unlikely. There is also the theory that a LCR may regulate the expression of individual 
OR genes within a cluster. Recent data have shown that a negative feedback mechanism mediated by 
the OR protein itself ensures that all the other ORs are not expressed in that cell (Serizawa et aI., 2003; 
Lewcock and Reed, 2004). 
It has been suggested that the stage at which these genes are expressed along the neuronal lineage is 
likely to be important for understanding how a neuron chooses a single OR to express (Fan and Ngai, 
2001; Brunjes and Greer, 2003; Iwema and Schwob, 2003). In their study using catfish, Fan and Ngai 
(2001) sought to determine the onset of OR gene expression along the ORN developmental pathway. 
They proposed that if the expression of these ORs was activated early in the lineage (i.e stem cells, 
transit amplifying cells or the immediate neuronal precursors) that would imply that the ORNs derived 
from a common mitotically active precursor would all express a specific OR transcript. However, their 












differentiated neuronal cells (no cells were doubly labelled with BrdU and OR riboprobes). They 
therefore concluded that the ORN precursors were not committed with regard to expression of OR 
The onset of expression was activated later, such that ORNs derived from a common presursor would 
all express different ORs. The results that I have described in this study are consistent with this model 
of expression. At the non-differentiated state (at 33°C) the OP27 cell line has properties of a transit 
amplifying cell population (lIling et a!., 2002) that does not express OR genes as yet The ORs were 
ftrst detected at 2 days following treatment with FGF-2 and this was coincident with the up-regulation 
of GAP-43, a marker for immature ORNs, in these cells (Chapter 3). This suggests that both the 
commitment to express a particular OR (receptor choice) and the activation of ORs likely take place at 
the immature neuronal stage. Two other studies conducted in mice have reported similar patterns of 
expression In one study, the expression of ORs was found to precede both the dissapearance of GAP-
43 and the onset ofOMP expression in adult mice (Iwema and Schwob, 2003). Similarly, the earliest 
expression of the mouseM4 OR within the OE neuronal lineage was detected frrst in immature ORNs 
(Qasba and Reed, 1998). 
The results obtained in this study with respect to OR expression in OP27 cells also confrrm already 
published in vivo data that OR expression can be activated independent of signals from the olfactory 
bulb (Sullivan et a!., 1995; Fan and Ngai, 2001; Iwema and Schwob, 2003). Thus the OP27 cell line is 
the mst OE in vitro model system to be shown to express endogenous ORs and this might render them 
useful in studying the regulatory mechanisms involved in OR expression. They could be useful for 
gene targeting and transfection studies in an attempt to elucidate these mechanisms. Another cell line, 
3NA12, derived from the OE ofH-2Kb-tsA58 transgenic mice has also been suggested to express ORs 












profiles of single cells of this line to a number of structurally different odorants. There was an even 
distribution of cells responding to each of the odorant ligands tested, with ninety percent of responsive 
cells being stimulated by only one odorant whereas only 10010 responded to 2 odorants. None of cells 
were stimulated by more than 2 odorants (Barber et al., 2000). 
In conclusion, the OP27 cells are not committed to express a single OR The expression of a small 
spectrum of OR genes in the cell line would suggest that there was simultaneous differentiation of a 
subpopulation of OP27 progenitor cells along different lineages with regard to OR gene expression. 
Secondly, because different spectra of OR genes were expressed at both the 2-day and 4-day time-
points, it is likely that the decision of which OR to express is made de novo each time the neurons 
differentiate. Lastly, the ORs identified in this study are not co-localized in the genome but are widely 
distributed in different chromosomes thus suggesting that these cells are not committed to express ORs 












Characterization of the transcriptional expression of proneural bHLH 
• 
transcription factors and Notch signalling pathway components in 
, ... ,. 
OP27 cells following treatment with FGF-2 
'.' :,:~ 
.. 
5.1. Regulation of olfactory neuron development by bBLB and rHLB transcription factors 
Data from analysis of pattern of gene expression and genetic studies has identified several 
transcription factors that regulate cell fate at different stages in the development of olfactory 
neurons. These transcription factors include members of the bHLH family (Jvfashl, Ngn2, Ngnl, 
NeuraD, Hesl, Hes5); the mammalian OlfllEBF (OlE) family of repeated helix-loop-helix (rHLH) 
transcription factors (OlEl, O1E2, OIE3); homeodomain transcription factors (Dlx5); paired-box 
proteins (Pax-6), homeobox (Gtx2) and winged-helix transcription factor (F oxg lIBF-l). 
Studies conducted in mouse have shown that members ofHLH proteins are sequentially activated to 
regulate olfactory neuronal development (Cau et aI., 1997; 2000; 2002), in a similar manner to that 
observed in primary neurogenesis (Fig. 1.6, Chapter 1). Analysis of the spatial and temporal pattern 
of expression of the bHLH genes, Mashl, NgnJ, and NeuraD, relative to markers for mitotic cells 
(identified by BrdU incorporation) and immature neurons (identified by expression of class ill 13-
tubulin) revealed that they are expressed in different populations of cells during mouse olfactory 











Mashl is the first of these transcription factors to be expressed. High expression levels were found 
preferentially in BrdlY apical and basal progenitor cell clusters that were found outside of the 13-
tubulin expression domains (Cau et al., 1997; 2002). NgnJ, on the other hand, was transiently 
expressed in mitotically active basal cells that intermingled with f3-tubulin + cells although there was 
,,," 
f' 
no overlap between f3-tubulin and NgnJ expression. NeuroD expression was expre~edin the last 
cell division and at the beginning of differentiation of the postmitotic neurons as shown by double-
" 
labelling with f3-tubulin. These patterns of expression would suggest that, in the mouse OE 
development the bHLH proteins are sequentially expressed, with MashJ at the beginning, followed 
by Ngnl and lastly NeuroD (Fig. 5.1), and that Mashl may specify the ORN fate by activating the 
expression of the other two bHLH genes. Indeed, deletion of Mashl results in the loss of NgnJ and 
NeuroD expression and, as a consequence, the block of neuronal differentiation (Cau et ai., 1997). 
Another bHLH transcription factor, Ngn2 was found expressed in a subset ofORN progenitors that 
were independent of MashJ function. These Ngn2 positive progenitors persist and continue to 
express NgnJ and NeuroD in the absence of Mashi. This suggests that Ngn2 may have a similar 
function to that of Mas hi in this cell population, activating both Ngni and NeuroD (Fig. 5.1, Cau et 
al., 1997). 
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Figure 5.1 Sequential activation of bHllI transcription factors in mouse olfactory neuronal lineages. Mashl is 
expressed in the progenitor cell population (both apical and basal) and is followed by the expression of Ngnl in the 
immediate neuronal precursor (INP) and NeuraD by cells that are leaving the cell cycle to begin to differentiate into 
olfactory receptor neurons (ORN). Ngn2 is also expressed in the OE but in a separnte domain to that of Mashl but has 












5.1.1 The role of O/E-l in olfactory development 
O/E-l was first cloned by genetic selection for transcription factors that bind to a conserved, cis-
• 
acting element found in promoters of several olfactory neuronal-specific genes, including OMP, 
olfactory cyclic nucleotide gated cation channel (OCNC), type ill adenylate cyclase~(ACill), and 
Golfo: (Wang and Reed, 1993). Recently, several potential O/E-l binding sites have' also been 
" identified in promoters of a human olfactory receptor gene cluster (Glusman et al., 2000). 
In the OE, the O/E-I protein is transiently expressed in neuronal precursor cells that are leaving the 
cell cycle and begin to differentiate, well before the onset of expression of OMP, OCNC, Golfo: etc. 
Its expression is maintained in the neuronal cell layers of the OE. This pattern of expression 
suggests that O/E-l has a critical role in ORN differentiation and may function to activate 
transcription of the ORN specific genes (Davis and Reed, 1996). It is likely that O/E-l is a 
downstream target of Mash1 since expression of O/E-l mRNA transcripts was abolished in Mash1 
mutant OE (Cau et al., 2002). Two O/E-I mouse homologs, O/E-2 and O/E-3 have been identified. 
Genetic analyses have revealed that the functions of these proteins are, to a degree, redundant in 
olfactory development. While the expression of olfactory specific genes like OMP and components 
of the olfactory transduction pathway was not affected in 01E-2 and 01E-3 mutant mice, the 
olfactory bulb was reduced in size and ORNs failed to project to the olfactory bulb (Wang et aI., 
2004). 
5.1.2 Expression of Otx2 in the olfactory neuronal lineage 
Otx2 is a member of the homeobox gene family that has been implicated in the development of 












1996). Immunocytochemical analysis of the OTX2 protein showed it was already expressed at the 
mouse placodal stage (E9.5-ElO.0) before the formation of olfactory pits (Mallamaci et aI., 1996). 
In E14.5 OE explant cultures, Otx2 mRNA was generally expressed in ORN precursor cells that 
• 
were migrating away from the explant to begin to differentiate. Little or no expression was detected 
in differentiated ORNs and expression of the transcription factor was therefore ptopQsed as a 
general marker for ORN progenitors (Calof et al., 1996). 
5.1.3 FoxGl as a regulator of timing of neuronal differentiation 
FoxGI, formerly known as brain factor 1 (BF-l), is a winged-helix transcription factor specifically 
expressed early in the telencephalic neuroepithelium and in the olfactory placode during embryonic 
development (Tao and Lai, 1992). In the telencephalon, the expression levels of FoxgJ gene are 
highest in rapidly proliferating cells and levels decline once the cells become post-mitotic and begin 
to differentiate (Xuan et ai., 1995). 
In FoxgJ null embryos, the cerebral hemispheres of the telencephalon fail to expand as a result of 
the depletion of the neural progenitor pool. In these mutants, the neural progenitors exit the cell 
cycle and begin to differentiate prematurely thus retarding the growth of the telencephalon (Xu an et 
aI., 1995). The cerebral cortex of FoxgJ null mice is characterized by an overproduction of early 
cortical neurons, the Cajal-Retzius neurons, at the expense of neurons that are normally generated 
later (Hanashima et al., 2004). On the other hand, ectopic expression of FoxgJ in the neural plate 
of Xenopus embryos leads to the expansion of the neuroectoderm while inhibiting neuronal 
differentiation (Bourguignon et ai., 1998). These studies suggest that the function of FoxgJ is to 
maintain neural progenitor cells in a proliferative state and to control the timing of neuronal 












binding domain, and indirectly by interacting with the transcription co-repressor GrouchoillE and 
lIES 1 (Yao et aI., 2001) . 
• 
FoxGI is also an important regulator of cell proliferation and neurogenesis in the OE. Its mRNA 
t 
transcripts are expressed early during the placodal stage (Tao and Lai, 1992; TIling etal., 2002) and 
also in the OE at E14.5 (Calof et ai., 2002). The OE is also greatly reduced in size and most 
• 
proliferating cells are missing in transgenic mice in which Foxgl is deleted, compared to wild-type 
embryos (Xuan et aI., 1995; Calof et al., 2002). Foxgl may therefore playa very important role in 
the regulation of olfactory neurogenesis. 
5.1.4 Regulation of olfactory neurogenesis by Notch signalling 
A clue that lateral inhibition may be operating in the OE first came from in situ hybridization 
expression studies of the Notch signalling pathway components (Lindsell et ai., 1996). Notchl and 
its ligand Deltal were expressed in the basal progenitors whereas two other Notch homologues, 
Notch2 and Notch3 were found throughout the OE, except in the basal layer. Genetic studies 
carried out in the laboratory of Guillemot showed that lateral inhibition is instrumental in regulating 
the number of neuronal cells that are generated in the OE (Cau et aI., 2000; 2002). From these 
studies, it was shown Notch signalling regulates the ORN production at the level of the proneural 
transcription factors Mashl and Ngnl (Fig.5.2). This action is mediated by the Notch effectors, 
Hesl and Hes5, which have distinct expression patterns in the OE progenitors. At E12.5, when the 
OE has attained its layers, Hesl transcripts are found only in most progenitors at the apical side of 
the OE before the onset of Mashl expression. Hesl mutants display ectopic expression of Mashl in 
cells that do not normally express it and an increase in the number of Mashl+ cell clusters. At this 












Mashl in the apical progenitors. Hesl is expressed together with the Notch ligand Serl(Jagl) in 
apical progenitors downstream of Mashl as shown by targeted mutation of Mashl. It is proposed 
that Mashl selects apical progenitors that will become basal progenitors by activating Notch 
signalling. Therefore, the Notch ligand Ser 1 and effector Hesl regulate production of basal 
progenitors by targeting Mashl (Fig 5.2). 
apical 
basal 
Figure 5.2 Interaction of positive bHLH transcription factors Mash} , Ngn}, and NeuroD and the negative bHLH 
regulators Hes} and Hes5 in regulating olfactory neurogenesis. Shown above is a schematic representation of the OE at 
E12.5 showing the apical (top) and basal (bottom) sides of the neuroepithelium Both sides are populated by lineage 
related progenitor cells that express defined sets of positive and negative regulators of olfactory neurogenesis. The 
apical progenitors express Mash}, the Notch ligand Serrate} (Ser}), and the effector Hes}. Mash} selects progenitors 
that will differentiate into basal progenitors by activating the expression of Serl and Hes} through Notch signalling 
(lateral inhibtion). Through Hes} activation (downstream of Notch signalling), Mash} expression is repressed in some 
apical progenitors and as a result these cells are not fated to become basal progenitors. Hes} is also activated 
independently of Notch signalling (indicated by the dashed arrow in the diagram) to limit the expression of Mash} in 
the apical progenitors (Can et 0/., 2000). The apical progenitors fated to become basal (shown in grey) translocate into 
the basal side of the neuroepithelium and continue to divide. In this population of progenitors Mash} has been shown to 
also activate lateral inlubition through a distinct set of Notch ligands and effectors. The ligands, Delta like 3 (DU3) and 
Serrate2 (Ser2) and the effector Hes5 are activated downstream of Mash} function. Hes5 then synergizes with Hes} to 
repress expression of the transcription factor Ngn} which is required for neuronal differentiation of the basal 
progenitors. Mash 1 also activates at least 2 downstream programs of ORN differentiation in the basal progenitors. In 
one programme, Ngn} is required to activate the expression of the differentiation gene NeuroD and to generate ORNs. 
Members of the OlfllEBF family (OlE-I, 01E-2 and 01£-3), shown to be functionally redundant for the expression of 
olfactory-specific genes (Wang et 0/.,2004), are also activated in a programme ofORN differentiation downstream of 
Mash} function but independently to Ngn} expression (Cau et al., 2002). 
The basal progenitor population is characterized by the expression of a distinct set of Notch ligand 
and effector molecules from that found in apical progenitors, namely, D1l3, Ser2, and Hes5 . These 
have been shown to regulate the production ofORNs at the level of Ngnl. At this level, Hes5 co-












expression of Ngn] which is required for the differentiation of ORNs. Thus, Notch signalling 
regulates olfactory neurogenesis in at least 2 different steps along the neuronal pathway (Fig.5.2). 
t 
The regulatory loop involving Mash] and Notch signalling ensures that not all the apical 
~. 
progenitors generate basal progenitors that are destined to become the ORNs.~ Instead, an 
alternative fate is probably promoted at the expense of the neuronal lineage. The sustentacular 
" cells, the non-neuronal cells in the OE, are thought to be generated by apical progenitor cells in the 
adult OE (Cau et al., 2002). Targeting of Mash] by the Notch pathway in apical progenitors would 
probably promote the generation of these cells. Recent Mash] knockouts studies have shown that 
the majority of the cells in the mutant OE express Steel, a marker for sustentacular cells (Murray et 
aI., 2003). 
5.1.5 Regulation of intrinsic molecules by extrinsic signals in olfactory neurogenesis 
As shown earlier, vertebrate neurogenesis is regulated by both intrinsic and extrinsic factors, 
starting from the early commitment of multipotential neural progenitors, right to their terminal 
differentiation into neuronal cells. How the various secreted signals and the intrinsic transcription 
factors co-operate in regulating this process remains largely unknown. There is evidence that 
extrinsic signals regulate expression of these transcription factors. ill the differentiation of neural 
crest progenitor cells into autonomic neurons, Mash] is required for competence of the cells to 
respond to BMP2, a member of the BMP subclass of TGF~ proteins. Exposure of the neural crest 
progenitor cells to BMP2 maintains Mash1 expression and leads to differentiation. Mash] on its 
own is not sufficient to drive neurogenesis and cells that initially express the transcription factor but 
not exposed to BMP2 fail to differentiate (Edlund and Jessel, 1999; Lo et aI., 2002). ill the OE, 












neurogenesis in this tissue (Chapter 3; Shou et al., 1999; 2000). BMPs have been shown to regulate 
neuron number in EI4.5-15.5 OE explant cultures by targeting Mashl. At low concentrations 
(O.lng/mI), BMP4 has a stimulatory effect on neurogenesis, promoting the survival of newborn 
• 
neurons. At high concentrations (lOng/ml) it blocks proliferation of MASH 1 + progenitors and their 
-
subsequent differentiation by mediating a rapid proteasorne-dependent degradatia6* of MASH1 
(Shou et al., 1999). Overexpression of Notch in small-ceIl-lung cancer cells has been shown to also 
" down-regulate the HASHI protein (the human homolog of .MASHl) via the same degradation 
pathway (Sriuranpong et al., 2002). It is therefore possible that in the OE, Notch signalling and 
high BMP levels may co-operate to negatively regulate OE neurogenesis. 
FGF -2, on the other hand, has been shown to have a stimulatory effect on OE neurogenesis by 
promoting proliferation of the putative ORN stem cell and that of the INP (DeHamer et al., 1994; 
Calof et aI., 2002). I have also shown that FGF-2 promotes neurogenesis in OP27 cells, first 
promoting proliferation and subsequently, neuronal differentiation. However, whether FGF-2 
exerts any effects on the regulation of the transcription factors has not been explored. In this 
chapter I have studied the effect of FGF -2 on the expression of transcription factors that are 
important for OE neurogenesis. I have also studied the expression patterns of the components of 
the Notch signalling pathway during FGF2- induced differentiation ofOP27 cells. 
5.2 RESULTS 
5.2.1. Expression of intrinsic components of neuronal differentiation in OP27 cells 
To begin to determine whether FGF-2 has any role in the regulation of the various transcription 












RT-PCR analysis with specific primers was used to determine which of these components were 
contained in OP27 cells at the undifferentiated state (at 33°C) and at 6, 24 and 48 hours following 
FGF-2 treatment. 
The earliest marker in the OE neuronal lineage is Mashl, with high expression levels in apical and 
basal progenitor cells before Ngnl and NeuroD (Fig. 5.1). I could not detect any Mashl mRNA 
transcripts in OP27 cells whether at the undifferentiated state or following treatment with FGF-2 
(Fig. 5.3A). mRNA transcripts of another early marker, the blll.H transcription Ngn2 were also not 
detected in these cells (Fig. 5.3B). Ngn2 is expressed by a subset of progenitor cells in the 
ventrocaudal domain of the olfactory placode independent of Mashl expression (Fig. 5.1 Cau et al. 
1997). The primers used to amplify both Mashl and Ngn2 were able to amplify the specific 
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Figure 5.3 ExpresSion profiles of positive regulators ofORN lineage development in 0P27 cells. RT-PCR analysis for 
the various positive regulators of olfactory neuronal differentiation was conducted in OP27 cells when maintained at 
33°C (Oh) and when treated with FGF-2 at 39°C for various times (h, hours; d, days) . Mouse genomic DNA was used 
as a positive control (ctrl) in all the RT-PCRs. OP27 cells do not express the cDNAs for Mash] (454 bp) and Ngn2 
(545 bp). +, reverse transcribed eDNA template; -, RNA sample that was not reverse transcnbed used as a negative 
control. Primers for ~-actin were used as control for loading of samples. Molecular weight sizes (in base pairs, bp) are 












The expression of Ngn-l and NeuraD has been shown to under the control of Mashland mark the 
population of dividing immediate neuronal precursors and the onset of neuronal differentiation of 
the postmitotic cells (Cau et al., 1997; 2002). Ngnl transcripts could be detected at in OP27 cells at 
33°C and up to 2 days following treatment with FGF-2 (Fig. 5.3C). No Ngnl transcripts were ever 
detected after 2 days. NeuraD, on the other hand, was not present in OP27 at the non-differentiated 
state but could be detected after 24 hours and 48 hours following treatment with FGF-2, with the 
levels lower at the 48-hour time point. No PCR product was ever detected after 48 hours in FGF-2 
(Fig. 5.3D). 
Next to be analysed were the transcript profiles ofOtx-2 and OlE-i. Otx-2 has been suggested to be 
expressed by neuronal precursor cells or transit amplifying cells down-stream of Mashl in the 
olfactory neuronal lineage (Calof et aI., 1996; 2002). OP27 cells expressed both Otx-2 and O/E-l 
transcripts both at 33°C and after treating the cells with FGF-2. Levels did not change in response 
to FGF-2 treatment during the 48 hours (Fig 5.4). 
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Figure 5.4 Expression of Otx-2 and 0/£-/ transcription factors in OP27 cells. RT -PCR analysis for Otx-2 and OIE-/ 
was conducted in OP27 cells when maintained at 33°C (Oh) and when treated with FGF-2 at 39"C for various times (h, 
hours). Mouse genomic DNA was used as a positive control (ctrl) in all the RT-PCRs. +, reverse transcribed cDNA 
template; -, RNA sample that was not reverse transcribed used as a negative control. Primers for ~-actin were used as 












The expression profiles of Notch, its ligand Delta and both effectors, Hesl and Hes5, were also 
examined in OP27 cells. The messages for both Notchl and Deltal could be readily detected in 
OP27 cells at 33°C and at 39°C with FGF-2 treatment (Fig. 5.5A), with Deltallevels beginning to 
increase around 2 days after FGF-2 treatment (Fig. 5.SB). 
A Oh 6h 24h 48h 








Oh 6h 24h 48h 




Oh 6h 24h 48h 
810-+ - + - + - + - ctrl 
510- -~ Hes-5 
450-
~ j3-actin 
Oh 6h 24h 48h 
400-
+- + -+ - +-ctrl 
;. .... 'F.- c -~""'7 
&< 
1. _ ~ 
(--Foxgl 
(-- j3-actin 
Figure 5.5 Expression of Notch I, its ligand and blll..H effectors in 0P27 cells. RT -PCR analysis for Notch signalling 
components was conducted in 0P27 cells when maintained at 33°C (Ob) and when treated with FGF-2 at 39"C for 
various times (h, bours). Mouse genomic DNA was used as a positive control (ctrl) in all the RT-PCRs. 0P27 cells do 
not express the eDNA for Hes5 (449 bp) but the 592 bp genomic fragment could be detected using the sampe primers. 
+, reverse transcribed eDNA template; -, RNA sample that was not reverse transcribed used as a negative control. 
Primers for p-actin were used as control for loading of samples. Molecular weight sizes (in base pairs, bp) are shown on 












Notch signalling suppresses neuronal differentiation through the induction of bIll-H transcription 
factors, Hesl and Hes-5 that inhibit both the expression and/or transcriptional activity of Mashl and 
Ngn-l. Only Hesl transcripts could be detected in OP27 cells with levels increasing once the cells 
were cultuwd at the non-pennissive temperature with FGF-2 (Fig. 5.5C). The primers for Hes-5 
were able to amplify the expected transcript in the genomic DNA template (592 bp) but-never in the 
~ 
OP27 cDNA (449 bp) (Fig.5.5D). The transcription factor Foxgl (SF-I) which was shown to 
interact with Hesl to repress transcription (Yao et aI., 2001), was expressed in OP27 cells"before 
and afiertreatment with FGF-2 with levels not changing with treatment (Fig. 5.5E). 
5.2.2 Changes in expression levels of the various transcriptional markers following treatment 
with FGF-2. 
Only one model that integrates the regulation of transcription factors with extracellular signals 
during the olfactory neuronal lineage has emerged (see section 5.1.5). I therefore sought to examine 
whether FGF-2 had any influence on the expression levels of the messages contained in the OP27 
cells. In Fig.5.3- Fig.5.5 it was established that the OP27 cells expressed a panel of both positive 
and negative regulators of neuronal differentiation thus making these cells suitable for use as model 
system to study the interplay between extrinsic signals and transcription factors during olfactory 
neurogenesis. A semi-quantitative RT -peR approach, using fewer peR cycles, was therefore used 
to analyse the transcriptional levels of the genes following FGF-2 induced differentiation. 
Semi-quantitative RT -peR is a very useful technique to measure changes in the level of expression 
of very low abundant mRNA transcripts (e.g. transcription factors) between samples during cellular 
processes such as differentiation (Foley et al., 1993). It is still widely used and is much more 
sensitive than the more commonly used northern blotting and ribonuclease protection assays 












co-amplified with a house-keeping gene that acts as an internal control whose expression does not 
vary with the experimental condition. The internal controls that are commonly used in semi-
quantitative RT -PCR include ~-actin, glyceraldehyde-3-phosphate dehydrogenase, 18S ribosomal 
• 
RNA and tubulin (Thelin et al., 1999). The co-amplification of both the gene of interest and the 
,,.. 
t 
housekeeping gene controls for the variation in template concentration and amplification efficiency. 
This permits the quantitation of the gene under study relative to the internal control. QUantitation is 
" performed when the PCR reactions are in the linear range of amplification for both transcripts 
before the reaction components become limiting (Foley et aI., 1993). The ~-actin was used as an 
internal control in this study as it was shown by northern blotting that its mRNA levels do not 
change with FGF-2 treatment ofOP27 cells (see Chapter 6). 
When the OP27 cells were shifted to the non-permissive temperature and induced to differentiate 
with FGF-2, transcript levels of Delta and Hesl genes were observed to change while that of others 
did not. Notch-l levels were not observed to change significantly with FGF-2 treatment when 
compared with the control cultures (Fig. 5.6A). On the other hand, the Delta mRNA levels were 
significantly up-regulated 48 hours after FGF-2 treatment and levels remained significantly higher 
than the levels of cells at the non-differentiated state (Fig. 5.6B). In a similar fashion, Hesl 
transcripts were significantly increased in FGF-2 treated OP27 cells but the up-regulation preceeded 
that of Delta by 24 hours. Hesl levels were maintained higher until 10 days after treatment with 
FGF-2 (Fig. 5.6C). 
The transcripts of another negative regulator, Foxgl were also analysed. Foxgl has been shown to 
potentiate the repressive effects of Hesl. However, no appreciable changes were observed in its 
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Figure 5.6 Regulation of Notch signalling components in OP27 cells, Representative semi-quantitative RT -PCR 
analyses of NotchI, Deltal, Hesl and Foxgl mRNAs in OP27 ceUs treated with FGF-2 for the indicated times, CeUs 
that had not been treated (33°C) were included as controls. The genes were co-amplified with p-actin. h, hours; d, 
days, (+) amplification from RNA that had been reverse transcribed, (-) RNA that were not reverse transcribed as 
negative controls, mRNA levels were determined by densitometric scan of the bands at each time-point and 
nonnalized to p-actin. Data are expressed as fold increase in the ratio of gene-of-interestlp-actin with the value of 
the cells at 33°C (time 0) taken as L Data represent mean ± SEM values of 3 independent experiments, 












After 2 days in FGF-2 OP27 cells were observed to change into a bipolar morphology. This 
apparent neuronal differentiation should be accompanied by changes in transcript levels of positive 
neuronal regulators. In the OE neuronal lineage NeuraD marks the population of cells at the last 
cell cycle before they differentiate. In OP27 cells NeuraD was expressed after 24 hours with FGF-2 
(Fig. 5.3D). This is the time that transcript levels of Hes1 have reached a maximum. OlE-I, like 
neuraD, is transiently expressed during the last cell cycle and beginning of neuronal differentiation 
(Davis and Reed, 1996). In OP27 cells OIE-1 is expressed before the onset of NeuraD expression. 
There was no significant change in 01£-1 mRNA levels within the first 6 days but levels decreased 
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Figure 5.7 Regulation of 01£-J in OP27 cells. Representative semi-quantitative RT -PCR analyses of OIE-J mRNAs in 
OP27 cells treated with FGF-2 for the indicated times. Cells that had not been treated (33°C) were included as controls. 
The genes were co-amplified with [3-actin. h, hours; d, days. mRNA levels were determined by densitometric scan of 
the bands at each time-point and normalized to [3-actin. Data are expressed as fold increase in the ratio of gene-of-













5. 3 Discussion 
RT -PCR analysis of OP27 cells has shown that the Notch receptor, its ligand Delta and the effector 
• 
Hesl are all expressed in these cells. This expression pattern indicates that Notch signalling, which 
" mediates lateral inhibition between neighbouring cells, may be active in OP27 cells ... While FGF-2 
had no significant effect on the transcript levels of Notch, levels of both Hesl and Deltal were 
" significantly up-regulated by FGF-2 treatment with the up-regulation of Hesl preceding that of 
Deltal. Hesl was up-regulated within 24 hours following treatment with FGF-2. This is the time 
when the OP27 cells have not displayed any gross morphological changes yet (Fig. 3.5). It has been 
shown that overexpression of the Hesl gene results in the delay or suppression of neuronal 
differentiation by maintaining neural stem cells in a proliferative state (Ohtsuka et al., 2001). The 
up-regulation of the Hesl gene in OP27 cells at 24 hours may be required to delay the 
differentiation of these cells. The inhibition of neuronal differentiation is mediated via the 
transcriptional repression of other bHLH transcription factors such as Mash-l and Ngn-l by HES 1. 
In the OE neuronal lineage HESI has been shown to restrict the expression of Mash-l and later to 
repress the transcription of Ngnl downstream of Mashl (Fig. 5.2). While no Mashl transcripts 
could be detected in OP27 cells, Ngnl, which marks the population of INPs in the OE neuronal 
lineage (Fig. 5.1) was present in low levels (judging by the faint bands following 35 cycles ofPCR, 
Fig. 5.3C). Low Ngnl levels in these cells probably indicate an enhanced Notch signalling that 
restricts the expression of this transcription factor. 
The actions of FGF-2 within the first 24 hours are consistent with the work done by Faux et al. 
(2001) on murine forebrain neuroepithelial precursor (NEP) cells. FGF-2 was found to influence 












Deltal. In the presence ofFGF-2, NEP cells were maintained the NEP cells in a proliferative state 
by up-regulating Notch expression while Deltal was repressed . 
• 
By the definition of lateral inhibition, the cells that are fated to become neurons up-regulate Delta! 
and subsequently activate Notch signalling in the neighbouring cells thus inhibiting them from 
differentiating into neuronal cells. The significant up-regulation of Deltal at 2 days and its 
" maintained high levels after that (Fig. 5 .6B) is concomitant with the emergence of differentiating 
OP27 cells with a bipolar morphology at 2 days and an increase in the number of the bipolar cells 
with time (Fig. 3.6). Up-regulation of Deltal in OP27 cells is also concomitant with the onset of 
NeuroD expression, which is indicative of a pathway leading to neuronal differentiation. In 
Xenopus the expression of X-Ngnr-l precedes then overlaps that of X-Delta-l whereas XneuroD is 
expressed later (Ma et aI., 1996). Ngn-l has been shown to activate the expression of both Deltal 
and NeuroD (Ma et al., 1996; Cau et aI., 2002). Thus, following treatment of OP27 cells with FGF-
2 for 2 days, Ngnl probably up-regulates Deltal expression and in addition, it may also lead to 
expression of NeuroD and the subsequent neuronal differentiation. The patterns of expression of 
both Ngnl and NeuroD suggested that these were transient in OP27 cells, consistent with their 
expression in olfactory progenitors in vivo (Cau et aI., 1997) and in cerebral cortex primary cultures 
in vitro (Katayama et aI., 1997). 
It is paradoxical that the neuronal differentiation of OP27 cells occurs in the midst of high levels of 
Heslgiven that it is a negative regulator of this process. Hesl is first up-regulated at 24 hours 
before Deltallevels are increased. Whether the initial up-regulation Hesl was mediated by Notch 
signalling is unclear. However, later lateral inhibition activated by increased Delta! may have 
maintained levels of Hesl high. Following up-regulation of the ligand in some cells, Deltal signals 












differentiation. This suggests that there are two sub populations of OP27 cells, with one 
differentiating (with high Deltal levels) and other proliferating (with high Hesl levels). This is 
consistent with the data that I have presented in Chapter 3 that while there was a progressive 
increase in the number of bipolar cells beginning at 2 days there were cells that were still not 
.;*"" 
• differentiated (Fig. 3.6). It is likely that these cells under the influence of FGF-2. would reveal 
differential expression patterns of both RES 1 and Deltal. The use of either in situ hy1:)ridizations 
and/or immunocytochemistry would perhaps help resolve these. 
It is also possible that RESI may be inhibited thus allowing for neuronal differentiation to take 
place. NGF was shown to phosphorylate the basic DNA binding domain of RES 1 via the activation 
of the protein kinase C (PKC) pathway. The DNA binding ability of RES 1 was as a result 
effectively inhibited thus allowing for the neuronal differentiation of PC 12 cells (Strom et a!., 
1997). Since PKC is one of several pathways downstream of FGF -2 signalling (Fig. 1.4), it is 
therefore likely that FGF-2 may interfere with the activity of RES 1 in a similar manner in OP27 
cells. 
In conclusion, I have presented data that show that FGF-2 may regulate FGF-2 induced olfactory 
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6.1 Introduction 
Cellular developil.!ent is characterized by proliferation of progenitor cells, exit from cell cycle and 
then differentiation. These are always accompanied by continuous changes in patterns of gene 
expreSSIOn. Certain tra.llscripts may be down-regulated or tUiIied off to allow for cells to eXit 
the cell cycle while genes may be specifically expressed during differentiation. This ultimately 
grves nse to the gieat diversityT of cell that are found in multicellular organisms. 
changing patterns are 'Vv-ell-regulated both tempoially' and spatially to .-.11 .. -...... " r allVVV normal 
developiiient~ HOVv~eyer, in disease such as cailcer cells escape the confines ot growth control 
and continue to as a result transcription. to understand 
disease and vanous h ., 1 • 1 otllcr biOlogical processes, 
, 
researcners w'ould need to 
methods to identify these and study how their expression is modulated. The identification of 
genes that arc differentially regulated and the analysis of role ill changing the properties of 
cells IS one \Jv&ay? in w'hich Vie can start to uIIfavel the complex processes of development ru"1.d 
disease. There are a number of toois that are avaiiable that one couid use to measure differentiai 
gene expreSSIon at include differential h:ybiidizatiolt, 
hybridizatior~ display, microailays, analysis of gene expression 











6.1.1 Differential display peR as a tooi to clone genes that are differentiaiiy regulated. 
Differential display PCR (DD) was introduced in 1992 as a tool to compare the expression levels of 
a subset of mIU'>fA transr..:ripts from different but related ceils, and to identify differentially 
expressed genes (Liang and Pardee, 1992). The subset of mRNA transcripts is seiected for 
amplification by PCR by using a combination of primers that selects between 50 and 100 templates 
from the total template pooL The products of the PCR reactions are then compared on a denaturing 
polyacrylamide sequencing geL Any PCR produ('i that is differentially amplified between the cell 
types under ~tudy can be recovered and cloned. The basic outline of the protocol is shown in 
Fig.6.1. 
6.1.1.1 The principles ofDD 
The first step of DD involves the reverse transcription of a subset of the J::IiR1'JA population into 
eDNA. This is achieved by using an anchored-oligo(dT) primer with one or two additional bases at 
its 5-'end to help anchor the cDNA at the 3'-end of the RNA transcript. Different anchored-
oligo( dT) primers with different additional bases can therefore be used to synthesize flrst-strand 
cDNA from different mRNA subsets in different reaction tubes. The anchored oligo(dT) used for 
reverse transcription of cDNA is then used together with an arbitrary primer to allow for peR 
amplification of a subset of cDNAs. The arbitrary primer, typically at least 10 bases long, should in 
theory be randomly distributed in distance from the oligo( dT) for different cDNAs, resulting in 
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Figure 6.1: Schematic representation of the differential display peR technique. Each anchored oligo(dT) primer (blue 
arrow) is used to reverse transcnl>e a subset ofmRNA transcripts from the total RNA pool, extracted from cell types (X 
and Y) under comparison. The anchored oligo(dT) primer is then used in combination with a series of arllitrary primers 
(red arrows) for amplification of the mRNAs by peR. The peR products are then analyzed and bands that are 












The cDNAs are amplified in the presence of a radiolabeHed deoxynucleotide (dJ\i'TP) a..l1d a low 
concentration of unlabelled dNTPs to label the products to a high specific activity for detection. As 
the PCR primers are short, a low annealing temperature of 40°C is used in the PCR reaction to 
allow for efficient priming. Under these conditions, a certain amount of degeneracy in priming is 
allowed, resulting in the amplification of mRl'lA templates that do not have a perfect fit to the 
arbitrary primer sequence. The radiolabelled PCR products are then resoived on a denaturing 
polyacrylamide gel eiectrophoresis to obtain clear separation of the large number of products that 
have been amplified. Side by side comparison of the banding patterns (visualized by 
autoradiography) oftne PCR products derived from two different cells, allows the identification of 
gene transcripts that are ditterentially expressed (i.e. present in one celi type and absent in the 
other). Bands that are present in one lane of the sequencing gel but not in the other can be 
A theoretical number of primer 
combinations can be calculated to generate patterns of bands that might represent almost ali 10000-
15 000 genes expressed in a particular cell. The number of primer combinations that have been 
suggested to allow a complete coverage of ali the mRNAs have been hypothesized to be weB over 
'lflO(R ·1"1 I ~n.93 "-TSI SI dF·l . -994' .dJ _auer _¥ a ., 1 Y ; W _tson _n emmmg, 1 ). 
Once a potential differentiaHy expressed gene has been isolated it is important to verify by northern 
blot analysis that it represents true differential expression. Alternative strategies that have been 
used to confirm differential expression include reverse northern blot analysis when multiple 
candidate genes have been isolated (Zhang el al. 1996; Dilks ei al., 2003), semi-quantitative RT-
PCR with primers designed from the candidate differentially expressed genes (Brown el ai., 1999), 
ribonuclease protection assays (Gesemaml el ai., 2001), virtual northems (Franz el ai., 1999) and in 












The last part of DD before the fimctional characterization of the candidate differentially expressed 
gene is determining their nucleotide sequences following confirmation of their differential 
expression. 
6.1.1.2 Advantages of differential display PCR 
Aithough techniques like subtractive hybridization and microarrays can also be used to analyse 
differential gene expression between two cell types, differential display peR has some advantages. 
Firstly, the method is cheap, relatively simple and easy to use because it uses basic molecular 
biology procedures such as peR and gel electrophoresis to search for differentially regulated genes. 
Differential display peR is also useful when RNA is iimited. Techniques like subtractive 
hybridization required a large qua.qtity of RNA (Wan et aI., 1996). 
The technique IS versatile in that it aHows a large number of comparisons to be done 
simultaneously. Examples of this are the identification of a wide representation of differentially 
expressed gene transcripts in different stages of development (Zimmermann and Schultz, 1994), 
isolation of cDNAs from different time points following treatment of cells (Garnier et aI., 1997), 
and screening for tissue specific genes (pascoio et aI., 1999; Santhanam and Naz, 2001). Genes that 
are up- and down-regulated can also be simultaneously identified in the same experiment. 
DD is carried-out without prior hypothesis as to which genes should be examined. Often with 
rnicroa.rrays, a collection of pre-determined cDNAs or expressed sequence tags (EST) are used. 












6.1.1.3 Limitations of differential display 
Even though differential display PCR is an attractive approach in isolating differentially expressed 
genes, there are two main limitations associated with it. The !ligh rate of false positives present 
among cloned candidate genes is one of these. False positives are those candidate cDNAs which 
are apparently differentially expressed on the differential display screen but whose patterns of 
differentia! expression cannot be reproduced on a northern blot. Some studies have reported a false 
positive rate as high as 85% (Zegzouti et al., 1997). The low annealing temperatures used in the 
PCR reaction and genomic DNA contamination have been suggested to contribute to decreased 
reproducibility and the increase in the rate of false positives (Zhao et ai., 1995; Diachenko et ai., 
1996). There are a number of precautions that have been suggested in order to reduce the number 
of false positives before time and ettort were invested in characterizing a potential clone. Firstly, it 
is of paramount importance that the RNA template be of high quality and is free of genomic DNA 
contamination. To ensure that there is no genomic DNA contamination, peR should be performed 
on a sa.rnple of DNase-treated Rl'lA that has not been reverse tra.l1scribed. This should not give any 
bands in the differential display gel. It is also vital to use equal amounts of template for DD PCR, 
so that any observed difference between RNA samples under study are not due to slight differences 
in RI~A c()ncentrations (McClelland et al., 1995) or due to variations in reverse transcription 
efficiencies (Kretzler et ai., 1996). Lastly, it is essential to run reactions in dupiicate or triplicate to 
sort out true differences from non-reproducible faise positives. 
The sec()nd problem with the technique is that only the 3' non-coding regions of gene transcripts are 
cloned. i\S a consequence, identifiable open reading frames are often not found in the isolated 












reactions to clone the full-length sequences (Chen et al., 1996; Dandoy-Droy et ai., 1998). few 
tecp_nlcal modifications in the DD protocol have been performed in an attempt to clone genes with a 
coding sequence. The use of the rTth DNA polymerase which has the ability to generate cDNAs 
between 200bp and 2kb in length, has been shown to improve the amplification of cDNA fragments 
that contain the coding regions (Jurecic et ai., 1998). In an attempt to maximize the amplification 
of cDNA fragments with coding sequences, Brown et al. (1999) used a set of statisticaHy designed 
oct..adecanucleotides that showed a strong bias towards coding regions of mammalian genes. Lastly, 
the availability of more and more EST sequences in the dbEST database should facilitate the full-
length in silico cloning of differentiaHy expressed genes. This approach would involve starting 
from the knovvn sequence obtained in a differential display screen and identify overlapping 
sequences from the dbEST database and assemble these in contigs to obtain the coding sequence 
(Senju and Nishimura, 1997). 
6.1.1.4 Applications of differential display peR in neuronal development 
Since 1992 when the DD technique was invented there have been 3800 publications describing the 
use of the DD technique and its popularity continues to grow even in the presence of the fast 
emerging DNA microarrays (Liang, 2002). The technique has found wide applications in 
developmental, oncogenic and various other eukaryotic paradigms, and has contributed to the 
identification of a number of genes. I discuss a few examples of the application ofDD in the study 












During early vertebrate brain development the neural tube is patterned along the dorsoventral and 
rostrocaudal neural axes to form the forebrain, midbrain, and the hindbrain. To identify genes that 
might be important in the brain regionalization along the anteroposterior axis, Chambers et al. 
(2000) used a modified DD protocol by comparing gene profiles of midbrain and anterior hindbrain. 
Sprouty2, an antagonist of receptor tyrosine kinase signalling and a target ofFGF-8, was found to 
be specificaHy expressed at the midbrain-hindbrain junction. Sprouty2 was therefore postulated to 
playa crucial role in the specification and regionalization of the midbrain and hindbrain. 
Various cell Hnes of neural origins have been used to screen for genes that respond to treatment 
with growth factors and which may be important for neuronal development (Table 6.1). PC12 cells 
undergo neuronal differentiation when cultured in the presence of FGF and NGP. DD PCR has 
identified a number ofNGF responsive genes in PC12 cells. MARKI, a serine/threonine kinase 
and MAP kinase 3 (MAPKK3) were two of the majority of genes that were up-regulated by NGF 
while Notch4, a known inhibitor of neuronal differentiation, was down-regulated by the treatment 
(Table 6.1, Brown et aI., 1999). 
EG6, a neural cell Hne immortalized from embryonic rat septum has also been used to screen for 
genes regulated by FGF-2 during neuronal ditterentiation. Ten differentially expressed genes 
(Table 6.1) were identified in this study, 4 of which were genes known to be either expressed in the 
brain or shown for the first time, in that study, to be expressed in the brain. One of the novel genes, 
clone 2C, identified in the study as being induced by FGF-2, was specifically expressed in the 












Table 6.1 Some of the genes identified by DD peR in various cells of neural origins. 
CeDtype 
PC12 cell line 





SV40 T antigen 
Bipotential hmnan 
neuroblastoma 
NllB-1 cell line 
Bipotential hmnan 
neuroblastoma 
NUB-1 cell line 
Growth factor 
treatment and 
effect on cells 
NGF 
















a..catenin, SatBl, MARKl, 
Sec61, MAPKK3, En-SA, 
ornithine decarboxylase, 
gluthione reductase, 
pS4 nucleoporin, RNA binding 
protein, 
2 brain derived cDNAs, 
S EST clones 
Calmodulin, novel clone I C, 
brain specific clone 2C 
HMG-CoA reductage, 
clone 5-2, clone 5-1, 
clone 5-4 
clone 5-4, 
novel zinc finger ID-3 













evident after 5-10 
days in culture 
N/A 
Gsh-l homozygous Trnnsfected with a 
mutant tet-inducible Gsh-l 
hypothalamic cell expression 
line construct 
Neurofilament, 
monocyte chemotactic protein 
(MCP-l) 
N/A 
protease Cathepsin L, 
mitochondrial rRNA, novel 
clone 45A, f3-activinA subtmit 
homolog, homolog of the rat 
DRM gene that inhibits cell 
growth 
Down-regulated genes Reference 
Guanylate cyclase 13 subunit., Brown et al., 
p 150 chromatin assembly factor, 1999 
Notch4 
Thrombospondin 1 (TSPl), 
cytokine-inducible nuclear 
protein, osteoblast specific factor 
2 (OSF2), clone 12, clone 24C-b 
N/A 
N/A 







Cai et ai., 1999 
HLH protein Id-2H, 90KDa heat Kilo et al., 1997 
shock protein HSP90, high 
mobility group protein-l (HMG-
1), threonine kinase, ribosomal 
proteins 825 and L 7 
Phosphate inhibitor protein Pip- Chauhan et m., 
1, heat shock protein Hsp4O, 2002 
Purkinje cell protein Pcp4, 
mitochondrial cytochrome 
oxidase, ESTAA331381 
MCL-l homolog that promotes 
cell survival, 
novel clone 40B 












In the bipotential neuroblastoma cell line NUB-7, cells differentiate into neurons in the presence of 
dibutyryl cAMP and into Schwann cells in the presence of retinoic acid. Dv PCR was used to 
identify 3 different sets of inducible cDNAs from the :NUB-7 cell line, namely those induced by 
dibutyryl cAMP, those induced by retinoic acid and those reponsive to both (Table 6.1, 
Dimitroulakos et ai., 1999). Comparison of non-induced and FGF-2 induced cultured chick lens 
epithelial expiants identified a novel lens specific cDNA, clone 2, which was down-regulated upon 
differentiation of the cells (Cai et aI., 1999). 
DD has also been used to identify transcriptional targets of transcription factors involved in 
neuronal development. Li et al. (1999) used a hypothalamic progenitor cell line carrying a 
homozygous mutation in the Genetic screen homeobox-l (Gsh-l) gene and transfected the cells 
with an inducible Gsh-l expression construct to identify candidate downstream target genes of the 
transcription factor. Several growth and differentiation related genes were identified in this study 
(Table 6.1, Li et ai., 1999). Similarly, eight gene transcripts either directly or indirectly regulated 
by P AX6 were identified in a DD screen comparing wild type versus Pax6 heterozygous mouse 
lenses (Table 6.1, Chauhan et aI., 2002). 
Current research on olfactory neuron development is focussing on known transcription factors and 
signalling molecules e.g. FGF and BMP, which have been shown to be important regulators of 
ORt'!" development. In an attempt to further increase our understanding of ORN development, I set 
out to identify differentially expressed genes as the OP27 cells differentiate, by using differential 













6.2.1 Differential Display analysis ofFGF-2 regnlated gene transcripts 
DD was performed on OP27 ceils that had been treated with FGF-2 for 0, 6, 24, and 48 hours 
except for 4 experiments in which the 48hr time point was omitted. The zero hour time-point 
represents untreated, control OP27 ceils that were maintained at 33°C. A total of 24 primer 
combinations comprising the 8 different arbitrary sense primers and the 3 different one-base 
anchored antisense oligo( dT) primers (Table 2.4) were used. The PCR products from duplicate 
reactions from the same experimental sample were electrophoresed in parallel in a denaturing 
acrylamide gel. The results of the DD screen are shown in Fig. 6.2. One primer combination, H-
TllA I H-AP24, did not result in any PCR products while the H-TllC I H-AP23 combination was 
less efficient compared to others. For each primer combination used, approximately 50-100 bands 
could be visualized per lane as expected. 
Theoretically, anchored oligo( dT) primers reverse transcribe different mRNA sub-populations and 
when these are amplified with the arbitrary sense primers, distinct display patterns are generated 
(Liang and Pardee, 1992). This is clearly evident in the display patterns generated in OP27 cells 
(Fig. 6.2). When one sense (arbitrary) primer was used with each of the antisense oligo(dT} 
primers, distinct display patterns were observed. The majority of the bands within each primer 
combination showed equal intensity with the FGF-2 treatment while very few bands showed 
varying intensities with the treatment. Those that showed changing intensities were identified as 












expressed based on visual inspection of the autoradiographic X-ray films (Fig. 6.2). Some of the 
candidate differentially expressed transcripts were represented by very faint bands on the X-Ray 
films and as a result were not visible on the images shown in Fig. 6.2. The candidate differentially 
expressed differentially expressed cDNAs were identified according to the primer combination used 
to display that fragment. For example, 17 Al is a cDNA fragments that resulted from the display 
using H-API7 and H-TllA Thirty-two of the cDNA fragments scored as being differentiaHy 
expressed represented up-regulated genes while 39 gene transcripts that were apparently down-
regulated. A list of both the up-regulated and down-regulated genes identified in this study is 
included in the Appendix. 
Figure 6.2 Gene expression profiles in 0P27 cells following FGF-2 treatment The differential display patterns 
produced by specific primer combinations at the different time intervals of FGF-2 treatment were run in parallel. 
Anchored primer/arbitrary primer combinations used for each display are shown at the top and the time intervals of 
FGF-2 treatment are indicated in hours (0, 6, 24, and 48). Candidate differentially expressed transcripts are labelled 
according to the primer combination used. The mRNA transcripts that were successfully re-amplified as single PCR 
products, and whose change in expression levels was subsequently confirmed by either reverse northern blot, northern 
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All 71 bands were excised from the sequencing gel and reamplified using the primer combination 
originally used to display them. One apparently equally expressed cDN~ 21C2 was also excised 
and used as a control in reverse northern slot blot analysis. The reamplified fragments ranged in 
size from approximately ~100 bp to -800 bp. PCRreamplifications of some cDNAs (see Appendix) 
failed while some resulted in the co-amplification of at least 2 PCR products in one tube (Fig. 6.3 
and Appendix). 
6.2.2 Verification of differential expression by reverse northern blot analysis 
Reverse northern slot blot analysis was used to confirm the differential expression of the candidate 
differentially expresed genes. Out of 71 cDNAs that were identified, forty-five that were 
successfully reamplified and gave single PCR products were blotted along with cDNAs for J3-actin, 
glyceraldehyde dehydrogenase (GAPDH) and 21 C2 which were used as internal controls. The 
clone 21 C2 was excised and purified from the differential display gel. Duplicate blots were 
generated and were hybridized to eDNA probes prepared from total RNA extracted from OP27 cells 
at 33°C and from cells that had been treated with FGF-2 for 6 hours. The samples used for 
preparing the probes were from an independent FGF-2 experiment from that used in the differential 
display screen. The reverse northems are shown in Fig. 6.4. Thirty-one of the candidate 
differentially expressed genes could be detected in both blots whereas a few did not give any 
signals. The intensities of some of the clones (e.g 17A1 in slot AI, 1966 in slot D3, and 22C1 in 
slot C3, Fig. 6.4) differed between the 2 blots. These represented differential regulated clones that 
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Figure 6.3 Agarose gel electrophoresis of the PCR reamplified candidate differentially expressed cDNAs. The 
cDNAs were excised from the polyacrylamide gels, purified and reamplified using the primer combination used in the 
differential display protocol. Few of the reamplifications failed even after a second round of PCR (data not shown). 
Some of the PCR reactions resulted in more one PCR product (marked with an asterix). These clones were excluded 
from subsequent analysis. Clone numbers corresponding to DD PCR products identified in Fig. 6.2 are shown above 
each photograph. Molecular weight markers (Promega's lOObp ladder and lambda DNA digested with Pstl) are shown 












1 2 3 4 5 6 7 8 9 10 11 12 
Blot 1 17Al 17A2 19A1 19A2 20A4 20A6 20A7 20A8 20A9 20AI020A12 20A13 
A 
.. 
22Al 22A2 22A3 23Al actin 17C5 17C7 18Cl 18C2 18C4 19C7 200 
B , , I 
C 
2lCl 210 22Cl 24Cl 17Gl 17G2 18Gl 18G2 GAPDH 18G3 19G2 19G3 
D 
19G4 19G5 19G6 I9G12 20Gl 20G2 20G3 20CI 20C2 23A2 23Gl 24G1 
I 2 3 4 5 6 7 8 9 10 11 12 
Blot 2 17A1 17A2 I9Al 19A2 20A4 20A6 20A7 20A8 20A9 20AI020A12 20A13 
A 
22Al 22A2 22A3 23A1 actin 17C5 17C7 18Cl 18C2 18C4 19C7 200 
B 
21Cl 21C2 22Cl 24Cl 17Gl 17G2 18Gl 18G2 GAPDH 18G3 19G2 19G3 
C 
19G4 19G5 19G6 19G12 20GI 20G2 20G3 20Cl 200 23A2 23GI 24Gl 
D 
Figure 6.4 Verification of candidate differentially expressed cDNAs using reverse northern slot blot analysis. Blots 
showing signal of 32P-Iabelled cDNA probes hybridized against PCR reamplified cDNAs. Blot 1 was probed with 
radiolabeUed eDNA synthesized from total RNA extracted from OP27 celJs grown at 33°C while blot 2 was probed 
with [aYP]-labelled cDNA synthesized from total RNA from OP27 cells cultured at 39"C for 6 hours in the presence 
of FGF-2. 6-actin (in slot B5), GAPDH (slot C9), and 21 C2 (slot C2) were also blotted as controls to equalize 
differences in efficiency of reverse transcription. Differentially expressed cDNA clones following normalization (Fig. 












To ensure that the observed differences arose as a result of FGF-2 treatment rather than from 
external variations such as efficiency in probe labelling or inaccurate quantitation of labelled probe, 
the signal intensities of the 3 house-keeping genes, f3-actin, 21 C2 and GAPDH were measured and 
compared between the 2 blots. Their intensities were found to be consistently higher in blot 1 
compared to blot 2 thus implying differences in probe labelling. The signal for 13-actin in blot 1 was 
2.6 times that in blot 2, whereas the signals for 21C2 and GAPDH in blot 1 were 1.4 and 1.2 times 
that in blot 2, respectively. It was therefore necessary to normalize the data. The method used by 
Dilks et al. (2003) was then applied to normalize the signals of clones used in the reverse northerns. 
In this approach, the signals of each of the house-keeping genes are determined in both blots and 
compared in a ratiometric fashion between both blots. The average ratio of all the house-keeping 
genes is then applied as a scaling factor to the signals of the clones in the blot that has a lower 
intensity (in this case, blot 2). Since 21C2 and GAPDH showed a similar variation in the 2 blots 
(mentioned above), their average ratio (i.e 1.3) was used as a scaling factor for the signals in blot 2. 
13-actin was totally excluded in the analysis as the ratio of 2.6 suggested that it was not evenly 
expressed. The scaled-up signals in blot 2 (experiment) were then compared with those in blot 1 
(control) and expressed as a fold- change difference in expression. The normalized fold-changes of 
each clone used in reverse northern analysis are shown in Table 6.2 and summarized in Fig. 6.5. 
The results obtained using both 21C2 and GAPDH were consistent with the verification by northern 
blot analyses (Fig. 6.6). On the other hand when 13-actin was used to normalize the data the up-
regulated genes were more pronounced whereas the down-regulated genes showed no apparent 












Table 6.2 Normalized fold-change (OP27 cells at 33°C versus 6 hours at 39°C with FGF-2) in 
expression of DD clones that were detected in reverse northern blot analysis. The fold-changes 
were then plotted on a LOGz scale in Fig. 6.5 
DD clone Fold-change LO~ 
17Al 1.68 0.75 
17A2 0.8 -0.32 
17CS 0.49 -1.03 
17G1 1.34 0.42 
18C1 1.86 0.89 
18C2 1.91 0.93 
18C4 1.06 0.08 
18G2 1.17 0.23 
18G3 1.05 0.07 
19C7 1.57 0.65 
19G2 1.06 0.08 
19G4 0.99 -0.01 
19G5 1.19 0.25 
1906 1.73 0.79 
19G12 1.22 0.29 
20A4 0.43 -1.21 
20A6 0.38 -1.39 
20A7 1.07 0.1 
20A8 1.38 0.46 
20A9 1.39 0.47 
20AlO 1.01 0.01 
20Gl 2.59 1.37 
20G3 1.6 0.68 
21Cl 1.12 0.16 
21C2 0.95 -0.07 
22Al 1.6 0.68 
22A2 1.63 0.7 
22A3 1.22 0.29 
22Cl 2.2 1.14 
23Al 1.3 0.38 
23Gl 2.99 1.58 
24Gl 1.41 0.49 
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Figure 6.5 A summary of the expression patterns of cDNA clones used in reverse northern blot analysis. The signal intensities for each clone at 6 
hours after FGF-2 treatment (blot 2 in Fig. 6.4) was compared with that at 0 hours (blot 1 in Fig. 6.4) and expressed as a fold-change (Table 6.2) 
following normalization using the internal controls 21 C2 and GAPDH. The fold-change in expression was then plotted on a log scale as a log2 ratio 
shown above. DD clones that had at least 1.5-fold increase or 2-fold decrease in expression (shown as +0.65 or -Ion the plot) were thus confirmed as 













The fold-changes in expression between the 2 blots ranged from 0.38 (for 20A6) to 3.0 (for 23Gl). 
All the genes that had a fold-change of expression close to 1 were designated as genes whose 
expression was not affected by treatment with FGF-2. Genes that had a 0.5 fold change were 
designated as genes that showed a robust down-regulation by FGF-2 treatment. cDNAs that fall 
into this category include 17CS, 20A4, and 20A6. On the other hand, genes that had a fold-change 
of at least 1.5 in expression levels were designated as up-regulated gene transcripts. The genes that 
fall into this group are the following: 17Al, 18Cl, 18C2, 19C7, 19G6, 20Gl, 20G3, 22Al, 22A2, 
22CI, and 23Gl (Fig. 6.5). However, the expression pattern of several of these DD cDNAs in this 
assay contradicted that in the DD screen. For example, 19G6, 20Gl, 20G3 and 23G1 were 
identified on the basis of down-regulation but the subsequent reverse northern analysis showed that 
their transcripts were up-regulated. Similarly with 20A4 and 20A6, the DD screen showed an up-
regulation of these cDNAs whereas the reverse northern showed an opposite pattern of expression 
(Fig. 6.2, 6.4 and 6.5). Often with DD, it is possible to isolate multiple other transcripts when 
single bands are purified and reamplified (Averboukh et at, 1996; Callard et al., 1994). It was 
therefore necessary to confIrm expression changes of these cDNAs using northern blot analysis as 
an alternative assay. 
6.2.3 Verification of differential expression by northern blot analysis and RT-PCR 
Northern blot analyses were performed to confirm the differential expression of the candidate 
cDNAs. Selected cDNAs were cloned and inserts used to probe blots of OP27 cells that had been 
treated with FGF-2. The cDNAs included transcripts whose expression change in the by reverse 
northern analysis was consistent with that in the DD screen, those whose expression changes in the 












The clone 17C5 was isolated on the basis of its down-regulation in the DD screen and that was 
confirmed with the reverse northern analysis (Fig. 6.5). The northern blot using this clone as a 
probe on the other hand showed a transient down-regulation of its extremely large transcript. It was 
first down-regulated at 6 hours, consistent with both the DD and reverse northern results, but it was 
up-regulated again at 24 hours (Fig. 6.6A). The clones 19C7, and 22Al were confirmed as being 
up-regulated on the reverse northern analysis and this was reconfirmed with their respective 
northern blot analyses. The clone 19C7, represented by a -4.8 kb message on the blot, displayed an 
up-regulation in differentiating OP27 cells. However, its up-regulation was more evident after 24 
hours following FGF-2 treatment on the northern compared with the 6 hours on the reverse northern 
(Fig. 6.6B). The northern blot for 22Al revealed that the clone is a product of an alternatively 
spliced transcript that is up-regulated with FGF-2 treatment (Fig. 6.6 D). Thus the northern blot 
analysis of 17C5, 19C7, and 22Al was consistent with the results of both the DD screen and the 
verification by reverse northern. 
20C3, 20G2 and 24Cl were among clones that did not give detectable hybridization signals on the 
reverse northern. However, signals for 20C3 and 24C 1 could be detected with the northern 
hybridization after long exposures of their respective X-ray films. The clone 20C3, isolated on the 
basis of its transcriptional up-regulation in the DD screen, could be detected on the 6-hour time 
point only. This probably reflects a transient up-regulation of its transcript over 6 hours, which was 
followed by a down-regulation over the following 24 and 48 hours (Fig. 6.6C). The northern blot 
for the clone 24C 1 also showed a transient up-regulation of its -1.8 kbp transcript within the first 6 
hours ofFGF-2 treatment. It could still be detected after 24 and 48 hours although at a lower level 
compared to 6 hours (Fig. 6.6F). The clone 20G2 did not give any signal with the northern blot. 
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Figure 6.6 Verification of differential expression by northern blot hybridization and RT -PCR Total RNA from OP27 
cells treated for 0,6,24, and 48 hOUTS with FGF-2 was transferred onto a membranes and hybridized with radiolabelled 
probes for DD clones 17C5 (A), 19C7 (B), 20C3 (C), 22A I (D), 23G (E), and 24Cl (F) in northern blot analyses. The 
probes were removed and membranes were hybridized to a p-actin probe to control for loading. Densitometer readings 
from northern hybridization signals of 17C5 (A, bottom) and 22Al (D, bottom) were generated, normalized with 
respect to J3-actin levels and expressed as a fold-change in expression over the reading at 0 hOUTS. (G-K) Semi-
quantitative RT -PCR analysis was performed to verify the differential expression of DD clones PP2 B56y, 19G6, 
Cathepsin L (Cts£), 20A6, and 20G2 on first strand cDNA prepared from total RNA which was extracted from 0P27 
cells treated for the same time points as for northems. p-actin primers were also included in each PCR reaction. * A 
different pair of J3-actin primers (that amplify a 360 bp fragment) was used for the RT -PCR assays for 19G6 (G) and 












Northern blot analyses were also performed with clones that showed opposite patterns of expression 
in the DD screens and in the reverse northern blot. However, none of these cDNAs, with the 
exception of 23Gl, gave a detectable signal on the northern blots even though their hybridization 
signals were clearly detected on the reverse northern. The clone 23G1, on the other hand, showed a 
robust up-regulation within 6 hours of its ~1.8 kb message and its levels continued to increase 
thereafter (Fig. 6.6E). 
The nucleotide sequences of the clones that could not be detected with the northern blot analysis 
(19G6, 20A4, 20A6, and 20G2) were therefore determined and gene specific primers designed for 
semi-quantitative RT-PCR assays. 19G6 could not be confirmed to be differentially regulated using 
the semi-quantitative RT -PCR (Fig. 6.6G) and was therefore excluded from further analysis. 
Although the reverse northern assay showed that the 20A4 and 20A6 clones were down-regulated 
with FGF-2 treatment, the semi-quantitative RT-PCR result was consistent with their expression 
changes in the DD screen (Fig. 6.6H and I). It was therefore concluded that both 20A4 and 20A6 
were up-regulated in FGF-2 induced OP27 cells. 20G2 whose signal could not be detected on the 
reverse northern was confirmed using this assay to be indeed up-regulated in OP27 cells following 
induction with FGF-2 (Fig. 6.6J). 
6.2.4. Sequence analysis of differentially expressed cDNAs 
The nucleotide sequences of the genes that were confirmed to be differentially expressed by the 
different assays were analyzed by BLAST searches against both the non-redundant (i.e nr) and EST 
databases (i.e dbEST) at the NCB!. The results revealed both previously identified mouse genes 












Table 6.3 Summary of clones isolated by differential display following FGF-2 treatment of OP27 
cells. t= Up-regulation in FGF-2, -J.-= down-regulation in FGF-2, t -J.-= transient up-regulation, -J.-t= 
transient down-regulation, 
ND= not detected. 
DD Clone ~nBaD.k. Expression Expression Expression ~nBaD.k. match Accession E-
clone size Accession profile in cbangein change in number value 
(bp) numbers DDscreen reverse northern! 
ofDD northern RT-PCR 
l7Al 170 CK850014 t t t Protein phosphatase BCOO3979 3e-72 
2A B56y regulatory 
subunit 
17C5 534 CK850015 it Collagen IV a2 NM_009932 Exact 
(COLIVa2) match 
I8CI 426 CK850016 t t IMAGE:6514303, XM_357642 Exact 
similar to 60S match 
ribosomal protein L34 
18C2 205 CK850017 t t ND Protein phosphatase 4, NM_182939 2e-76 
regulatory subunit 2 
(ppp4r2) 
19C7 313 CK850018 t t t Amyotropbic lateral NM_028717 2e-59 
sclerosis (Als2) 
20A4 485 CK850020 t .J, t CathepsinL NM_009984 e-174 
20A6 169 CK850021 t .J, t Metallotbionein II NM_OO8630 6e-58 
(Mf-ll) 
20C3 457 CK850022 t ND H lMAGE:9442282? AA545476 Exact 
similar to mouse match 
arginine rich protein 
20GI 620 .J, t ND BAC clone RP23- AC 1222 I 9 2e-86 
119F18 
20m 618 t ND t BAC clone RP23- AC123842 Exact 
400N18 match 
2OG3 594 CK850023 .J, t t 2610002J02Rik XM_131827 Exact 
match 
22Al 351 CK850024 t t t Ocular development- AB047921 Exact 
associated gene match 
(ODAG) 
22A2 135 CK850025 t t EST D330002D23 AK084462 6e45 
22CI 374 t t HmnanChr14 AL136418 e-167 
BAC R-596D21 
23G 540 CK850026 .J, t t Hypothetical GCN5- AK015640 Exact 
related NAT protein match 












Several of these clones matched to genes that have been implicated in neuoronal differentiation. 
The 17 Al clone, up-regulated by FGF-2 treatment in OP27 cells, revealed a 9golo identity to the 
brain-specific y isoform of the regulatory subunit B (also known as B56) of the mouse protein 
phosphatase 2A (PP2A). The B56 y isoform has been shown to induce neuronal differentiation in 
vitro (Strack, 2002). Semi-quantitative RT -PCR analysis using B56 y isoform specific 
oligonucleotides showed that this gene is indeed up-regulated in FGF-2 induced OP27 cells (Fig. 
6.6K). The clone 17C5 which was first down-regulated then up-regulated by FGF-2, represented 
transcript for the extracellular matrix protein a2 collagen IV which has also been implicated in 
neurogenesis (Ali et aI., 1998). 19C7, up-regulated in OP27 cells exhibited high similarity to a 
gene designated as AIs2 (amyotrophic lateral sclerosis 2) which encodes for the protein ALSIN. 
Although the function of this gene is unknown, its high expression levels have been detected in the 
CNS (Yang et aI., 2001). The 22Al clone which is up-regulated by FGF-2 is homologous to 
ODAG, a Qcular developmenH!ssociated gene, recently identified in a screen for genes that may 
playa role in eye development (Tsuruga et al., 2002). The clone 24Cl which was transiently up-
regulated by FGF-2 had high homology to the cytoskeletal protein transgelin 2. Its mRNA 
transcripts were up-regulated in PC 12 cells following NGF induced neuronal differentiation 
(Angelastro et al., 2000). Clones 20A4 and 20A6, both up-regulated in FGF-2 induced 
differentiation of OP27 cells, revealed high homology the protease cathepsin Land metallothionein 
2 (MT-ll). 
Although homologs for the clones 18Cl, 20C3, 20G3, 22A2, and 23Gl could be identified, the 
functions of those genes are unknown. Clones 18Cl, 20C3, 20G3, and 22A2 exhibited high 
homologies to mouse ESTs. The ESTs that match I8CI and 20C3 have been identified among 
potential Gtx2 target genes that are up-regulated in Gtx2-1- early gastrulating mouse embryos (Zakin 












6.3). These clones were therefore characterized with the use of web based bioinformatic tools 
(Table 2.6). On the other hand, 3 DD clones 20G1, 20G2, and 22Cl had no homology to any 
previously identified sequences nor ESTs but searches against the mouse High Throughput 












6.2.4.1 20C3, a novel and putative scoffoltl/matrix, attachment region binding protein 
The nucleotide sequence encoded by the clone 20C3 was found to have high homology with several 
mouse ESTs that were annotated as highly similar to the human l!:rginine-rich, mutated in ~arly 
stage tumours protein ARMET (ARMET is also known as Arginine Rich ~rotein, ARP). The 
function of ARMET is unknown but it has been found mutated in a number of cancers, including 
those of the lung, breast, prostate, head and neck (Shridhar et aI., 1996). It is also among OTX2 
target genes up-regulated in Ot:x2-1- early gastrulating mouse embryos (Zakin et ai., 2000). One 
EST that matched 20C3, the IMAGE:944282 clone (accession no. AA545476) was purchased from 
Research Genetics and sequenced fully. A nucleotide sequence alignment of 20C3 and the 849 bp 
IMAGE:944282 is shown in Fig. 6.7 A As shown in the nucleotide sequence alignment, 20C3 is 
missing a 172 bp insert at position 414. It is possible that 20C3 is a product of an alternatively 
spliced transcript. To determine whether this was the case, the genomic structure of IMAGE 
944282 was analyzed. The information on the genomic structure of the entire transcript was 
derived from a BLAST search of the HfGS database at NCB!. A 158137 bp mouse BAC clone 
RP23-239F13 from chromosome 9 (Accession number AC123065) was found to contain the whole 
of the IMAGE:944282 nucleotide sequence. Both the mRNA and the corresponding genomic DNA 
were aligned using the program Spidey at the NCB!. The transcript consists of 4 exons and 3 
introns that span a 3154 bp between bases 63799 and 66953. No exon splice or donor sites were 
found in the 172 bp deletion identified in the clone 20C3. Instead, the sequence missing in the DD 
clone 20C3 was found within the 3' exon 4 (Fig. 6.7B). This therefore suggested that the region 
missing in 20C3 was not a result of alternative splicing. An alternative explanation is that the 
172bp sequence is capable of forming a stable secondary structure that would cause the reverse 
transcriptase to jump across this junction and continue with cDNA synthesis thus resulting in a 




































1 11111 1 1111111111 1111 111111111111111111 1 11111111111111111111 
GTTGTGCTACTACATTGGAGCCACAGATGATGCTGCCACCAAGATCATCAATGAGGTGTC 
GAAGCCCCTGGCCCACCATATCCCTGTGGAAAAGATCTGTGAGAAGCTGAAGAAGAAAGA 
111111111111111111111 1 111 11 11111111111111 11 111111111 111 11111 
GAAGCCCCTGGCCCACCATATCCCTGTGGAAAAGATCTGTGAGAAGCTGAAGAAGAAAGA 
CAGCCAGATCTGTGAACTAAAATACGACAAGCAGATTGACCTGAGCACAGTGGACCTGAA 






111111 1 1 11 111111111111 11111111111111111111111111111111111111 
CTGTGCAGAAAAGTCTGACTATATCCGGAAGATAAATGAACTGATGCCTAAATACGCCCC 
CAAGGCAGCCAGCGCACGGACTGATCTGTAGTCTGCCCAATTCCTGCTGCACCTGAAGGG 
11111111111111111111111 1111 111111111111111111111111111111111 
CAAGGCAGCCAGCGCACGGACTGATCTGTAGTCTGCCCAATTCCTGCTGCACCTGAAGGG 
GAAAAAGCAGTTTATCTGTCTCTTCCCCAAATAACCATTTTGTAATTT ......... .. . 
1 1111111111 1 1111 11 1111111111 1111111111111111111 
GAAAAAGCAGTTTATCTGTCTCTTCCCC . AATAACCATTTTGTAATTTATTTTTTAAGCG 
GGCTCCTGACAATGAGATGTGAACCTAGAGCTTTCCTAGTGATGCTGGCTCTGCAGTTCC 
CTCTTGCCCATCCCCGAGTGGGGACATTTCCCCATCCCCAAGTGGGGACATTTACTTCCT 
. ... .... .. ..... . ........................ ATTTTTTTATTAAAAAAAAT 










Figure 6.7 Analysis of the nucleotide sequence of the 20C3 clone. (A) Nucleotide sequence alignment of the 
differential display clone 20C3 with its matching EST IMAGE 944282 clone (accession no. AA545476). The top 
sequence in the alignment is the DD clone 20C3. The dashes represent the region missing in the 20C3 cDNA. (B) The 
exon-intron organization of the IMAGE 944282 clone was determined from nucleotides 63799-66953 of the BAC 
clone RP23-239F13. The exons are represented by open and black-shaded boxes. The hatched box within exon 4 
represents the 172 bp sequence missing (nuc\eotides 632-805 of IMAGE 944282) in the DD clone 20C3. Introns are 
represented as lines joining the exons. The mRNA and genomic co-ordinates are shown above and below, respectively. 
The coding exons are shaded in black and both start and stop codons are shown. Further analysis of the BAC clone 
RP23-239F13 using GENSCAN revealed a putative 40 bp promoter at bases 62580-62619, indicated by the block 
shaded in grey. (C) The hairpin structure of the 172 bp deletion identified in clone 20C3 . The structure was predicted 












Indeed, RNA structure analysis using the MFOLD program revealed that the missing 172 bp is 
capable of forming a stem loop structure (Fig 6.7C) that may have eluded reverse transcription of 
this mRNA transcript during cDNA synthesis. 
A northern blot analysis was performed to detennine whether the IMAGE:944282 clone had the 
same pattern of expression as 20C3 in FGF-2 induced OP27 differentiation. 20C3 hybridized to a 
distinct a transiently up-regulated (Fig. 6.6C). The IMAGE:944282 also showed a similar pattern 
of expression as that of 20C3 in an independent FGF-2 experiment. A signal is transiently up-
regulated in OP27 cells with FGF-2 treatment, with levels barely detectable in cells at 33°C while a 
band was visible after 6 hours follwing treatment with FGF-2. The transcript was not detected after 
6 hours (Fig. 6.8). 
o hr 6h 24h 48h 
3. 
2 
Figure 6.8 Northern blot analysis of IMAGE 944282 in OP27 cells following FGF-2 treatment Total RNA from an 
independent FGF-2 experiment was analyzed and blotted. The membrane was hybridized with the IMAGE 944282 
probe. IMAGE 944282 hybridized to a message of - Ikbp on the northern blot (arrow). 
Translation of the IMAGE cDNA revealed a 537 bp open reading frame which codes for a 179 
amino acid polypeptide, extending from 17 to 553 bp, thus giving a very short 5' UTR (16 bp) and a 












20.3 KDa and a pI of8.26. IMAGE 944282 contains an N-terminal hydrophobic signal peptide that 
may target the protein to the secretory pathway. The signal peptide, which shows a high 
hydrophobicity index (Fig. 6.9B), is predicted to be cleaved between the residues Ala21 and Leu22, 
according to SignalP VI.I (Nielsen et aI., 1997). 
Several consensus phosphorylation sites (Table 6.4) were also identified, including 2 for casein 
kinase II dependent phosphorylation, one for a c-AMP and c-GMP dependent phosphorylation, one 
for tyrosine kinase phosphorylation and a protein kinase C phosphorylation site right at the C-
terminus (Fig. 6.9A). The presence of these phosphorylation sites suggests that phosphorylation 
events are involved in regulating the activity of this protein. 
Table 6.4 Consensus phosphorylation recognition motifs (Kemp and Pearson, 1990). 
Protein kinase Consensus recognition motif 
Casien kinase IT StrXXDlE 
cAMP and cGMP dependent kinase RlKXXsrr 
Tyrosine kinase R/KXXXD/EXXXY 

















































M W A T R G L A V A L A L S V 
GCTGCCTGACAGCCGGGCGCTGCGGCCAGGAGACTGTGAAGTTTGTATTTCTTATCTGGG 
L P D S RA iL R P G D C E V CIS Y L G 
ACGATTTTACCAGGACCTCAAAGACAGAGATGTCACATTTTCACCAGCCACTATTGAAGA 
R r Y Q D L K D R D V T F SPA TIE E 
AGAACTTATAAAGTTTTGCCGTGAAGCAAGAGGCAAAGAGAATCGGTTGTGCTACTACAT 
ELI K F C REA R G KEN R L C Y Y I 
Chapter 6 
20C3 primer 1 
TGGAGCCACAGATGATGCTGCCACCAAGATCATCAATGAGGTGTCGAAGC-;CCTGGr.:CCA 
G A T D D A A T K I I N E V S K P L A H 
:CA r A n'CCCTGTGGAAAAGATCTGTGAGAAGCTGAAGAAGAAAGACAGCCAGATCTGTGA 
H IP V E K IC E K L K Q ICE 
ACTAAAATACGACAAGCAGATTGACCTGAGCACAGTGGACCTGAAGAAGCTCCGGGTGAA 
L K Y D K Q I D L S T V D L K K L R V K 
AGAGCTGAAGAAGATCCTGGACGACTGGGGGGAGATGTGCAAAGGCTGTGCAGAAAAGTC 
E L K K I L D D W GEM C 
20C3 primer 2 
3 ' - GGGTTrrG'T'CGGTCG(:G 
TGACTATATCCGGAAGATAAATGAACTGATGCCTAAATACGCCCCCAAGGCAGCCAGCGC 
I RK I N ELM P K YAP K A A 
TGCCTGACT-5' 
ACGGACTGATCTGTAGTCTGCCCAATTCCTGCTGCACCTGAAGGGGAAAAAGCAGTTTAT 
















Amino acid number 
Figure 6.9 Analysis of the amino acid sequence of IMAGE 944282, (A) Translation of the nucleotide sequence of 
IMAGE clone 944282. The numbers written in black refer to the cDNA sequence and those in blue refer to the amino 
acid sequence. Both the start (ATG) and the stop (TGA) codons are written in bold. The signal peptide is Wlderlined 
and the cleavage site is indicated by an arrow. The putative SAF-Box is double underlined. The casein kinase IT 
dependent phosphorylation sites are shaded in yellow, the c-AMP and c-GMP dependent phosphorylation site is shaded 
in grey, the tyrosine kinase phosphorylation site is shaded in green and the protein kinase C phosphorylation is shaded 
in red See Table 6.4 for consensus phosphorylation motifs (Kemp and Pearson, 1990). (B) Hydrophobicity plot of the 












Searching the SMART domain database using the amino acid sequence of the IMAGE 944282 
clone discovered the scarff'old attachment factor box (SAF-Box) (PF AM model PF02037) between 
positions 129 and 165 (Fig. 6.9A). The SAF-Box is a conserved DNA binding domain that is found 
in diverse nuclear proteins that bind the scaffold attachment region (SAR) DNA (Aravind and 
Koonin, 2000; Kipp et aI., 2000). The region containing this motif has a high content of positivel y 
charged amino acids, particularly Lys, that may make contact with the negatively charged backbone 
of the DNA. An alignment of the putative SAF-Box of IMAGE 944282 with those of the other 
SAR binding proteins is shown in Fig. 6.10. Most of the conserved amino acid residues within the 
SAF-Box are present in IMAGE 944282. Unlike in the other proteins, the putative SAR binding 
domain of the EST IMAGE (the SAF Box) maps to the C-tenninus of the protein while the SAF-
Box of the other SAR binding proteins is located in the N-terminus (Aravind and Koonin, 2000). 
ceC43Ell 





consens us 2 
SAF-BOX 
~ ~~:~~.S ~IN~~~~~I=j_ ~~~~~~~i : ~ 
1 PVNVKKL KE KKRR LS D - - LME RLQAALDDE 41 
1 MS DYKSL RE EKGLST - - LVSRLTTAATESN 42 
1 LKKL KI DDWGEMC C SDYIRKI NE LM 37 
l kV E l~ L R L G K L RL a 
hpl pLb h b h G K L 1 
Figure 6.10 Alignment of the putative SAF-Box of FIG-1 with SAF-Boxes from other species. The other 4 SAF boxes 
shown in the alignment that have been shown to bind to SAR DNA (Kipp e/ aI. , 2000). The consensus sequences of the 
SAF-Box have been manually inserted in the alignment from Kipp et al., 2000 (consensus 1) and Aravind and Koonin, 
2000 (consensus 2). In consensus sequence 2 ' h' is for hydrophobic residues; l., aliphatic; p, polar; b, bulky. The species 
abbreviations are ee, Caenorhabditis elegans; at, Arabidopsis thaliana; Hs, Homo sapiens; sp, S. pombe. 
A BLASTP search of the NCB I database revealed a high sequence similarity with both the 
published sequences of the human ARMET protein (P55145), mouse Armet (NP _083379) and with 
ARMET -like putative proteins from various species. A multiple sequence alignment of the 
ARMET homologous proteins is shown in Fig. 6.11. The mouse Annet sequence NP _ 083379 












The putative SAF-Box is also conserved across all species in the alignment. Phylogenetic analysis 
of the various sequences revealed that the mouse Armet sequence is 99% identical to the rat 
sequence (XP _2366142) and 97% identical to the human ARMET sequence (Fig. 6.12). An 
orthologue of the rat sequence (XP _ 341562) was also identified. This orthologue shares a 50010 
sequence identity with both the rat and mouse Armet sequences (Fig. 6.11). 
MIn NP 08 337 9 1 
Rn XP 236614 1 
Hs P55145 1 
Xl AAH43846 1 
Rn XP 341562 1 
Dm NP 477 445 1 
Ag xp_311862 1 
Ce NP 500273 1 
Mm NP 083379 51 
Rn XP 236 614 51 
Hs P55145 51 
Xl AAH43846 52 
Rn XP 341562 61 
Dm NP 4774 45 51 
Ag xp_ 311 862 58 
Ce NP 500 27 3 45 
MwAT RGLAVALALSVLP- DSRALRPG DCEVCISYLGRFYQDLKDR Dv.TFSP 5 0 
MWATRGLAVALALSVLP- DSRALRPGDCEVCI SYLGRFYQDLKDR DYIT FSP 50 
MWATQGLAVALALSVLP- GSRALRPGDCEVCI SYLGR FYQDLKDRDYITFSP 50 
MLPLALLTVTGIMVLLPSDAGALKAGDCEVCI SFLS FYQSLKERKVE FKP 51 
MRCTS PAALVTFCAGLWI SNHVLAQGLEAGVRSRADCEVCKE FLNRFYNSLLTRGI DFSV 60 
MKTWYMVVVIG FLATLAQTSLALKE EDcEVCVKTVRRFADSLDD-STKK DY 50 
MAE RKFLSGRLVLLGTVCLILFLLPHSTALREGDCEVCVKTVNTfMETLSD-ETKKDT 57 
MSRLVLLISLVI VVASAAAPQCEVCKKVL DDVMAKV PA-GDKSKP 44 
ATI EEELIKFCREARGKENRLCYYI GATDDAATKI INEVSKPLAHHI PVEKIC-EKLKKK 1 0 9 
ATI EEELIKFCREARGKENRLCYYIGATDDAATKI INEVSKPLAHHI PVEKIC-EKLKKK 109 
ATIENELIKFCREARGKENRLCYYIGATDDAATKI I NEVSKPLAHH I PVEKI C-EKLKKK 109 
DIVEKELLmCNDARGKENRLCYYIGATSDAATKITNEVSKPLSNHI PPEKIC-EKLKKK 11 0 
qTIEEEL~~FSADTKGKENRLCYYLGATKPSATKILG VTRPMSVHMPTVKI C-EKLKKM 11 9 
KQI ETAF~FCKAQKNKEHRFCYYLGGLEESA~GtLNELSKPLSWSMPAEKIC-EKLKKK 10 9 
KRI EDE FRAFCKKS KN KEQRFCYYLGGVEDSATGI LGELSKPISWSMPAEKIC-EKLKKK 116 
D~GKVIREHCETTRNKENKFCFY IGALPESAT9IMNEVTKPLSW~PTEKVCLEKLKGK 10 4 
MIn NP 083379 
Rn XP 2 36614 
Hs P5514 5 
Xl AAH4 3846 
Rn XP 3 41 562 
Dm NP 4774 45 
Ag xp_ 311 86 2 
Ce NP 500 27 3 
11 0 DSQICELKYDNQIDLSTVDLKKLRVKELKKILDDWG&MCKGCAEKSDYI RKINELMPKY~ 1 69 
110 DSQICELKYDKQIDLSTVDLKKLRVKELKKILDDWG~CKGCAEKSDYI RKINELMPKYA 169 
11 0 DSQICELKYDKQI DLSTVDLKKLRVKELKKI LDDWGETCKGCAEKSDYIRKINELMPKY~ 1 69 
111 DGQICELKY DKQIDLSTVDLKKLKVKELKKI LDDWGESCKGCAEKSDFIRKINELMPKYA 170 
120 DSQICELKYEKKLDLESVDLWKMR¥AELK~ILHSWGEECRACAEKH DYVNLlKELAPKYV 179 
11 0 'DAQI CDLRYEKQI DLNSVDLKKLKVRDLKKI LNDWDESCDGCLEKGDFI KRI EEL KYlS 169 
117 DAQICDLRYDKQI DVNAVDLKKLKVRDLKKI LSDWDEECDGCLEKTDFIKRIEELKH KYV 17 6 
105 DAQICELKYDKPLDWKTIDLKKMRVKELKNtr LGEWGEVCKGCTEKAELI KR~EEL~KYV 164 
MIn NP 083379 
Rn XP- 236614 
Hs P551 45 
Xl AAH43846 
Rn XP 34156 2 
Dm NP 47744 5 
Ag xp_ 311 862 
Ce NP 50027 3 
1 kV eL K L R L G K L RL a 
170 ,PKAASARTDL 1 79 R 
1 70 PKAASART DL 179 
1 70 PKAASARTDL 179 
171 PNAANARTD 179 
180 ETRPQTEL 187 
170 RSEL 173 
177 KTEL 18 0 
1 65 KE EL 1 68 
Figure 6.11 Multiple alignment of the IMAGE 944282 amino acid sequence (represented by the mouse Armel sequence 
Mm NP _083379) with sequences from various species. GenBank accession numbers are shown next to the species 
prefix. Mm, Mus musculus; Hs, Homo sapiens; X I, Xenopus laevis; Rn, Rattus novergus, Dm, Drosophila 
melanogaster; Ag, Anopheles gambiae; Ce, Caenorhabditis elegans. Identical amino acid residues are shown in grey 
while conserved residues are in yellow. The putative SAF-BoX/SAP domain which is conserved is double underlined. 
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Chapter 6 
Figure 6.12 Phylogenetic analysis of the Annet-like sequences from the different species. The phylogenetic tree is 
based on the ClustalW multiple sequence alignment of the various sequences (shown in Fig. 6.11 above). GenBank 
accession numbers are shown next to the species prefix. Mm, Mus musculus; Hs, Homo sapiens; X I, Xenopus laevis; 
Rn, Rattus novergus , Dm, Drosophila melanogaster; Ag, Anopheles gambiae; Ce, Caenorhabditis elegans. 
While the N-terminal signal peptide may target Armet for secretion, the presence of the putative 
SAF-Box would also suggest a nuclear localization of the protein. Using the PSORTII software, no 
nuclear localization signal sequences were identified in the Armet amino acid sequence. However, 
Reinhardt's method for cytoplasmic/nuclear discrimination which is based on the composition of 
basic residues (Reinhardt and Hubbard, 1998), predicted a nuclear localization with a reliability of 
71%. Thus, the presence of both the N-terminal signal peptide and the SAF-Box would suggest that 
Armet is probably fated for a dual subcellular fate. 
The distribution of the Armet mRNA on mouse tissues was analyzed with RT-PCR using gene 
specific primers (Fig. 6.9 for primer location). The transcript was present in the brain, OE and the 




0P27 brain heart kidney liver OE 
+ + + + + + - - +-20C3 
+- f3-actin 
Figure 6.13 Tissue distnbution of the Annet mRNA as detected by RT -PCR on mouse tissues. Primers designed from 
the nucleotide sequence of the DD clone 20C3 were used to amplify the transcript from 0P27 cells at 33°C and from 












6.2.4.2 Sequence analysis of 20G2, a clone with no homology 
The 618 bp 20G2 clone was one of 4 DD clones that had no homology to any sequences in both the 
nr and dbEST databases. However, BLAST searches against the HTGS database revealed high 
homology to the mouse BAC clone RP23-400N18 (Accession number ACI23842). To determine 
the full-length sequence of 20G2, 5' RACE was performed by using the SMARTTM RACE 
amplification technique (Fig. 6.14A). Several PCR products of varying intensities sized -0.5 to 3kb 
were obtained when the gene specific antisense primer, 20G2a.s was used together with the 
'universal primer' supplied in the kit (lane I, Fig. 6.14B). The identity of the PCR products was 
confirmed by probing a Southern blot of the PCR products with a labelled internal sense primer, 
20G2s. Several PCR products ranging from 0.5-1 kb in size gave a positive signal on the Southern 
blot thus confirming their identity as 5' sequence of the DD clone 20G2 (Fig. 6.14C). The largest 
PCR product running just below 1 kb (see arrow in Fig. 6.14C) was recovered from the agarose gel, 
cloned and sequenced. Sequence analysis of the 919 bp clone (known as cln3.9) confirmed the 
presence of the nucleotide sequence that overlaps with the original DD clone. No open reading 
frame was found within the nucleotide sequence of cln3.9. A northern blot analysis using cln3.9 as 
a probe confirmed the up-regulation of 2 transcripts at -6 and -3-4 kbs on OP27 cells following 
FGF-2 treatment (Fig. 6.14D), in agreement with the RT -PCR result in Fig. 6.6J. Both the 
nucleotide sequences of the original DD clone 20G2 and the SMART RACE PCR product cln3.9 
were assembled into the 1104 bp contig ASl (depicted in Fig. 6.l4A). The contig ASI was then 
analyzed by BLAST searches against the sequence databases at the NCB!. Only nucleotides 1-414 
at the 5' end of contig AS 1 matched to nucleotide sequences of cDNA clones deposited in the 
GenBank. The alignment of the cDNAs with contig ASl is depicted in Fig. 6.15. Contig ASI had 
a lOOO/O homology with the 5' ends of several RIKEN clones but was never contigous with any of 
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Figure 6.14 Cloning of the full-length sequence of the 20G2 clone. (A). Gene specific primers were designed from the 
nucleotide sequence of the DD clone 20G2 (shown with black arrows above). The antisense primer 20G2a.s was used 
in combination with the UPM primer (shown with a red arrow on the left) to amplify the 5' sequence of 20G2. The 
resulting clone c103.9, 919bp in size (blue arrows), overlapped with 20G2. Both the nucleotide sequences of20G2 and 
c1n3.9 were assembled into 1104 bp contig AS 1 (B). The SMART RACE reactions were conducted using the universal 
primer mix (UPM) supplied in the kit in combination with the primers shown above. Lane 1, UPM plus the antisense 
primer,20G2a.s. Lane 2, 20G2a.s on its own. Lane 3, UPM on its own. Lanes 2-3 served as negative controls. Primer 
locations shown in the diagram in A. Molecular weight sizes are shown on the left, in kilobase pairs (kb) (C). 
Southern blot analysis of the SMART RACE PCR products. The oligonucleotide 20G2s was labelled and used to probe 
the Southern. The -o.9kb PCR product that was recovered, cloned and sequenced is indicated with an arrow. (D). 
Northern blot hybridisation with c1nJ.9 as a probe on OP27 cells treated with FGF-2 for various time points. Times 
shown in hours (h). The hybridising signals are indicated by arrows. The membrane was stripped and reprobed with P-
actin to control for loading. 
The BLAST search also revealed a 100% homology over a 220 bp region (nucleotides 17-237 of 
contig AS1) with the 3' UTR of the mouse ramp2 gene (Accession number NM_019444). The 3' 
end of the contig AS} (nucleotides 454-1104) which had no homology with any of the cDNA 
clones mentioned above, shared a high sequence identity with the genomic BAC clone RP23-
400N18 (Accession number AC123842) (Fig. 6.15). Contig ASI was also aligned with sequences 
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Figure 6.15 BLAST search analysis of eontig ASI against the nucleotide databases. The clones that match contig ASI 
at either the 5' or 3' ends are indicated by their accession numbers and their descriptions. The alignment positions are 
shown. Red lines represent regions of 100% sequence homology while dotted lines represent regions of no homology. 
Since only the nucleotide sequences in the 5' ends of these ESTs were deposited in the database, we 
purchased and analyzed one EST, IMAGE:2331824 (accession number AW319227, Fig. 6.15) to 
detennine whether this EST and contig AS 1 had the same nucleotide sequence at the 3' end. A 
northern blot was first perfonned with IMAGE 2331824 as a probe to determine whether it had a 
similar expression pattern to that ofcln3 .9 shown in Fig. 6.14D. Like cln3 .9, the EST hybridized to 
two transcripts of --6kb and - 4kb transcript that were up-regulated with FGF-2 treatment. The up-
regulation of these transcripts was, however, delayed. The signals for the transcripts were evident 
starting after 48 hours and continued to increase with time (Fig. 6.16). IMAGE 2331824 was then 
fully sequenced to determine whether the nucleotide sequence at its 3' end was similar to that of 













Oh 6h 24h 48h 4d 6d __ ..... 8d;,. 
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~~-actin 
Figure 6.16 Northern blot hybridisalion with IMAGE:233 1824 as a probe on 0P27 cells treated with FGF-2 for various 
time points. Times shown in hours (h) and in days (d). The hybridising signals are indicated by arrows. The blot was 
stripped and reprobed with ~-actin a shown below. 
Nucleotides 17-419 at the 5' end of contig AS 1 matched perfectly with nucleotides 1-401 of 
IMAGE 2331824 whereas the sequences at the 3' end had no match with the EST (Fig. 6.17). It 
was therefore concluded that the EST and contig AS 1 were not the same cDN A. 
17 419 1104 
Conlig ASl 
:"'-____ -11 un nnnnnnn n .nn 
•••••••• ••• n . n • ••• • • .. . ...n ••••••••• 1 AW319227 IMAGE 2331824 
401 1313 
Figure 6.17 Nucleotide sequence alignment of the conlig ASI and IMAGE:2331824. The 2 clones match only at the 5' 
ends and no sequence homology was evident at the 3' end. The region of high sequence similarity is indicated by the 
red line while the region of no homology is represented by the dotted line. 
No PCR products were identified from a second round of SMART RACE PCR using the nucleotide 
sequence of the c1n3 .9 to obtain more 5' sequence information. Secondly, I had established that the 
c1n3.9 had high sequence similarity with the 3' UTR of the mouse ramp2 gene (Fig. 6.15). I 
therefore designed a sense primer upstream of the coding region of ramp2 and used it together with 
the 20G2as primer in RT-PCR to attempt to amplify the nucleotide region that might be flanked by 
the primers. No sequence was ever amplified by this primer combination, thus suggesting that 
cln3 .9 was not the 3' UTR of the mouse ramp2 gene. Further attempts to find more sequence 













6.2.4.3 Identification of 20G3, a protein that is targeted to the mitochondria 
The clone 20G3 was one of cDNAs that were identified as being differentially regulated by FGF-2 
in OP27 cells. BLAST analysis of the GenBank non-redundant nucleotide database revealed high 
sequence identity to a mouse RIKEN cDNA 2610002102 gene (Accession number XM_131827). 
An IMAGE clone (IMAGE: 4191674, Accession number BF540440) that matched both 20G3 and 
the RIKEN cDNA was purchased and sequenced fully to reveal a 1480 bp insert. The nucleotide 
sequence of 20G3 was located at positions 885-1480 bp in the insert sequence (Fig. 6.18). 
1 aaGCttGTTGTGCCAGAA . GCGTTTGCCCCGAAGTTGCCCCAGCTAGATGTGGATAGCCACC 
II 1111 11111 111 1111111 11 11 1 11 I I 1111111111111111111111 11 
883 TTGCCCGTTGTGCCAGAAGGCGTTTGACCCGAAGCTGACCCAGCTAGATGTGGATAGCCACC 
62 TTGCTCAGTGCTTGGCTGAGTGCACCGAAGATGTGGTGTGGTGAGCATCAGGGTGCCTTG 
11111 111 1 1111 11 11 1111 11 11 111 11 11 1111 11111 11111111111111111 11 
945 TTGCTCAGTGCTTGGCTGAGTGCACCGAAGATGTGGTGTGGTGAGCATCAGGGTGCCTTG 




1111111111111111111111 111111111111111111 11111 11111 11111 1111 1 
1065 TGGACACCTGAGTATTGGCTCCTTCTGGTTTTGTTCATGGGCATTGGACATAATGCTGGT 
241 CACTGACAGCAGGCAGCACTGATCCTCTGTGGACTCATCTTCATTGTCAGCCTGACAGGA 
11111111111111111111 11111111111111 1111111111111111 1111 111111 




361 CTGGGACAGGAAGTCCCAGCTGAATGTGGGTGGCACCGTGGCCT . GGGTCCCACTGATTG 
1111111 111111111111 1111111111111111111111111 111111111111111 
124 5 CTGGGACAGGAAGTCCCAGCTGAATGTGGGTGGCACCGTGGCCTGGGGTCCCACTGATTG 
420 AAAAGGGAAAATGGAGAAATTGAGCTGTTTCCTCACTGGGGATGTGATGAGATGCACCGC 
111111111111111 11111111 11 11 1111111 111 1111111111111111111 1111 
1305 AAAAGGGAAAATGGAGAAATTGAGCTGTTTCCTCACTGGGGATGTGATGAGATGCACCGC 
480 TCGCCTGCTACGGCAGCCATAGCTACTTTTGCTACTGTGCCCTCCTTGCCACAGGGACTG 
11111111111111 11111111111 11111111111111111111111111111111111 
1365 TCGCCTGCTACGGCAGCCATAGCTACTTTTGCTACTGTGCCCTCCTTGCCACAGGGACTG 
540 TACCTTAACTGTGAGCCAGAATAAATTTTAAGTTGCTTTCCAAAAAAAAAAA 
111111111111111 11111111111111111111111111 1111111111 
1425 TACCTTAACTGTGAGCCAGAATAAATTTTAAGTTGCTTTCCGAAAAAAAAAAA 
Figure 6. 18 Nucleotide sequence alignment of the differential display clone 20G3 with its matching EST IMAGE 
4191674 clone (accession no. BF540440). The upper line in the alignment is the DD clone 20G3. The DD primers are 













Since the differential expression of 20G3 in the reverse northern analysis contradicted that in the 
DD screen, RT-PCR primers were designed from the nucleotide sequence of IMAGE 4191674 and 
were used to analyze the pattern of expression of 20G3 in FGF-2 induced OP27 cells. A semi-
quantitative RT-PCR assay showed an up-regulation of the 20G3 transcripts as the cells 
differentiate in the presence ofFGF-2 at 39°C (Fig. 6.19) consistent with the reverse northern blot 
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Figure 6.19 Semi-quantitative RT -peR analysis of 20G3 in differentiating OP27 ceUs. (A) Up-reguJation of 20G3 
mRNA transcripts by FGF-2 in 0P27 ceUs. A representative semi-quantitative RT -PCR analysis of 20G3 in OP27 cells 
treated with FGF-2 for various times (in hOUTS, h). 20G3 and ~-actin were co-amplified in the same reaction tube. +, 
amplification from total RNA that had been reverse transcribed; -, amplification from total RNA in a reverse 
transcription reaction in which the reverse transcriptase was omitted. Molecular weight sizes (in base pairs) are 
indicated on the left of the gel. (B) 20G3 and ~-actin signals were quantitated at each time-point and plotted as fold-
increase in the ratio of 20G3/~-actin with the ratio at Oh taken as 1. Data represent mean ± SEM values of 3 
independent experiments. Significance, *p<O.05 compared to time 0 hOUTS. 
The same oligonucleotides were used to study the expression of 20G3 in mouse tissues. Several 
E 12.5 embryonic tissues, including brain, heart, kidney and OE expressed the gene encoded by 
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Figure 6.20 RT -PCR analysis of 20G3 in mouse tissues. Primers designed from the nucleotide sequence of IMAGE 
4191674 clone were used to amplify the transcript from 0P27 ceUs that were treated with FGF-2 for 6 hours at 39°C 
and from adult mouse tissues. ~-actin was also amplified from the tissues to control for loading. 
Translation of the 1480 bp EST sequence revealed a 528 bp ORF extending from 458 to 986 bp. 
This ORF codes for a hypothetical 176 amino acid protein, refered to as 20G3 in this study (Fig. 
6.21). The 20G3 protein sequence was analysed for the presence of functional domains using 
various bioinformatic tools (Table 2.6). Two consensus phosphorylation motifs (Table 6.4) were 
identified by the PROSITE motif programme: 4 potential CKII phosphorylation sites at amino acids 
24-27,61-64, 127-130, and 155-158, and 3 potential PKC phosphorylation sites at 95-97, 113-115, 
and 122-124 (Fig. 6.21). 
The subcellular localization of the 20G3 was investigated to suggest a possible function of the 
protein. The PSORTII programme revealed a mitochondrial targeting sequence motif at residue 18 
on the N-terminus (Fig. 6.21). Targeting predictions with 2 other software packages, TargetP 
version 1.01 and Predotar version 0.5 supported a mitochondrial localization of 20G3 with high 























































M P R L T L P V 
GCTTCCCAGGCCCCCTAACTGCCGCCCTTGGTTTCTCTCGGAGGGAAGTAAGAGTGAGCC 
L P R P P N C R P W F L S E G S K S E P 
CTGGGCTGCTCTGTTGCGCAGCACCGTGAGCGGGACCGCGGATTGGACCCCGAACCGTCA 
W A ALL R S T V S G TAD W T P N R Q 
GCCATTACCACCGCTGCCTGCTTTTCCCAGCCAGGAGTCTCTACCTGACCCAGAGTCCAC 
P L P P L P A F P S Q E S L PDP EST 
TGTGCCTCCTGAGGCCTTCACTGTGGGATCCAAGACTTTCTCCTGGACGCCTTTGCCACC 
V P PEA F T V G S K T F S W T P L P P 
TGCCCTTCGTGGCTCTGGAAGCTCCCGCCACCTGTTCTGTGAACCTGAAGGCTCCCTGGG 
A L R G S G H L F C E PEG S L G 
GTCACCTACTCCGTCCCTGAAAGGATGCCCTGCACTAAATTCTGGTCGAACTCCCAGCGC 
S P T P G CPA L N T P S A 
CCAGGAGTGTGTGCCTGTGCAGAGTCCACTTGCGTTGCTGAGTTGCCCGTTGTGCCAGAA 
Q E C V P v Q S P L ALL S C P L C Q K 
GGCGTTTGACCCGAAGCTGACCCAGCTAGATGTGGATAGCCACCTTGCTCAGTGCTTGGC 
A FOP K L T Q L 0 V 0 S H L A Q C L A 
TGAGTGCACCGAAGATGTGGTGTGGTGAGCATCAGGGTGCCTTGCTGTATCTCCGTTCAA 










Figure 6.21 Analysis of 20G3 putative amino acid sequence. Translation of the full-length 20G3 nucleotide sequence. 
The numbers written in black refer to the cDNA sequence and those in blue refer to the amino acid sequence. The 
polyadenylation signal sequence is underlined. Both the start (ATG) and the stop (TGA) codons are written in bold. 
Severa] stop codons (written in bold small capital letters) are present upstream of the ATG start codon. The 
mitochondrial targeting sequence motif is double underlined The casein kinase II dependent phosphorylation sites are 
shaded in yellow, and the protein kinase C phosphorylation is shaded in red. The consensus recognition motifs of the 
phosphorylation sites are shown in Table 6.4 
BLASTp analysis using the 20G3 protein sequence revealed high homology to other rodent and 
human hypothetical proteins (Fig. 6.22). 20G3 shares a 94% sequence identity with another mouse 
sequence (XP _131827) with differences in the N-terminus. The rat sequence also has a high 
sequence identity with both 20G3 and XP _13]827 (with 8]% and 88% identity, respectively). The 












between them, have very limited sequence identity (50%) with the rodent sequences. This suggests 
that the 2 human sequences are probably orthologues of 20G3 like sequences not identified in the 
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1 MEEERRLRGRLS------------RR----------RPPAGG- - -----------G--- PP 
1 MP------------RL----------TLPVLP-------------R---PP 
1 ME EERRLRGRLS------------RR----------RPPAGG-------------G---PP 
1 MBAARR PRLGLS------------RR----------RPPPAG-------------G--- PS 
64 LHQKAARAFWLSLPAAKLRHHSSRWLRRSGAFSSGSTLKPP PS PSPAPLCHADNLRTGRTRPS 
24 NCRPWFLSEGSKSE-'PWAALLRSTVSGTADWr PNRQPL PPLPAFPSQESL PDPESTVPPEAE'T 
14 NCRPWFLSEGSKS8-PWAALLRSTVSGT PNRQPLPPLPAFPSQESLPDPESTVPPEAE'T 
24 NCR PWFLS8ESKS8- PWAALLRSTVGGNTDWT PNSQPLPPLPAFPSQESLPDPESTVPPEVE'T 
24 GGR PWFLLGGDERERLWAELLRTVS P----ELIL DHEVPSLPAFPGQEPRCGPE--- PTEVE'T 
127 GGR PWFLLGGDERERLWAELLRTVS P----ELIL DHEVPSLPAFPGQEPRCGPE---PTEVE'T 
86 VGS KT FSWTPLPPALRGSGSSRHLFCE PEGSLGSPTPSLKGC PALNSGRTPSAQECV PVQS PL 
76 VGSKT FSWT PLPPALRGSGSSRHLFCEPEGSLGS PT PSLKGC PALNSGRTPSAQECVPWQS PL 
86 VGSKTFSWTP FPPALRGSGSSCRLLRQPEGS PGSPAPSLKGCPALDSRQTPSTQECV--QSQL 
80 VGPKTFSWTPFPP~WGPGf\SYRLLHGAGGHLE;SPARSLPQRPAPDPCRAPRVEQQPS'JEGAA 
183 VGPKTFSWTPFPPDL GPGRSYRLLHGAGGHLESPAASU PQRPAPDPCRAPRVEQQPSVEGAA 
14 9 ALLSCPLCQKAFDPKLTQLDVDSHLAQCLAECTE DVV---W 186 
13 9 ALLSCPLCQKAFDPKLTQLDVDSHLAQCLAECTEDVV---W 176 
147 VLLNCPLCQKAFDPKLTQLDVDSHLAQCLAESTEDVV---W 184 
14 3 ALRSCPMCQKEPAPRLTQLDVDSHLAQCLAESTEDVTCLSWMCKTLNDPGSQG 195 
246 ALRSCPMCQKEFAPRLTQLDVDSHLAQCLAESTEDVT---W 283 
~--------------------------A1m20G3 
L---------------------------Mm XP 131827 
I..------Hs BAC86730 
L'-------Hs BAB70965 





















Figure 6.22 Multiple alignment of the 20G3 amino acid sequence with sequences from mouse, rat and human. (B). 
Phylogenetic analysis of the 20G3-like sequences. The phylogenetic tree is based on the ClustalW multiple sequence 
alignment of the sequences (A). GenBank accession numbers are shown next to the species prefix. Mm, Mus musculus; 












6.1.4.4 Identification and sequence analysis of 13G1, a putative N-acetyltransferase 
The clone 23Gl was originally identified as a down-regulated cDNA transcript in the DD screen 
but subsequent verification by reverse northern and northern analyses showed an up-regulation with 
the FGF-2 treatment (Fig 6.5 and 6.6). The 540 bp 23Gl insert contained both H-AP23 and H-TuG 
primer sequences used to display the transcript. A 1427 bp mouse cDNA (Accession number 
AK0l5640) that was 98% identical (9 nucleotide differences, Expect = 0.0) to 23Gl was identified 
during BLAST searches of the nucleotide sequence databases. As expected for a cDNA identified 
in a DD screen, 23Gl matched the 3' UTR of AK015640 between bases 901 to 1427 (Fig. 6.23). 
The mouse cDNA (Accession number AK015640) was annotated as a gene that codes for a 
hypothetical GeNS-related N-acetyltransferase (NAT). The AK015640 nucleotide sequence is 
smaller in size compared to the message (which is approximately 1.8 kb) predicted for 23Gl on the 
northern blot analysis shown in Fig. 6.6E. Attempts to identify the full-length cDNA of 23G in 
OP27 cells using the SMAR'fTM RACE technology were not successful possibly as a result of 
severe secondary structures in the mRNA transcript. A conceptual translation of the AK015640 
sequence predicted a 183 amino acid (549bp) open reading frame (ORF) extending from 675-1226 
bp (Fig 6.23). The original DD clone 23GI matched the 901-1427 region that includes the C-
terminal 108 amino acids ofthe protein (Fig. 6.23). 
The amino acid sequence of the predicted protein encoded by AK015640 (refered to here as 
23GINAT) was subjected to various bioinformatic tools to characterize the protein. A 
transmembrane (TM) domain was predicted between residues 74 and 97 and a bipartitie nuclear 
localization signal (NLS) sequence was found by PSORTll at positions 101-116. The NCBI 
Conserved Domain Search predicted a GeN5-related N-acetyltransferase (GNAT) domain between 










































Rik62 1 pcimer 
CGGGGGCGGCGAGCGACCCCGCTGCGGCCCGAAATGGACTGGTGGAGGGCACCGAGCAGC 
AGGAGGAGGAGGAGATGGACGAGCAGGTGCGGCTGCTGTCTTCGTCTCTGACCACCGGCT 
M D E Q v R L L S S S L T T G 
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ACGTCCGATATGAATCTGAGCTCCAAATGCCTGATATCATGAGACTGATCACCAAAGATC 
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TGTCTGAACCCTACTCCATTTATACGTATAGATATTTTATCCACAACTGGCCACAGCTGT 
L S E P Y SlY T Y R Y F I H N W P 0 L 
H-AP23 p r imer 
5 '-aag CTTGGCtATG-3 ' 
901 GTTTCTTGGCCATGGTAGGGGAGGAGTGTGTAGGTGCCATCGTTTGCAAGTTGGATATGC 
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1 38 1 
f p 433 primer 
3' - ATCGGTACAATCGGCACCTGAG-S ' 
ACAAAAAGATGTTCCGCAGAGGTTATATAGCCATGTTAGCCGTGGACTCCAAATACAGGA 
H K K M F R R G Y I A M L A V D SKY R 
GAAATGGCATTGGTACTAACTTGGTAAAGAAAGCTATATATGCCATGGTTGAAGGAGACT 
R N GIG T N L V K K A I YAM V EGO 
GTGACGAGGTTGTTTTGGAAACAGAAATTACAAATAAGTCTGCTTTGAAACTTTATGAAA 
C 0 E V V LET E I T N K SAL K L YE 
ATCTTGGTTTTGTTCGAGATAAGAGGCTGTTCAGATACTATTTAAATGGAGTTGACGCAC 
N L G F V R D K R L FR Y Y LN G V 0 A 
TGCGACTTAAACTGTGCGTGCGCTGAGGAACTGACAGCAAGGAACGACTCCACCCACACG 




3 '-GTTTTTTTTTTTCGAA- S , 
H-TIIG primer 
Extracellular domain 1M Intracellular domain 
I I _ GNAT I L----'--/_ ~'-------~------1 
RRGYlAMLA VDSKYRR 
Figure 6_23 Nucleotide sequence of 23GINAT cDNA (accession AK015640), and the deduced amino acid sequence. 
(A) The cDNA region (23Gl) identified by differential display is boxed. The DD primers, H-AP23 and H-T11G, which 
were used to display this cDNA are shown inside the box. The mismatches between the H-AP23 primer sequence and 
the 23GINAT sequence are shown in small capital letters. The numbers written in black refer to the cDNA sequence 
and those in blue refer to the amino acid sequence. Both the start (ATG) and the stop (TGA) codons are written in bold. 
The polyadenylation signal is located at nucleotides 1403-1408 (bold and underlined)with the poly(A) at beginning at 
nucleotide 1427. In the amino acid sequence, the bipartite nuclear localization signal sequence is underlined and the 
putative transmembrane is double underlined The location of the primers, Rik621 and fp433 which were used for RT-
peR in Fig. 6.26 are shown in red letters. (B) Schematic diagram showing the localization of the GNAT domain 
(shaded in green), the potential transmembrane domain (lM, within the GNAT domain) and the bipartite nuclear 
localization signal (NLS, shown in gray) in the 23GINAT sequence. The NLS contains 2 positively charged amino 












All members of the GNAT superfamily transfer an acetyl group from acetyl CoA to different amino 
groups of different proteins. This superfamily has members from all kingdoms of life, including 
yeast, bacteria, plants, and vertebrates (Neuwald and Landsman, 1997). Blast analysis using the 
protein sequence of 23G 1 NAT revealed that the best matches represented hypothetical 
acetyItransfereases from rat, human, arabidopsis, fruit-fly and worm. The yeast N-acetyltransferase 
gene MAK3 also revealed high homology to the mouse 23GINAT. A multiple sequence alignment 
of the protein sequences shows highly conserved sequences (Fig. 6.24). 
The GNAT superfamily ofNATs is characterized by four conserved sequence motifs (C, D, A, B) 
which span over 100 residues (Neuwald and Landsman, 1997). Motif A (Arg/Gln-X-X-Gly-X-
Glyl Ala) which is involved in binding the AcCoA, is the most highly conserved among NATs in 
generaL This is also the case in the protein alignment shown in Fig. 6.24A. Site-directed 
mutagenesis of anyone of the conserved residues in this short segment reduces NAT activity of the 
protein (Wolf et al., 1998). This short segment is present in the protein sequence of 23GINAT at 
position 115 and is well conserved across species. Additional highly conserved amino acid 
sequences are found downstream of the motifs C, D and B (Fig 6.24A). 
Mouse genomic databases were searched using the AK015640 cDNA, revealing a genomic clone 
RP24-142A23 (Accession number AC102726) that contained the gene in its entirity. Alignment of 
the full length cDNA sequence with the genomic clone using Spidey revealed a 5 exon structure for 
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- - ---------------------------------------------------GNEQEEEE-DEQVR 263 
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GG DGGGSDSNSLKPEEKPITATSKTTANIHPTTTTDPKPKVSEDVAVEQGVHVATGSGHSR-EQERK 199 
MEK-EMEDK 8 
MVT IVPYSH----QYLKPI CQLI QKDLSEPYS RYF 35 
---------------------HVEELPQELQY IKYEHKLEAEYLP~RALI SKDLSEPYSIY RY E 73 
VPEASKWPHCQHMISQDEAPRNDELASPNI RIVAYKDE---SQIN IMRLITKDLSEPYSIYTYRYF 129 
MEIVYKPLDI RNE---EQFAS KKLI DADLSE PYSIYlVY RY E 39 
LLSSSLTTGCSLR-SSQGREAE PG-EDRTI RYVRYESE---LQMPDIMRLI TKDLSE PYSIYTYRY F 68 
LLSSSLTTGCSLS-SSLGREAE PG-EDRT~ RYV~YESE---LQMPDIMRLITKDLSE PYSIYTYRYE 325 
LLSSSLTADCSLR-S PSGREVE PG-EDRTI R~RYESE---LQMPDIMRLITKDLSEPYSIYTYRYF 247 
QPPSDYAEGATPTITAQLQLPE PAISADErVYKEYEAE---HQMH DIMRLI QAELSEPYSIYTYRY F 263 
E---EFDEG-------------------E~EYTSYAGE---HHLPLITMSLVDQELSE PYSE FTYRY F 50 
Motif C 
( ] 
VHQWPEFS FVALD-----NDRFIGAVI CKQD---VHRGTTLRGYIAMLAI VKEYRGQGI A'IlKLTQAS 94 
LYQWGHLCFMALH P---VDSSLI GVl I CKLEPHASHS PPTLRGYIAMLAVSSQHRGHGI ATELVRM 137 
LHNWPEYCFLAYDQ---TNNTYI GAVLCKLE---LDMYGRCKGYLAMLAVDESCRRLGI GTRLVRRA 190 
LNQWPELTYIAVDNKSGTPNIPIGCIVCKMD---PHRNVRLRGYIGMLAVES~YRGH AKKLVEIA 103 
IHNWP~LCFLAMVG-----EECVGAIVCKLD---MHKKMFRRGYIAMLAVD ~RRNGIGTNLVKKA 127 
IHNWP~CFLAMVG-----EECVGAIVCKLD---MHKKMFRRGYIAMLAVDS~RRNGIGTNLVKKA 38 4 
IHNWPQLCFLAMVG-----EECVGAIVCKLD---MHKKMFRRGYIAMLAVDSKYRRNGIGTNLVK~ 306 
IYNWP~CFLASHD-----NQYVGAIVCKLD---MHMNVRR-GYIAMLAVRK YRKLKIGTTLVTKA 321 
VYLWPQLCFLAFHK-----GKCVGTIVCKMG---DHRQTF~-GYIAMLVV;I K~YRGRGIASELVTRA 108 











S. pombe NP_ 596246 95 
Neur . c rassa XP 331 1 93 138 
C . elega ns NP_ 504411 191 
C . ce rev i si a e NP 0153 7 6 104 
Mm XP 283 206 128 
Rn XP 224013 385 
Hs XP 05866 1 307 
Om NP 569903 322 
At NP 181 3 48 109 
S. pombe NP 59 62 46 1 33 
Neur. cra ssa XP 331193 176 
C. el eg a ns NP_ 5 0 4411 229 
C. c e r e vi siae NP 01 5 376 1 42 
Mm XP 283206 166 
Rn XP 22 4013 452 
Hs XP 058661 34 5 
Om NP 569903 360 
At NP 18134 8 1 47 
B 
Chapter 6 
LDVMKNRGAQE------------ - ----------------I VLETEVDNEAAMS FYERLGECRYKRL 1 32 
l OAMAQRDADE----------- - ----------------- IVLET~ETN I PAMRLYERLGfVRSKKL 17 5 
LDAMQSKGCDE-----------------------------I VLETEVSNKNAQRLi1SNLGFI RQKRL 228 
~DKMQREHCDE------------ ------ -----------IMLETEVENSAALNLYEGMGFIRMKRM 14 1 
IYAMVEGDCDE--------------------- - -------WLETEITN SALKLYENLGfVRD)<RL 1 65 
I YAMVEGDCDEKVKDHGWSRDWQLNAEHAEE EEGDPVKLSVVLETEITNKSALKLYENLG FVRDKRL 451 
]YAMVEGOCDE-----------------------------VVLETEITNKSALKLYENLGFVRDKRL 344 
l EAMLADNADE------------------- -- - -- -----VVLETEMRNQPALRLYENLGFVRDKRL 359 
lKAMMESGCEE--------------- --- --- - --- - ---~LEAEVSNKGALALYGRLGFlRAkRL 1 46 
YRYYLNGTDAFRYILYPN 
HRYYLNGNSAYRL'vLLLRSVDADATN---DYAPDDRD IALR 






































Figure 6.24 Multiple sequence alignment and phylogenetic analysis of the GCN5-related N-acetyltransferases. (A) 
Identical residues are shaded in green and strongly similar residues are in gray shading. The underlined regions in the 
alignment correspond to motifs C, D, A, and B as designated by Neuwald and Landsman (1997). The ArglGIn-X-X-
Gly-X-Gly/Ala segment found in motif A is boxed in blue. Residues in S. cerevisiae MAIGp that abolish NAT activity 
when mutated are shown in red letters. The GenBank accession numbers of the putative NATs from the various 
organisms are given in the alignments. (B) Phylogenetic analysis of the hypothetical GeN5-related sequences from the 
different species. The phylogenetic tree is based on the ClustalW multiple sequence aligmnent of the various sequences 
(shown in A). GenBank: accession numbers are shown next to the species prefix. Mm, Mus musculus; Rn, Rattus 
novergus; Hs, Homo sapiens; At, Arabidopsis thaliana; Dm, Drosophila melanogaster, Ce, Caenorhabditis elegans. 
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Figure 6.25 A schematic representation of the genomic organization of the mouse 23GINAT. The exons are 
represented by the blocks with the lines joining blocks representing intronic sequences. The genomic and cDNA co-
ordinates are shown. The positions of the start and stop codons are indicated, with coding regions in black blocks and 
the 5' and 3' UTR sequences in open blocks. 
Tissue-specific distribution of the 23G1NAT mRNA was analyzed by RT-PCR using the primers 
fp433 and Rik621 (Table 2.2, Fig. 6.23). The RT-PCR demonstrated the presence of the gene in all 
the mouse tissues studied (Fig. 6.26). This is consistent with the vast collection of mouse ESTs 
from various tissues that matched 23G (UniGene Cluster Mm.275688, July 2004). This multi-
tissue distribution pattern suggests that 23G has more of a generalized function rather than having a 
specific role in olfactory development. 
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Figure 6.26 E"l'ression of23GlNAT in multiple tissues as detected by RT-PCR Primers Rik62 I and fp433 were used 
to amplify a 388 bp fragment from 0P27 cells cultured at 33°C from various adult tissues. +, total RNA reverse 













In this study, FGF-2 induced differentiation of the OP27 cell line has presented a model system for 
the study of gene expression changes involved in olfactory neurogenesis. Differential display was 
used to identify genes that are differentially regulated by treatment with FGF-2. Twenty four 
primer combinations, comprising the 3 one-base anchored oligodT primers and eight arbitrary 
primers, were employed in this study_ Both up- and down-regulated genes were identified. Sixteen 
of these genes were confirmed to be differentially regulated with FGF-2 treatment, with 15 up-
regulated and one down-regulated. 
Sequence analysis of the 16 clones revealed both previously characterized genes (8 clones) and 
those that have not been characterized (8 clones). Several genes identified in this study to be 
regulated by FGF-2 have been shown to be involved in neuronal differentiation. PP2A is the major 
serine/threonine phosphatase that has been implicated in various signal transduction pathways (such 
as the W ntifS-catenin signalling pathway) and several cellular processes including regulation of cell 
cycle, transcription, differentiation and apoptosis (van Hoof and Goris, 2003; Zolnierowicz, 2000). 
The protein has been isolated as a heterotrimeric holoenzyme consisting ofa catalytic subunit (C), a 
structural subunit (AR) and a third variable subunit known as the B regulatory subunit (BR) that 
influences substrate specificity and specific activity ofPP2A. Three BR protein families have been 
identified. These are 855, B56, and PR72. B56, has 5 isoforms, viz. a., fS, 'Y, 0, and & (McCright et 
al., 1996). The B56 'Y subunit which is identical to the clone 17Al, up-regulated with FGF-2 
treatment in OP27 cells, is highly expressed in the brain (Akiyama et aI., 1995). Transient 
transfection of the B56 'Y has been shown to cause the PC12 cells to exit the cell cycle and 
differentiate into neuronal cells by activating the MAP kinase pathway (Strack, 2002). This 












regulation in the OP27 cells is consistent with this. The work presented here would therefore be the 
first report to show induction of this gene by FGF-2. 
Collagen type IV, one of the major components of the extracellular matrix has also been implicated 
in the regulation of both proliferation and differentiation in various tissues. The expression of 
ColIV a2 was induced by the differentiation of the F9 teratocarcinoma cells upon induction with 
retinoic acid (Weigel and Nevins, 1990). FGF signalling has also been shown to activate Col IV 
gene expression leading to basement assembly and the induction of ectodermal differentiation (Li et 
ai., 2001a; 2001b). When added to E16 rat cortical cell cultures, ColIV inhibited their proliferation 
and promoted their differentiation towards a neuronal fate while inhibiting the astroglial fate (Ali et 
ai., 1998). In the rat olfactory system the protein has been hypothesized to contribute, along with 
other major ECM components, to axonal outgrowth from the OE and neurite guidance into the 
olfactory bulb (Julliard and Hartmann, 1998). FGF-2 is involved in the regulation of interactions 
between neuroepithelial cells and their immediate ECM during neurogenesis (Ali et aI., 1998). The 
identification of Col IV in differentiating OP27 cells is therefore in line with this. However, it is 
not clear why the expression of Col IV was first down-regulated in the first 6 hours and later 
induced. 
ODAG, a novel gene recently identified in a cDNA array screen for genes that may have a role in 
eye development (Tsuruga et aI., 2002), is also up-regulated by FGF-2 in OP27 cells. ODAG is 
under temporal regulation during eye development, with mRNA levels high during the period E13-
P6 and undetectable after PI0. This gene has been proposed to playa role in transcriptional control, 












Als2! Alsin is a putative cytoskeletal protein whose function is not known. It is thought to play a 
role in regulating cell membrane organization, trafficking of molecules in cells and cytoskeletal 
assembly. Its expression is highest in neurons throughout the brain, spinal cord and motoneurons 
and less in tissues outside of the CNS (Yang et aI., 2001). 
Transgelin 2 (also called SM22(3) is a actin-associated ctyoskeletal protein that is homologous to the 
22KDa calponin-related smooth muscle specific protein SM22a. and to the neuron-specific protein 
NP-25 (Zhang et aI., 2002). Although its function is known, SM22a. is one of earliest markers of 
smooth muscle differentiation. Its expression is down-regulated in a variety of cell tumours, a 
consequence of the deregulation of the Ras signal transduction pathway (Shields et aI., 2002; 
Vasseur et aI., 2003). On the other hand, a 'transgelin-like protein' was identified in a SAGE 
analysis as one of substantially up-regulated transcripts in NGF-promoted neuronal differentiation 
of PCl2 cells (Angelastro et al., 2000). Transgelin 2 was also up-regulated in FGF-2 induced 
differentiation of OP27 cells but this regulation was transient, with transcript levels returning to 
basal levels. Whether this reflects what is happening in vivo is unknown. Both SM22a., SM22{3 
and NP-25 uind cytoskeletal actin filaments. Scp1, the yeast homolog has also been found to bind, 
stabilize and organize the yeast actin cytoskeleton (Goodman et aI., 2003). These observations 
would therefore point to the significance of regulation of the actin cytoskeletal network during 
differentiation. 
Cathepsin L, which is also up-regulated in differentiating OP27 cells, is a widely expressed 
lysosomal cysteine protease that has been reported to be involved in cellular growth and tumour 
invasion (Kirschke et al., 2000). Increased cathepsin L activity has been shown to initiate or 
propagate the signal transduction pathway of apoptosis in certain neural diseases (Tsuchiya et aI., 












neurons thus suggesting an important role in the CNS (Felbor et al., 2002) 
MT -II is a small cystein-rich, metal binding protein that is induced in response to cellular stresses. 
Although abundantly expressed in a variety of tissues, a role for MT-II in promoting neuronal 
survival has been demonstrated (Trendelenburg et al., 2002; Chung et aI., 2003). It has also been 
identified among potential targets of the transcription factor OTX2 (Zakin et aI., 2000). 
I have also characterized, by bioinformatics, several novel genes identified in this study as being 
differentially regulated by FGF-2. The clone 23G encodes a protein, which has been termed 
23 Gl NAT, with high homology to the yeast Mak:3p acetyltransferase and shares consensus 
sequences with a group ofN-acetyltransferases (NATs). Eighty five percent of eukaryotic proteins 
are subjected to N-terminal acetylation which is catalysed by NATs. These enzymes transfer an 
acetyl group from acetyl-CoA to the termini of a-amino groups of different proteins (polevoda and 
Sherman, 2000). In yeast 3 different NATs: Nat A, Nat B, Nat C act on different substrates having 
different N-termini. Nat A is a complex of2 genes NAT1 and ARDl. Mutations in both natl and 
ardl are characterized by a lack of NAT activity, slower growth of the yeast strain, failure to 
sporulate and failure to enter the Go phase of the cell cycle. A mouse homolog of NAT 1 (mNAT1) 
has been shown to be preferentially expressed in the developing brain, with high mRNA levels in 
proliferating undifferentiated regions. mNATl is then down-regulated as the cells differentiate into 
mature neuronal cells (Sugiura et aI., 2003). N-acetylation is a prerequisite for function for some 
proteins and can also regulate processes such as gene expression and nuclear import. Yeast Mak:3, 
the catalytic subunit of NatC is involved in the N-acetylation of the L-A viral major coat protein 
gag, which is essential for viral assembly (polevoda and Sherman, 2000). Lack of the N-terminal 












In future it will be important to investigate whether 23G identified in this study has any NAT 
activity, and if it does, what are the specific targets of this translation modification. It will also be 
necessary to investigate whether the N-acetylation of these targets has any biological significance 
especially during neuronal differentiation. 23GINAT is predicted to be a transmembrane protein, 
but it contains a putative NLS on its cytoplasmic domain that may target it to the nucleus. It is 
likely then that the activity of 23GINAT may be regulated by a proteolytic cleavage of its 
intracellular domain (similarly to the processing of Notch-I) which then trans locates to the nucleus 
to N-acetylate nuclear target proteins. 
The conceptual protein sequence of the 20C3/Armet gene is characterized by the SAP/SAF-Box 
like domain, a bihelical DNA binding domain that binds to genomic scaffold attachment regions 
(SARs). SARs are AT rich regulatory elements observed close to transcriptional enhancers. They 
have been implicated in chromosomal organization and in regulation of gene expression. The SAF-
Box was first identified in human scaffold attachment factor A (SAF-A) protein and has since been 
found in other non-orthologus proteins (Aravind and Koonin, 2000; Kipp et al., 2000). The binding 
capacity of the SAF-Box to SARs has been shown experimentally (Kipp et aI., 2000). The 
functions of most SAR binding proteins are not known but they may be important for replication, 
gene transcription, proliferation or differentiation. Deletion of the SAF-Box of the SAF-A protein 
has been demonstrated to result in decrease in the proliferation of the MCF-7 cells (Kipp et al., 
2000). To determine whether Armet is also SAR binding protein we would need to conduct a series 
of studies to demonstrate the binding capacity of the predicted SAF-Box like domain to SAR. 
In conclusion, differential display was used to characterize the gene expression patterns in OP27 
cells in response to FGF-2 treatment. Among the genes identified in this study were transcripts that 












regulated by FGF-2. Several other genes, whether up- or down-regulated have not been 
characterized before. These may represent useful markers to characterize the early stages of 
olfactory neuronal differentiation. The role of these transcripts could be explored by manipulating 















The main objective of this project was to study the effects of fibroblast growth factor-2 ~(FGF.-2) on the 
olfactory epithelium using an olfactory neuml precursor cell line, OP27 as a model system.! FGF-2 is a 
signalling molecule that has been implicated in various cellular processes during development, 
including mitosis, migmtion, and differentiation of various cell types. The 0P27 cell line was isolated 
by infection of primary cultures of olfactory epithelium from EIO.5 mouse embryos with retrovirus 
carrying tempemture sensitive allele of the SV40 large T antigen (Illing et aT., 2002). The retrovirus 
allows the cells to prolifemte at the pennissive temperature of 33°C, but the cells stop dividing when 
shifted to the non-permissive 39°C when the T antigen is inactivated. This cell line could thus be used 
as a in vitro model system to study neuronal differentiation in the olfactory epithelium. 
I have shown that the 0P27 cell line expresses only the main receptors for FGF-2, namely FGFR-I and 
FGFR-2. When treated with FGF-2 and cultured at the non-pennissive temperature, OP27 cells went 
through one round of cell division as assessed by thymidine incorporation. A gradual decrease in the 
rate of cell division then followed. This was accompanied by the appearance of cells that differentiate 
into cells with a bipolar morphology that was distinctly different from the cells at the permissive 
temperature. The number of the bipolar cells increased with time. In order to detennine whether the 
OP27 cells were undergoing neuronal differentiation at the biochemical level, the expression of well-
established markers that are consistent with differentiating neurons was studied in these cells using RT-
PCR, western blots and immunocytochemistry. The mRNA levels of GAP-43 which is a marker for 











with time, consistent with differentiating neurons in vivo. NCAM, also a marker for neurons 
downstream of GAP-43 , was up-regulated in 0P27 cells as they differentiate in the presence ofFGF-2 . 
• 
t 
Olfactory neuronal cells are hypothesized to select only one of the possible 1500 OR genes· to express 
as they begin to differentiate. The RT -PCR assay in combination with restriction eniyme digest 
analysis were carried out to establish whether FGF-2 induced 0P27 cells could express any 
endogenous OR genes and to determine whether these cells are restricted to express only one or a 
limited set of ORs. OP27 cells were found to express OR genes at the immature stage, before they 
could express OMP, a marker for mature ORNs. It was also demonstrated that 0P27 cells are not 
committed to express a single receptor. The choice of which OR genes to express was made each time 
the cells were induced to differentiate with FGF-2. The ORs identified in differentiating OP27 cells 
were found to be widely distributed in different chromosomes, an indication that these cells are not 
committed to express ORs that are clustered in the genome. 
I have also studied the expression, in OP27 cells, of various transcription factors (FoxGl, OlE-I, 
OTX2, RES-I, NGNl and NeuroD) and signalling molecules (Delta and Notch) that regulate cell fate 
choices at different stages in the differentiation of ORNs. While the expression of transcripts of some 
of these was not affected by FGF-2 treatment (viz. FoxgI, Otx2, OlE-I, and Notchl), others were 
differentially regulated. The mRNA transcripts of RES 1, an effector of Notch signalling and a known 
inhibitor of neuronal differentiation, were up-regulated by FGF-2 treatment within 24 hours, the period 
when OP27 cells were still proliferating. Hesl levels were maintained high even when OP27 cells 
were observe to differentiate into a bipolar morphology. This therefore suggested that RES 1 was 
required in a subpopulation of OP27 cells to inhibit neuronal differentiation. After 2 days following 












both the emergence of cells with a bipolar morphology and the increase in these cells with time. 
NeuroD, a marker of postmitotic progenitor cells that are beginning to differentiate, is not expressed by 
• 
OP27 cells at the non-differentiated state but when induced to differentiate, the cells are marked by a 
, .. , 
transient appearance of NeuroD mRNA transcripts downstream of both Ngn-l and D<!lta-l. NeuroD 
appeared after 24 hours after treatment with FGF-2 and remained until after 4 days. This "was a clear 
indication that these cells were indeed differentiating towards a neuronal phenotype. NgnJ which is 
transiently expressed by olfactory progenitors in vivo (Cau et al., 1997) is also transient in 
differentiating 0P27 cells. The transcription factor was expressed in OP27 cells at 33°C and until after 
48 hours in culture. 
The results summarized above therefore suggest that the behaviour of the 0P27 cells in culture is 
characteristic of differentiating ORNs. The cell line could thus be used as an in vitro model system to 
study the mechanisms involved in the control of neuronal differentiation. Such mechamisms may be 
underscored by coordinated regulation of gene expression. The differential display RT -PCR technique 
has been used to identify differentially expressed genes in 0P27 cells following FGF-2 induced 
differentiation. This was in an attempt to further increase our understanding of olfactory neuron 
development. I have identified genes that have been shown previously to be involved in neuronal 
development and genes that have not been characterized before. At present, it is difficult to correlate 
the function of the novel genes identified in this study to a role in neuronal differentiation. 
The DD screen used in this study employed only 24 primer combinations. It has been proposed that a 
selection of312 primer combinations would permit an almost complete analysis of the whole transcript 
pool. The number of primer combinations I have used here is considerably too low to allow for the 












olfactory progenitor cells. The use of the microarray technology in the model system described in this 
work should facilitate the characterization of a more global gene expression pattern (Tloti and llling, 
t 
work in progress). Nevertheless, it is hoped that genes identified in this screen will throw light on the ... 
t 
programme of gene activation that underlies neuronal differentiation and also ·the· molecular 
mechanisms by which FGF-2 influences olfactory neurogenesis. 
'" 
The characterization of the 0P27 cell line in this thesis indicates that it is potentially a very useful in 
vitro model to study both extrinsic and intrinsic mechanisms that are involved in the regulation of 
olfactory neurogenesis. The cell line can be used to investigate which of the FGF receptors expressed 
in 0P27 cells mediates the FGF-2 induced differentiation of these cells. The expression of the 
receptors in the OP27 cell line has been demonstrated using RT -PCR, we therefore do not know 
whether the 2 receptors are co-expressed in the same cell, or that a subpopulation of these cells express 
a single type of receptor and as a result acquire a distinct response to FGF-2. Immunocytochemistry 
with specific antibodies will be necessary to characterize the precise distribution of both receptors in 
the OP27 cell line, at the permissive temperature and in response to FGF-2 treatment at 39°C. 
Consequent to identifying the FGFR that is responsible for the FGF-2 induced neuronal differentiation, 
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List of clones identified in the differential display screen as being differentially expressed 
in OP27 cells following FGF-2 induced neuronal differentiation. The cDNAs were 
identified as being up- (1) or down-regulated U). PCR reamplifications of cDNAs that 
failed are indicated with a asterik while PCR reactions that resulted in the 00-
amplification of at least 2 PCR products in one tube are indicated by double asteriks. 
These were therefore not included in the reverse northern blot analysis. 
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